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Dmrt genes encode zinc finger transcription factors with important roles in sexual 
development as well as cell fate decisions in non-gonadal tissues. In zebrafish, two dmrt 
genes are expressed in overlapping domains of the early developing forebrain. Dmrt3 is 
expressed in the olfactory placodes and dorsal telencephalic regions. Dmrt5 is expressed in 
the telencephalon, olfactory placodes and the pituitary, as well as the ventral midbrain. I 
addressed the function of dmrt genes during forebrain formation in zebrafish by using knock-
down and knock-out approaches.  
Morpholino mediated gene knock-down of dmrt3 did not influence neurogenesis as 
expression of neurogenin was not affected suggesting a possible functional redundancy with 
the co-expressed dmrt5. In contrast, knock-down of dmrt5 revealed a crucial role during 
forebrain development by controlling neuronal differentiation and specification. In the dorsal 
telencephalon, dmrt5 knock-down resulted in the inhibition of differentiation and prolonged 
maintenance of early neuronal stem cell populations. Consequently, morphants developed a 
smaller telencephalon. In addition, dmrt5 was found to be involved in the development of the 
olfactory system. Morphants exhibited increased apoptosis of undifferentiated olfactory stem 
and/or progenitor cells and lacked proneural gene expression. This led to smaller noses and 
olfactory bulbs with reduced numbers of sensory neurons in dmrt5 morphants. Finally, also 
the pituitary, preoptic area and ventral midbrain were affected. These brain structures also 
displayed reduced neuronal differentiation and specification that eventually resulted in the 
lack of distinct neuro-endocrine cell populations such as corticotropic and gnrh2 expressing 
gonadotropic cells. The data obtained in this study show that a knock-down of dmrt5 affects 
neurogenesis in a tissue-dependent fashion independent of dmrt3. dmrt5 is a critical regulator 
of neuronal differentiation in the fore- and midbrain and of particular importance for the 
development of the telencephalon, olfactory system and the neuro-endocrine system. In 
parallel, I was able to knock-out dmrt3 in zebrafish by introducing frameshift mutations of 
variable length into the dmrt3 locus using zinc finger nucleases. These dmrt3 mutants provide 
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1.1 Dmrt genes 
Dmrt genes encode for doublesex and mab3 related transcription factors that are crucial for 
sexual development (Zarkower, 2001; Hong et al., 2007). Dmrt transcription factors are 
characterized by the presence of a DNA-binding DM domain (Fig. 1a), which was first 
described in doublesex (D. melanogaster) and mab3 (C. elegans) (Shen et al., 1988; Bownes, 
1994). The DM domain is an uncommon zinc finger domain with two conserved intertwined 
zinc binding motifs at the N-terminus and a non-conserved C-terminal tail. The function of 
the tail is to mediate DNA binding whereas zinc is necessary for proper protein folding. DM-
domain transcription factors bind into the minor groove of DNA leaving the opportunity for 
other transcription factors to bind to the major groove of DNA (Narendra et al., 2002; Huang 
et al., 2005; Murphy et al., 2007). 
DM-domain containing transcription factors are conserved within sex-developing pathways at 
rather downstream positions throughout different phyla, with the exception of dmrt1bY/DMY 
in medaka (Fig. 1b). They are expressed in primordial germ cells and in distinct cell 
populations of the gonads. Their gonadal expression regulates sex determination (Matsuda et 
al., 2002) or sex differentiation (Raymond et al., 2000; Guo et al., 2005; Kim et al., 2007). 
Remarkably, it seems that DM-transcription factors are conserved within sex-developmental 
pathways while no strict conservation can be found upstream of dmrt genes. This suggests 
that DM-containing transcription factors are the ancient conserved basis whereas the non-
conserved variable upstream parts of sex determining pathways evolved independently within 
different phyla (Matson et al., 2012). This hypothesis is furthermore supported by the partial 
interchangeability of dmrt genes between different species, e.g. a mab3 deficiency in C. 
elegans can be rescued by expression of male specific Drosophila dsx (Raymond et al., 
1998). However, target genes of conserved DM transcription factors are still largely unknown 






to mammals (right). Figure C kindly provided by C. Winkler. 
Zebrafish expresses at least five different dmrt genes (ZFIN database). An overview about the 
homologues of zebrafish Dmrt transcription factors are summarized as a phyllogenetic tree in 
Guo et al., 2004 (Guo et al., 2004). As transcription factors important for sexual development, 
dmrt genes are expressed early in the differentiating gonad as well as in the adult gonad 
(Winkler et al., 2004). Besides gonadal expression, dmrt genes are also expressed in restricted 
patterns in non-gonadal tissues, such as the presomitic mesoderm (Meng et al., 1999; Saude et 
al., 2005; Sato et al., 2010) and the nervous system (Guo et al., 2004; Gennet et al., 2010; 
Yoshizawa et al., 2011). Zebrafish dmrt2 is expressed in the presomitic mesoderm as well as 
in somites and is involved in the regulation of somitogenesis, myogenesis, establishing left-
right symmetry and positioning of organs (Meng et al., 1999; Saude et al., 2005; Sato et al., 
2010). Besides this, it is known from other dmrt genes that they are expressed in distinct 
regions of the developing nervous system, where they are involved in neuronal specification 
and differentiation. 
Fig. 1 Overall structure of Dmrt 
proteins, and their conserved position 
within sex-developmental pathways: A) 
Simplified scheme of the structure of 
DM-domain (red box) containing 
transcription factors. Besides the DM-
domain at the N-terminus of the protein, 
the C-terminal end contains a DMA 
domain (blue box) that is believed to 
mediate protein-protein interactions. The 
overview was generated using NCBI 
structure prediction programs 
(http://www.ncbi.nlm.nih.gov/Structure/c
dd/cdd.shtml) C) Dmrt genes encode 
transcription factors that are crucial 
during sex development. At least one 
member of this family was found to be 
involved in sex developmental pathways 









1. 2 Dmrt genes and their role during neuronal development 
It is known from different vertebrate models that several dmrt genes are expressed in the 
developing central nervous system (Guo et al., 2004; Gennet et al., 2010; Yoshizawa et al., 
2011) besides their gonadal expression at later stages.  
In Xenopus, Xdmrt4 expression starts in the anterior neural ridge and gets restricted to the 
olfactory placodes and the dorsal telencephalon at later stages. Its role during forebrain 
neurogenesis was demonstrated in Xdmrt4 morphants and mutants (Huang et al., 2005). 
Xdmrt4 regulates neurogenesis in the olfactory placode by acting as a transcriptional activator 
of the important proneural gene neurogenin. In Xdmrt4 morphants, neurogenin expression 
was down-regulated and olfactory placode development was severely impaired. As a 
consequence of failed neuronal differentiation, neuro-ectodermal stem cells of the olfactory 
placodes developed with a non-neural ectodermal cell fate instead of forming neural tissues 
(Huang et al., 2005). 
In chicken and mouse embryos, Dmrt5 is expressed in the olfactory bulb, the dorsal 
telencephalon and the ventral midbrain (Gennet et al., 2010). Dmrt5 over-expression in the 
naïve chicken neuroeptihelium led to the suppression of ventrolateral neuroepithelial cell fates 
and the up-regulation of ventromedial marker genes. As a consequence of the ectopic Dmrt5 
expression, neuroepithelial progenitor cells adopted medial midbrain cell fates. In addition, 
Gennet et al. (2010) showed that the overexpression of dmrt5 in neuralized embryonic stem 
cells can be used to induce elevated numbers of dopaminergic cells that are formed from 
ventral midbrain progenitor cells. These data suggest that Dmrt5 may act on early 
neuroepithelial cells by regulating midbrain progenitor specification and differentiation 
towards a dopaminergic cell fate.  
In zebrafish embryos, dmrt3 is expressed in the forebrain, olfactory placode and a subset of 
spinal cord interneurons. Its expression within these tissues starts between 14 hours post 
fertilization (hpf) to 20 hpf and ceases after 55 hpf (Rajaei, PhD Thesis 2012). To analyse the 
role of Dmrt3 in zebrafish, loss-of-function studies using antisense morpholinos were 
15 
 
performed. It was shown that Dmrt3 regulates specification and differentiation of distinct 
interneuron populations from P0 progenitor cells in the spinal cord of zebrafish embryos. 
Dmrt3 is required for the expression of a crucial determinant of spinal cord interneuron 
formation. In dmrt3 morphants, the expression of this fate determinant was reduced, which 
resulted in reduced numbers of spinal cord interneurons (Rajaei, PhD Thesis 2012) 
Additionally, dmrt5 is also expressed in the developing central nervous system of the 
zebrafish (Guo et al., 2004; Yoshizawa et al., 2011). Dmrt5 expression starts in the 
developing anterior neural ridge and gets restricted to the olfactory epithelium, the 
telencephalon and the ventral midbrain at 24 hpf. It was shown in a recent study using 
zebrafish dmrt5 mutants that her6 expression is ectopically up-regulated in the dorsal 
telencephalon. Her6 is a transcriptional repressor of neurogenin and prevents neuronal 
differentiation. As a consequence of the ectopic her6 up-regulation, dmrt5 mutants were 
characterized by neuronal differentiation defects in the dorsal telencephalon (Yoshizawa et 
al., 2011). Zebrafish Dmrt5 regulates neuronal differentiation in the dorsal telencephalon in a 
relatively similar fashion like it was described for Xdmrt4 in Xenopus. Moreover, since 
zebrafish do not have a dmrt4 gene, it seems that the Xdmrt4 function was taken over by 
Dmrt5 in zebrafish. 
These studies performed in various model organisms showed that the interference with DM-
transcription factor expression affects the formation of parts of the central nervous system 
from earliest neural stem cells as well as from more differentiated and committed neuronal 
progenitor cells. Therefore, it seems that several dmrt genes have conserved bi-functional 
roles during development: a) at late stages in gonads, where they regulate sex differentiation; 
and b) at early stages in the central nervous system, where they regulate neurogenesis from 
dmrt expressing neuronal stem- or progenitor cells to differentiated neurons. However, the 
underlying mechanisms of how dmrt genes regulate neurogenesis are still poorly understood 





During the development of the central nervous system, neuronal stem and/or progenitor cells 
give rise to differentiated neurons. The generation of mitotically inactive, but differentiated 
neurons from undifferentiated stem cells takes place in a step-wise manner and is called 
neurogenesis. The key components of neurogenesis are conserved between different phyla 
and will be discussed below.  
The very first step of neural development is the induction of a neural cell fate in the 
neuroectoderm. The neuroectoderm is formed during gastrulation and contains neuroepithelial 
stem cells with the potential to form epidermal as well as neural cells. The “default-mode” 
model of neural induction suggests that neuroepithelial cells develop into neural stem cells by 
default unless this neural cell fate is suppressed by Bmp signalling (Hemmati-Brivanlou et al., 
1997; Reversade et al., 2005; Reversade et al., 2005). However, recent data suggest that the 
“default-mode” model needs to be revised and is more complex as Wnt, Fgf, Igf and even 
Bmp signalling itself are involved in early neuroepithelial cell fate decisions (Hemmati-
Brivanlou and Melton, 1997; Bally-Cuif et al., 2003; Stern, 2005).  
1.3.1 Early neural stem cells and radial glia 
Neuralizing signalling pathways initiate the expression of neural specifiers in bipotential 
neuroepithelial cells which promote the commitment of these cells towards a neural fate. 
Among the very early expressed neural markers are sox1 and sox2 (Collignon et al., 1996; 
Mizuseki et al., 1998; Pevny et al., 1998; Graham et al., 2003), her6 (the zebrafish 
homologue of mouse Hes1) (Ishibashi et al., 1994; Pasini et al., 2001; Hatakeyama et al., 
2004; Scholpp et al., 2009) and pax6 (Krauss et al., 1991; Amirthalingam et al., 1995). After 
their initial commitment towards a neural fate, early neuralized neuroepithelial cells are 
proliferating to increase the pool of neural stem cells. During this initial proliferative phase, 
neural stem cells divide mostly symmetrically and give rise to two proliferative 
neuroepithelial daughter cells with the potential to form either glial or neuronal tissues (Rakic, 
1995). However, asymmetric cell division were also described for early neural stem cell 
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populations giving rise to neural stem cells and early neuron populations that are used as a 
primary framework to guide further cell movements of later born neurons (Kimmel et al., 
1991; Alexandre et al., 2010). After a phase of proliferation, early neural stem cells gradually 
change to another neural stem cell population with slightly different character. This gradual 
change from early to late derived neural stem cells is accompanied by a change of cell 
morphology from typical cylindrical neuroepithelial to bipolar shaped cells with long fibers 
and an oval nucleus (Rakic, 1972; Noctor et al., 2001; Noctor et al., 2002; Liour et al., 2003; 
Pellegrini et al., 2007). Based on their morphological features the later derived neural stem 
cell population will be further referred to as ‘radial glia cells’. Besides the morphological 
change, it is more common for radial glia cells to divide asymmetrically and give rise to 
different daughter cells, which can be committed neuronal progenitor cells with a determined 
neuronal fate and limited mitotically capacity as well as neurons, glia or glial progenitors 
(Fishell et al., 2003). Another difference between early stem cells and radial glia cells is that 
only radial glia cells are expressing marker genes such as glial fibrillary acidic protein: gfap 
(Levitt et al., 1980), monoclonal antibody radial cell 2: RC2 (Misson et al., 1988) and brain 
lipid binding protein: blbp (Feng et al., 1994). Therefore, it is possible to distinguish both cell 
populations based on their marker gene expression (Takizawa et al., 2001; Hatakeyama et al., 
2004). However, it is also noteworthy to mention that radial glia populations are very 
heterogeneous and distinct groups of neural stem cells may express different combinations of 
radial glia markers (Marz et al., 2010). 
1.3.2 Her/Hes genes 
It has been shown in different animal models that the maintenance of neural stem and 
progenitor cells is of great importance for the development of the central nervous system. One 
group of genes that supports neural stem cell maintenance is the group of hairy- and enhancer 
of split genes (Geling et al., 2003; Itoh et al., 2003), which were first described in Drosophila. 
The zebrafish and mice orthologous are called her and Hes, respectively. her/Hes genes 
encode for helix-loop-helix (HLH) transcriptional repressors that are important for the 
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maintenance of neural stem cell populations. The stem cell maintaining activity of Hes/Her 
proteins is achieved by antagonizing either the expression or the function of proneural basic 
helix-loop-helix (bHLH) genes and gene products, which are known to promote neuronal 
specification and differentiation (Akazawa et al., 1992; Sasai et al., 1992; Takke et al., 1999; 
Bae et al., 2005). It has been shown that the absence of her/Hes gene expression contributes 
to severe neuro-developmental defects due to the precocious up-regulation of proneural genes 
and the premature differentiation of neural stem cells towards neurons (Ishibashi et al., 1995; 
Geling et al., 2003; Hatakeyama et al., 2004). Furthermore, it was also found that the set of 
expressed her/Hes genes differ between early neural and radial glia stem cells. In mice, early 
stem cells are expressing Hes1 (zebrafish homologue: her6) and Hes3 (her3) but are negative 
for radial glia markers, while Hes1 and Hes5 (her15) expressing cells are also positive for 
radial glia markers (Hatakeyama et al., 2004). This illustrates that neuroepithelial cells can be 
distinguished from radial glia cells based on the sets of expressed her/Hes genes. At later 
stages of neural development, her/Hes gene expression is down-regulated and proneural gene 
expression is no longer suppressed. As a consequence, neural stem cells start to express 
proneural genes and neuronal specification and differentiation takes place (Skeath et al., 
1992; Blader et al., 1997; Kim et al., 1997; Kim et al., 1997; Guillemot, 1999). 
1.3.3 Notch signalling  
Neural stem cells are changing gradually. For the development of the full neuronal diversity, 
it is essential to maintain some of the neural stem cells until later when stem cell 
characteristics change (Ishibashi et al., 1995; Hirata et al., 2001; Nieto et al., 2001; Ohtsuka 
et al., 2001; Geling et al., 2003). Therefore, it is required to prevent that all neural progenitor 
cells are differentiating at the same time. This is achieved via “lateral inhibition”, which is 
mediated by Delta-Notch signalling between different neural stem cells (Greenwald et al., 
1992; Yoon et al., 2008). Notch is a transmembrane protein that is activated upon binding of 
its ligand Delta. At initial states, delta and notch expression is comparable in cells of the stem 
cell cluster (Fig. 2a/a’). At later stages, stochastic effects are generating slightly different 
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delta expression levels between different cells (Fig. 2b/2b’). As a consequence, these cells 
incorporate more Delta protein into their cell membrane. The increased binding of Delta to 
Notch molecules on neighbouring cells results in the cleavage of the Notch intracellular 
domain (NICD). The NICD translocates into the nucleus, where it binds to transcriptional co-
factors. These NICD-co-factor complexes then induce increased her/Hes gene expression 
(Bertrand et al., 2002; Cau et al., 2009; Fortini, 2009). As previously described, the 
expression of her/Hes genes results in the suppression of proneural gene expression, and thus 
prevents premature neuronal differentiation in neighbouring cells (Fig. 2c/2c’). Lateral 
inhibition was described to act at a population level in early neuroepithelial cells to hamper 
the development to more fate-limited neuronal progenitor cells (Mizutani et al., 2007), as well 
as at a single cell level in asymmetric dividing radial glia cells where lateral inhibition 
regulates the fates of the two daughter cells (Dong et al., 2012). While the Notch-signalling 
active cells remain mitotically active, the Notch-signalling negative daughter cell gives rise to 
neurons (Dong et al., 2012). Therefore, lateral inhibition is crucial for the correct timing of 
neural stem cell differentiation and the generation of the full neuronal diversity. 
Consequentially, mutations that result in the absence of Delta-Notch signalling contribute to 
reduced numbers of radial glia cells, increased numbers of early-born neurons and the absence 
of later-born neurons (Ishibashi et al., 1995; Itoh et al., 2003; Yoon et al., 2008). Contrary, 
the persistent expression of her/Hes genes in neural stem cells and the lack of proneural gene 
expression produce increased numbers of normally late-born glia at the expense of neurons 
(Nieto et al., 2001).  
1.3.4 Proneural genes 
A second essential group of genes involved in neurogenesis are proneural bHLH genes. 
Similar to her/Hes genes, proneural bHLH transcription factors govern neurogenesis at 
different hierarchical levels but with opposing effects to her/Hes genes. At early stages, 
proneural gene expression is induced by neuralizing signaling pathways in neuro-ectodermal 
stem cells at low levels, which defines prospective neural tissues. Her/Hes transcriptional 
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repressors restrict proneural gene expression and help to pre-pattern the forming central 
nervous system (Hirata et al., 2001; Geling et al., 2004). Pre-patterning becomes especially 
important during the development of organizers within the nervous system. Organizers, such 
as the mid-diencephalic organizer or the midbrain-hindbrain boundary, are structures that 
have patterning activity on surrounding tissues and do not develop to neurons. The ectopic 
expression of proneural genes in presumptive organizers leads to a loss of these structures and 
central nervous system patterning is heavily disturbed (Geling et al., 2004; Ninkovic et al., 
2005; Baek et al., 2006). Therefore, a persistently high expression of Hes/her genes is 
required to restrict proneural gene expression to defined proneural fields. At later stages, 
proneural genes are involved in neuronal specification and differentiation of progenitor cells. 
Paradoxically, proneural gene activity in the differentiating progenitor cells blocks proneural 
gene activity in neighbouring cell. This is mediated via an increased delta expression in 
differentiating cells, which enhances Notch signals in adjacent cells and fosters the 
suppression of proneural gene activity in surrounding neuronal progenitor cells (Fig. 2) (Lee, 
1997; Bertrand et al., 2002). This allows that only particular subsets of neurons differentiate 
at a distinct time point, while other progenitor cells are maintained in their stem cell niche 
(Cau and Blader, 2009; Fortini, 2009). Once single progenitor cells are determined to 
differentiate, they exit the cell cycle and start to express a second set of bHLH transcription 
factors that are particularly important for the maturation of these newborn neurons, for 




Fig. 2 Lateral inhibition and neuronal differentiation: A/A’) In radial glia cell clusters (grey), all 
cells express approximately identical levels of delta (blue) and notch (green/red). The binding of Delta 
to Notch, leads to the proteolytic cleavage of the intracellular domain of notch (NICD: red) on 
neighbouring cells. The NICD translocates to the nucleus and initiates her/Hes expression, which leads 
to the block of proneural gene expression and a down-regulation of delta expression. Since her/Hes 
mRNA and proteins are extremely unstable, suppression of delta expression persists only over a short 
time period before it gets up-regulated again (Kageyama et al., 2008; Shimojo et al., 2008). As all cells 
stimulate each other via the Delta-Notch signalling, cells in the whole radial glia cluster (red and blue 
double arrows in A) maintain each other in an undifferentiated state. B/B’) Upon the initiation of neural 
differentiation, proneural gene expression increases the expression of delta (bold) in the differentiating 
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radial glia cells (orange). As a consequence, Notch signalling is increased in the neighbouring radial 
glia cells (red arrows in B), which also leads to a reduced expression of delta in these cells. C/C’) 
Positive feedback loop between Delta and proneural gene products result in a further up-regulation of 
both and cells start to differentiate (brown). Adopted from (Alberts et al., 2002) 
It is noteworthy that studies in mice and zebrafish have shown that the expression of some of 
the her/Hes genes are initiated by Notch independent pathways before neuronal 
differentiation and specification can take place. It was shown in zebrafish that her5 expression 
is independent of Notch and probably initiated by local cues (Geling et al., 2003; Geling et 
al., 2004). Morpholino mediated knock-down of her5 resulted in the ectopic expression of the 
proneural genes neurogenin and coe2 and the loss of the MHB organizer structures (Geling et 
al., 2004). The zebrafish studies were complemented with results obtained in mice. 
Hatakeyama et al., 2004 described that Hes1/Hes3 positive neuro-ectodermal stem cells are 
Notch independent and delta-negative (Fig. 3-2), while later formed radial glia cells 
expressing Hes1/Hes5 and are also positive for Delta expression (Kageyama et al., 2008). 
Both papers indicated the multifunctional roles of her genes at different levels of 
neurogenesis i.e. a) at very early stages, where they act as pre-patterning factors defining 
prospective proneural competence fields (Fig. 3-2 to 3-3) and b) to select single progenitor 





Fig. 3 Overview over early neuronal development and involved marker genes: 1. During gastrulation 
undefined neuroectodermal cells are receiving multiple signal input from several neural inducing 
pathways. The combination of the received signals determines the future fate of the bipotential cells 
either to neural or epidermal cell fates. 2. Cells that were receiving neuronal signals are switching on 
further neural inducing gene expression such as sox2. These very early neural stem cells are expressing 
notch-insensitive her/Hes genes, which helps to determine proneural fields and the position of future 
organizers. 3. Once the prepatterning of neuronal fields is accomplished, early neural stem cells in 
these fields gradually change their morphology and character to radial glia stem cells. Radial glia 
populations are maintained via Delta-Notch signaling until later stages and the expressed her genes are 
Notch-dependent. 4. Radial glia divides asymmetrically and gives rise to neurons. Lateral inhibition 
prevents the synchronous differentiation of neighbouring radial glia cells and maintains radial glia cells 
in their stem cell niche till later time points. 
1.                                                2.                                            3.                                               4. 
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In summary, the development of differentiated neurons from neuroectodermal stem cells is 
regulated in a tightly controlled spatio-temporal manner. Hes/Her and proneural basic helix-
loop-helix transcription factors are playing essential roles during this process, mainly via 
mediating opposing effects. While Hes/Her proteins usually block neuronal development and 
maintaining neuronal stem cell characteristics, proneural bHLH proteins promote neuronal 
determination, specification and differentiation. The correct balance of neuronal promoting 
and blocking bHLH factors is the key to a normal neuro-development and perturbations in 
that balance very often results in an impaired development of the nervous system. 
1. 4 Zinc finger domains 
Recently developed techniques allow a targeted knocking-out of specific genes of interest in 
zebrafish. One of these techniques is making use of zinc finger nucleases (ZFN), which are 
fusion proteins of multiple zinc finger domains with a DNA cutting endonuclease.  
Zinc finger domains (ZFD) are DNA binding protein domains that can be commonly found in 
DNA interacting transcription factors (Brayer et al., 2008). More than 20 different groups of 
ZFD are described and one common characteristic between them is the formation of zinc-ion 
stabilizing structures (Matthews et al., 2002; Krishna et al., 2003).  
The most common group of ZFD are called C2H2 zinc fingers since the essential zinc ion is 
bound by two Histidine and two Cysteine residues within the domain (Fig. 4a). The biological 
importance of this particular group of ZFD is reflected by the high percentage of C2H2 ZFD 
containing proteins within the eukaryotic proteome. Almost 3% of the human proteome and 
2% of the zebrafish proteome contain proteins with a C2H2 domain (Kersey et al., 2005).  
C2H2 ZFDs are approximately 30 amino acids long and form two N-terminal β-sheets and 
one C-terminal located α-helix. The zinc binding amino acid residues can be found in the two 
β-sheets as well as within the α-helix (Fig. 4b). The DNA-binding is mediated by seven amino 
acids at the N-terminal end of the α-helix, especially amino acid residues -1, 2, 3 and 6 
(Elrod-Erickson et al., 1996). These amino acid residues are mediating the binding to a 
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specific nucleotide triplet within DNA. The binding to longer DNA target sequences are 
mediated by assemblies of multiple ZFDs. In zinc finger nucleases, the ZFDs are linked to the 
next domain via a five amino acid long linker. The connection of different ZFDs to one larger 
assembled zinc finger protein may influence the binding of single modules to their target 
sequence. The reason for this is that distinct ZFD can bind to their particular nucleotide triplet 
as well as to single nucleotides in the neighbouring triplet (red connection, Fig. 4b). This 
interaction may influence the sterical binding of adjacent domains and shows that the modular 
context is very important for the binding affinity of an assembled ZFP even if single ZFD are 
binding to their target triplet per se.  
 
Fig. 4 Structure of C2H2 zinc finger domains and their binding to distinct nucleotide triplets: C2H2 
zinc finger domains contain approx. 30 amino acid residues. A) The zinc ion (black circle) is bound by 
two Histidine (H) residues within the β-sheets (blue arrows) and two Cysteine (C) residues in the α-
helix (green helix). B) The DNA binding is mediated by seven amino acids at the N-terminal end of the 
α-Helix. Especially the amino acid residues at helix positions -1, 2, 3 and 6 are important for mediating 
the binding to a particular nucleotide triplet (grey connection) within the DNA. Note that one ZFD may 
also interact with nucleotides in neighbouring triplets (red connection). This can influence the binding 
of adjacent ZFD when assembled in ZFP. Nt= N-terminus; Ct= C-terminus. Image adapted from Brayer 








The fact that the specificity of DNA-binding is only mediated by a maximum of seven amino 
acids within one module makes it feasible to customize the DNA-binding motif in a way that 
it binds to any target triplet. Furthermore, by linking different engineered modules with each 
other, it is theoretically possible to generate ZF proteins that bind to any desired nucleotide 
target sequence. The customizability of ZFDs and their ability to form larger DNA-binding 
assemblies makes zinc finger proteins a bio-molecular tool that can be used to modify DNA 
when fused to endonuclease domains. 
1.5 Zinc finger nucleases 
Zinc finger nucleases (ZFN) are artificially designed fusion proteins of multiple ZFDs fused 
to the endonuclease domain of the restriction nuclease FokI. This fusion protein unites the 
specific DNA-binding ability of the ZFDs with the unspecific nuclease activity of the 
restriction enzyme FokI. The zinc fingers are used to target the restriction enzyme to a 
specific site within the genome whereas FokI induces DNA double strand breaks (Bibikova et 
al., 2001; Cathomen et al., 2008). The endonuclease activity of the FokI domain gets only 
activated as a dimer (Smith et al., 2000) and therefore it is necessary to use a second ZFN that 
binds specifically at a target site 5 to 7 bp up- or down-stream of the first ZFN binding site. 
To generate a knock-out of a gene, thus both ZFNs have to bind to their target sites since only 
then the two nuclease domains will be in close spatial proximity and the endonucleases 
become active. The DNA cut will be introduced in the 5 to 7 bp long spacer flanked by the 
two target sites. One target site contains 3 to 4 triplets. Since two binding sites are used, the 
overall length of the target site contains 18 bp which is long enough to determine a unique 
binding site (probability = 1/6.87x1010) within the zebrafish genome (zebrafish genome: 
1.56x109 base pairs according to Ensemble.org). 
To reduce the chance of unspecific off-target cleavages outside the determined target site 
even further, two different endonuclease domains with modified dimerization interfaces are 
used. This modification prevents the homodimerization of one ZFN with itself and therefore 
unspecific cleavage at other target sites where the right and the left binding site are identical. 
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The two used endonuclease domains are therefore called FokI-RR and FokI-DD reflecting the 
amino acid residue change within their dimerization interface (Meng et al., 2008). 
1.6 ZFN knock-outs in zebrafish 
One of the first successful knock-out that was described in zebrafish was performed by Doyon 
et al., 2008. The no tail as well as the golden gene were knocked-out with 4-domain ZFNs. 
Embryos into which ZFN encoding mRNA was injected showed an obvious phenotype and 
the knock-out efficiency of the method was between 20 to 30%. Furthermore, knock-outs of 
these genes were verified by sequencing the targeted sites and insertions as well as deletions 
could be identified around the spacer region. In addition, it was possible to identify founder 
fish that inherited these gene modifications to the next generation. This proof-of-concept 
experiment showed that a ZFN mediated knock-out, as it was already described for X. laevis 
(Bibikova et al., 2001) as well as D. melanogaster (Bibikova et al., 2002), was now also 
available for D. rerio (Doyon et al., 2008). 
1.7 Aim of this project 
Dmrt genes are essential regulators of sexual developmental pathways that are conserved 
across different animal phyla. In addition, several members of the dmrt family are also 
expressed in the central nervous system of vertebrates. Zebrafish dmrt3 is expressed in the 
olfactory placode, the dorsal telencephalon and a distinct subset of spinal cord interneuron 
progenitors. In the spinal cord, it regulates the specification and differentiation of V0 
interneurons (Rajaei, PhD Thesis 2012). The function of dmrt3 in the olfactory bulb and the 
dorsal telencephalon are unknown so far but its described role during spinal cord progenitor 
differentiation suggests that dmrt3 may have a similar role during neurogenesis in these 
forebrain regions. In Xenopus, it was previously shown that XDmrt4 regulates cell 
differentiation in the olfactory placode via the positive regulation of proneural gene 
expression (Huang et al., 2005). It was shown that mammalian Dmrt5 promotes dopaminergic 
neuron formation when over-expressed in neuralized embryonic stem cell cultures (Gennet et 
al., 2010). In addition, it has been reported that Dmrt5 is an important regulator of neuronal 
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differentiation in the dorsal telencephalon of zebrafish (Yoshizawa et al., 2011). From these 
studies it seems that dmrt genes may have a second important role during neuronal 
development in vertebrates besides controlling sexual development. Importantly, however, the 
underlying mechanisms regulating vertebrate neurogenesis are still poorly understood.  
The aim of this study was to analyse the function of zebrafish dmrt3 and dmrt5 during 
forebrain development and to gain insights into the underlying regulatory mechanisms. Of 
particular interest was the question, whether in regions with overlapping expression both 
genes govern neuronal development in a gene-specific or alternatively a fully or partially 
redundant manner. To answer these questions, I knocked-down both genes using antisense 
morpholino techniques and evaluated if dmrt morphants showed neurogenesis defects. These 
morpholino studies revealed various roles of Dmrt5 during neurogenesis in multiple brain 
regions. These data extend data recently published by Yoshizawa et al. (2011), and provide 
further insight into their proposed model of Dmrt5 function for the development of the dorsal 
telencephalon. Aim of my thesis also was to address processes in the other fore- and midbrain 
regions where dmrt5 is expressed during neurogenesis and to analyze whether Dmrt5 is 
crucial for neuronal differentiation in these distinct brain regions.  
In addition, since the knock-down of dmrt3 by antisense morpholino injection was not 
sufficient to interfere with dmrt3 function during forebrain development, loss-of-function 





This chapter describes the used methods while a completed list of all used Materials such as 
oligos, plasmids, chemicals and equipment can be found in the Appendix A2. 
2.1 Fish husbandry 
Zebrafish were kept in the fish facility of the Department of Biological Sciences, NUS under 
a 14 h light/10 h dark cycle. Water quality, photoperiod and temperature were kept constant 
and controlled daily. To produce eggs, mature fish were set up pair wise in separate mating 
tanks. On the next morning, mating was induced by removing the spacer between male and 
female. Eggs and embryos were collected and raised in 1x Danieau’s solution at 28°C until 
they developed to the required stage. Staging was done according to Kimmel (Kimmel et al., 
1995). To suppress pigmentation, embryos were treated with 1-phenyl 2-thiourea (PTU, 
Sigma) at a final concentration of 0.003% after embryos reached gastrulation stage. All 
experiments were performed in accordance with approved NUS IACUC protocols no 082/10. 
2.2 Fixation of embryos and adult tissues 
Zebrafish embryos were fixed at the desired stage with 4% w/v paraformaldehyd 
(PFA)/phosphate buffer saline (PBS) solution for further analysis. If required, embryos were 
manually dechorionized using watchmaker forceps before they were fixed. Incubation of 
embryos in PFA was done overnight, if not mentioned otherwise (modified for 
immunostaining protocols: chapter 2.6). Following the fixation step, embryos were washed 
three times for 5 min and subsequently stored in 100% methanol at -20°C. 
2.3 Gene knock-down by Morpholino injections 
Morpholino stock solutions were prepared by resuspending lyophilized morpholino to a final 
concentration of 25 mg/ml. This stock was further diluted in Milli-Q water to morpholino 
working solutions with the desired concentration of the morpholino. Before use, working 
solutions were heated up to 65°C before they were shortly incubated on ice and loaded into 
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glass capillaries. Glass capillaries (Harvard Apparatus) were prepared with a needle puller 
(Narishige). The exact sequences of used morpholinos can be found in the table below. 
Table 1: Used morpholinos and their sequences 
Name of morpholino 5’ to 3’ sequence  Reference 
dmrt3 splice up TGAGAAAGCGGTTACCTTGCGGTGT  Flora Rajaei; PhD thesis 2012 
dmrt3 splice down TCACTTAGGTCTGGAAAACACACAC Flora Rajaei; PhD thesis 2012 
dmrt3 mismatch TCAGTTAGCTCTGCAAAAGACAGAC Flora Rajaei; PhD thesis 2012 
dmrt5 splice up AACGTTTCTACTTACCAGAGTTTGA This study 
dmrt5 splice down TTTGATTCTCCTGGAATAGATTTGT This study 
dmrt5 scrambled (referred to 




her6 morpholino TATCGGCAGGCATCTTCTCTGGGAA Pasini et al., 2004 
p53 morpholino GCGCCATTGCTTTGCAAGAATTG Robu et al., 2007 
 
Morpholino working solutions were injected into the yolk of 1-cell stage embryos using an 
Eppendorf microinjector by means of applied air pressure. The injected droplet volume was 
around 0.5 to 1 nl per embryo. Injected embryos were transferred and kept in 1x Danieau’s 
solution at 28°C. Unfertilized and death eggs were discarded 6 hpf. Survival rates and, if 
present, alterations of morphological features were noted once daily. 
2.4 Molecular biology procedures 
2.4.1 RNA isolation 
Zebrafish RNA was isolated using Qiagen’s RNAeasy kit. The isolation of RNA was done 
according to the manufacturer’s manual. In short, 25 embryos were transferred into a 1.5 ml 
Eppendorf tube and manually homogenized in 350 µl RLT/β-Mercaptoethanol using a pestle. 
The homogenized embryos were well mixed with 70% ethanol and subsequently transferred 
onto RNA affinity columns. The columns were centrifuged to separate cell debris from 
column-bound RNA. Next, the filter material was washed several times with washing buffer 
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and the RNA was eventually eluted using RNAse free water. To remove traces of genomic 
DNA, the RNA was incubated for 30 minutes with 1 µl of DNAseI (Fermentas) at 37°C. The 
DNAse treated RNA was further purified with the RNeasy kit according to the RNA clean-up 
protocol. Briefly, RNA was mixed with RLT buffer and 100% ethanol and the mix was 
transferred onto RNA affinity columns. The columns were washed several times with 
washing buffer RW and RPE. Following that, the RNA was eluted from the columns with 100 
µl of RNAse free water.  
2.4.2 Phenol-Chloroform clean up 
To separate RNA from protein contamination, an acidic phenol-chloroform clean up was 
performed. For that, the eluted RNA was mixed with 100 µl phenol-chloroform, pH5.3 
(Amresco) and 50 µl 1:1 chloroform/isoamylalcohol mix (Merck). The tubes were vortexed 
and centrifuged at full speed for 5 min. After the centrifugation, two phases were visible and 
the RNA-containing upper phase was transferred to a new tube and mixed with Chloroform in 
a 1:1 ratio. The mixture was vortexed and subsequently centrifuged for 5 min. Two phases 
were formed and the aqueous RNA containing phase was transferred into a new 1.5 ml 
reaction tube. 
2.4.3 Sodium-acetate and ethanol precipitation 
To increase the concentration of the isolated RNA, the eluate was precipitated overnight at -
20°C with 1/10 volume 3 M NaAc, pH 5.3 (Sigma) and 2.5x volume of 100% ethanol. On the 
next day, the precipitated RNA was pelleted by centrifugation at full speed in a cooled table 
top centrifuge (45 min, Sorvall) and the supernatant was discarded. The RNA pellet was 
washed with 1 ml of 70% ethanol and the centrifugation step was repeated. Supernatant was 
discarded and the pellet was air dried and dissolved in 20 µl Milli-Q water. Finally, the RNA 
was quantified using a nano-drop photo spectrometer (WPA), and RNA aliquots were stored 




2.4.4 Reverse transcription 
To synthesize cDNA, “RevertAid first strand cDNA kit” (Fermentas) was used. 2 µg of total 
RNA was mixed with 2 µl of random hexamer primer (0.2 µg/µl), heated up to 70°C and 
cooled down to room temperature to anneal primers to their target sites. In the next step, 
reaction buffer, dNTPs and RNAse inhibitor (20 units) was added to the RNA. The reaction 
mixture was split into two separate reactions, one with reverse transcriptase (200 units) and 
the second without reverse transcriptase. The reaction without the reverse transcriptase was 
used as a negative control for testing for contamination with genomic DNA. Both reactions 
were incubated at 42°C for 1 hour. Reactions were stopped by heat inactivation of reverse 
transcriptase at 70°C. The synthesized cDNA was stored at -20°C and used as a PCR template 
for further reactions. 
2.4.5 Semi-quantitative PCR/ splice assay 
This protocol was used to evaluate the efficiency of the used dmrt splice-blocking 
morpholinos and based on a semi-quantitative PCR protocol (table 2). 
Table 2: Semi-quantitative PCR protocol 
Reagent Volume/Amount Final conc. 
 
Temperature Time Cycles 
cDNA 0.2 µl - 98°C 40 sec  
10 mM Primer forw. 2.5 µl 0.5 mM 98°C 10 sec 
35 cycles 10 mM Primer rev. 2.5 µl 0.5 mM 60°C 10 sec 
10 mM dNTPs 1 µl 0.2 mM 72°C 20 to 45 sec 
100% DMSO 1.5 µl 3% 72°C 10 min  
5x HF buffer 10 µl 1x 
Standard protocol for Phusion- PCR. The annealing 
temp. was 60°C unless stated otherwise. 
Phusion polymerase 
 
0.5 µl 0.5 U 
Milli-Q water up to 50 µl  
 
First, the relative amounts of cDNA from control and dmrt5 morpholino injected embryos 
were determined based on the expression of housekeeping gene gapdh (Sequence: Appendix 
A.2). Next, normalized amounts of cDNAs were used and splice test PCRs were set up and 
performed as stated in table 2 in a Veriti or Biometra thermocycler. Used primers were 
binding in exon sequences flanking the introns of dmrt5 or fezf2 (primer sequences are given 
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in Appendix A2). Correctly spliced transcripts and intron-retaining transcripts could be 
separated according to their size by means of gel electrophoresis. The relative amount of 
amplified PCR products were measured based on the intensity of PCR bands on the gel using 
ImageJ. The splice blocking efficiencies were calculated based on these intensity value 
differences between controls and dmrt5 morphants. A summarizing flow chart of this method 
is shown in figure 5. 
 
Fig. 5 Flow chart semi-quantitative PCR: The chart above summarizes the steps that are required to 
determine the splice blocking efficiencies of used morpholinos. 1) Normalization of cDNA amounts 
based on the expression of housekeeping genes, and 2) Determination of the splice blocking efficiency, 
based on the amplification of gene specific spliced- and intron-retaining transcripts.  
2.4.6 Amplification of gene specific cDNA templates 
To amplify DNA templates for riboprobe or mRNA preparations, 0.2- 1 µl of stock cDNA 
was mixed with the reagents according to table 2. To minimize the chance of sequence errors 
by amplification, proof-reading “Phusion” polymerase (Finnzymes) was used. PCR products 
were analysed on a 1% TAE gel and isolated with a gel extraction kit (2.4.8). 
2.4.7 Separation of PCR products by gel electrophoresis 
1% agarose gels were prepared by dissolving 1 g of agarose (1st Base) in 100 ml of 1x TAE 
(50x TAE: 242 g Tris Base, 57.1 ml Glacial Acetic Acid,100 ml 0.5 M EDTA) buffer. 5 µl of 
20000x concentrated Sybr-safe DNA stain (Invitrogen) was added to the agarose gels and 





solidified agarose gels were loaded with DNA or RNA samples and DNA/RNA ladders 
(Fermentas). Before loading the samples into the agarose wells, reaction products were mixed 
with loading dye (Fermentas) at a 10:1 ratio. Gel electrophoresis was performed at a constant 
voltage of 90V using a Bio RAD power pac for 30 to 60 min. DNA/RNA bands were 
visualized and documented using a G: box gel documentation system (Syngene). Fragments 
of interest were cut out with sterile lancet blades and isolated using a Promega gel extraction 
kit. 
2.4.8 Isolation of DNA from agarose gels 
DNA bands were visualized with a UV-transilluminator (WISD) and fragments of correct size 
were cut out from the gel. The DNA was isolated from gel fragments with a “Wizard® SV 
Gel and PCR Clean-Up” kit (Promega) according to the manufacturer’s instructions. After the 
extraction of DNA from gel fragments, DNA was quantified measuring the absorbance at 
260nm using a photo-spectrometer (WPA). 
2.4.9 Cloning of PCR fragments flanked by restriction sites 
2.4.9.1 Amplification, clean-up and digestion of PCR products and plasmids 
Column-purified PCR products that contained unique flanking restriction sites were digested 
with appropriate restriction enzymes and reactions were set up according to table 3. Around 1 
µg of DNA per 20 µl reaction volume was used. The used restriction enzymes were purchased 
from Fermentas or NEB and reaction conditions were optimized using the recommended 
restriction buffer.  
Table 3: DNA digestion reaction set up 
Reagent Volume/Amount Final concentration 
DNA 1 µg  
Restriction enzyme 1 µl 10 U/rxn 
Restriction buffer 2 µl 1x 
BSA (optional) 0.02 µl 1x 
Milli-Q water Add to 20 µl  
Digests were incubated for at least 2 hours at 37°C. The digestion reactions were stopped by 
heat-inactivating the enzymes at 65°C or 80°C. In parallel to insert digestions, plasmid 
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vectors of interest were linearized with the same restriction enzymes as the inserts using an 
identical reaction set up.  
2.4.9.2 Phosphorylation and dephosphorylation of PCR fragments and linearized 
vectors 
To increase the ligation efficiency and prevent religation of digested plasmids, 
phosphorylation of insert and dephosphorylation of plasmids were done according to the 
manufacturer’s protocols. For the phosphorylation of inserts, T4 polynucleotide kinase (T4 
PNK, Fermentas) was used. For dephosphorylation of linearized plasmids, shrimp alkaline 
phosphatase (SAP, Fermentas) was used. ATP and enzyme were added directly to the heat 
inactivated digestion reactions. 
Table 4: Phosphorylation and dephosphorylation set up  
T4 PNK reaction SAP reaction 
Reagent Amount Reagent Amount 
Linear ds DNA 1-20 pmol of 5’-termini Linear DNA (~3 kb plasmid) 1 μg (~1 pmol termini) 
10 mM ATP 1/10 of final volume, 1 mM 
Shrimp Alkaline Phosphatase 1 μl (1 U) per pmol of 5’ termini 
T4 Polynucleotide Kinase 1 μl (10 U) per pmol 5’ termini 
Reactions were carried out for 30 to 60 min at 37°C and subsequently purified using phenol- 
chloroform protocol similar to the previously mentioned protocol (see 2.4.2). The difference 
to the first protocol is that the phenol-chloroform solution had an increased pH of 8. 
Following the clean-up, the DNA was precipitated as described in 2.4.3.  
2.4.9.3 Ligation reaction 
Precipitated inserts and linearized vectors were mixed together in a molecular ration of 3:1. 
T4 ligase buffer (NEB) was added to a final concentration of 1x, 1 µl of T4 ligase (NEB) was 
added and the reaction was topped up to a final volume of 20 µl with water. Ligation 




2.4.10 Subcloning of riboprobe templates 
For in-situ probe production, pDrive (Qiagen), pJet (Fermentas) or TOPO-blunt end ligation 
kits (Invitrogen) were used. For amplicons generated with Taq-polymerase, the pDrive vector 
was used. For blunt end PCR products generated with Phusion polymerase, either pJet or 
TOPO blunt end vectors were used. Purified amplicons were added to the plasmids in a 
molecular ratio of 3:1 and reaction mixtures were set up according to the kit instructions. The 
reaction was incubated at room temperature (RT) for 1 hour and subsequently transformed 
into chemical competent DH5α cells.  
2.4.11 Transformation of plasmids into bacteria 
Ligation reactions were stored on ice for 5 minutes before 1-5 µl of the reaction were 
transferred and mixed with 100 µl of chemical competent E.coli, strain DH-5α. Bacteria were 
incubated for 30 min on ice before they were exposed to a 42°C pulse over 35 sec. After the 
heat shock, 250 µl of LB-media were added to the bacteria and they were incubated for 1 h in 
a thermo shaker (Infor). After that, bacteria were plated out on LB-agarose plates. LB-agarose 
plates contained either 50 mg/l Kanamycin or 100 mg/l Ampicillin, depending on the used 
plasmids. LB-plates were incubated at 37°C for 12-16 h until single bacterial colonies became 
visible.  
2.4.12 Colony-test PCR  
Single bacterial colonies were tested for the presence of the desired plasmid by colony-test 
PCR. Either a set of gene-specific primers, two insert flanking vector-specific primers (M13 
rev/forw or Sp6/T7) or a combination of vector-specific and gene-specific primer were used 
during the PCR. Bacterial colonies were directly used as templates for the PCR reaction and 
mixed with reagents as stated in table 5. Before the bacterial colony was mixed with the PCR 
reagents, the bacteria were transferred onto the surface of a fresh LB-plate (with the 
respective antibiotic). Growing bacteria contained the same plasmid as the PCR-tested sample 
and were used a plasmid stock for later applications. 
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Table 5: Colony-test PCR reaction protocol 
Reagent Volume/Amount Final conc. 
 
Temperature Time Cycles 
Bacterial template - one colony  95°C 10 min  
10 mM Primer forw. 1 µl 0.5 mM 95°C 30 sec 
35 cycles 10 mM Primer rev. 1 µl 0.5 mM 58°C 30 sec 
10 mM dNTPs 0.5 µl 0.25 mM 72°C 30 -60 sec 
25 mM MgCl2 1 µl 1.25 mM 72°C 3 min  
10x Taq reaction buffer 
with (NH4)2SO4 
2 µl 1x 
 
Taq polymerase 0.5 µl 2.5 U/rxn 
Milli-Q water Up to 20 µl  
PCR products were analysed on a 1% TAE gel by means of gel electrophoresis and positively 
tested colonies were transferred from the safety plate into 2- 5 ml of fresh LB medium 
(Becton Dickinson). Cultures were incubated overnight at 37°C under vigorous shaking at 
225 rpm (Infors). 
2.4.13 Isolation of plasmid DNA and preparation of bacterial glycerol stocks 
Plasmids from overnight cultures were isolated using “Promega Wizard plus DNA 
purification kits” according to the supplier’s manual. Overnight cultures were centrifuged and 
bacteria were pelleted and separated from the media. The bacteria were lysed and the lysates 
were transferred to the provided DNA affinity columns. The columns were spun and washed 
several times before the plasmids were eluated with Tris-EDTA (TE) buffer or Milli-Q water.  
In parallel to the isolation of bacterial plasmid DNA, 0.8 ml of overnight culture was mixed 
with 0.6 ml 100% glycerol (AppliChem), vortexed for 30 sec and stored at -80°C. Bacterial 
glycerol stocks can be stored long-term and were used, if plasmid propagation was necessary.  
2.4.14 Sequencing reaction 
To confirm the identity of isolated plasmids or amplified PCR products, sequencing reactions 
were carried out using a BigDye Terminator v3.1 Cycle Sequencing Kit (Applied 
Biosystems). 50 to 200 ng of purified DNA were mixed with 1 µl 10x BigDye buffer, 2 µl 
BigDye reaction mix, 1 µl of the appropriate sequencing primer and topped up to 10 µl with 
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Milli-Q water. Sequencing reactions were performed in a PCR machine and reaction settings 
are stated below. 
Table 6: Sequencing protocol 
Temperature Time Cycle number 
96ºC 1 min 
25 cycles,  
annealing temperature primer dependent 
96ºC 15 sec 
50ºC 10 sec 
60ºC 4 min 
After the reaction, sequencing products were precipitated according to protocol 2.4.3 and the 
pelleted DNA was air dried for 10 min at room temperature. Sequencing products were 
electrophoretically separated in a Abi3130x1 sequencer (Applied Biosystems) and resulting 
chromatograms were analysed using BioEdit v7.0.5.2 
2.4.15 mRNA synthesis 
To produce capped mRNA for zebrafish injections, 1-2 µg of linearized plasmid DNA was 
mixed with mMESSAGE mMACHINE Kit (Ambion) reagents as described in table 7. After 2 
h of incubation at 37°C, 1 µl of DNAse (Fermentas) was added to the reaction mix and 
incubated for another 30 min. 
Table 7: mRNA synthesis reaction mixture 
Reagent Volume/Amount Final concentration 
linearized plasmid 1 µg  
10x reaction buffer (either T7 or SP6) 2 µl 1x 
2x NTP/CAP solution 10 µl 1x 
SP6 or T7 RNA polymerase 2 µl  
RNAse free water Ad to 20 µl  
Proper polyadenylation is required for efficient translation and increased stability of the 
synthesized mRNA. To ensure correct polyadenylation, plasmid-internal polyadenylation sites 
were used. However, for some of the used plasmids it was not possible to linearize the 
plasmid 3’ of the poly-A signal without digesting the mRNA encoding sequence. Hence, 
poly-A tails were added to transcribed mRNAs during an additional polyadenylation reaction 
step using E-PAP (Ambion). After the DNAse digest of DNA template in in-vitro 
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transcription reactions, the transcribed RNA was mixed with the following components 
according to the manual’s instruction. 
Table 8: Poly-A tailing reaction mixture 
Reagent Volume/Amount Final concentration 
mRNA 10 µl  
E-PAP 2 µl 4 U/rxn 
5x reaction buffer 10 µl 1x 
10 mM ATP solution 5 µl 1 mM 
25 mM MnCl2 5 µl 2.5 mM 
Milli-Q water ad to 50 µl  
The reagents were gently mixed and incubated at 37°C for 30 min. The efficiency of the 
polyadenylation reaction was evaluated by analysing untreated mRNA (after in-vitro 
transcription) next to treated mRNA (with poly-A tail) on a gel. A size shift of around 150 to 
300bp was indicative for successful addition of multiple A’s to the 3’ end of mRNA. After 
polyadenylation reactions, mRNAs were purified using the phenol-chloroform protocol 
(2.4.3). In addition and following the phenol-chloroform clean up, mRNAs were further 
purified using Qiagen’s RNeasy kits according to the manufacturer’s manual. The quality and 
size of purified mRNA was evaluated on a 1% TAE gels by means of gel electrophoresis. If 
single, clear RNA bands could be visualized on agarose gels, mRNAs were stored at -80°C. 
2.4.16 Riboprobe production 
To produce probes for in-situ hybridization, 1-2 µg of linearized plasmid DNA was mixed 
with the reagents as listed in table 9 and incubated at 37°C for 2 h. After that, 1 µl of DNAse 
(Fermentas) was added to the reaction mix and incubated for another 30 min.  
Table 9: In-vitro transcription set up for RNA antisense probe production 
Reagent Volume/Amount Final concentration 
linearized plasmid 1 µg  
10x transcription buffer 2 µl 1x 
10x DIG/Fluorescein labelled dNTPs 2 µl 1x 
RiboLock RNAse Inhibitor 0.5 µl 20 U/rxn 
RNA polymerase (Sp6 or T7) 1 µl 20 U/rxn 
RNAse free water Ad to 20 µl  
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After heat inactivating the reactions at 65°C, riboprobes were cleaned-up using an RNeasy kit 
(Qiagen) and eluted in 25 µl RNase free water. 1 µl of riboprobe was qualitatively analysed 
by gel electrophoresis, while the other 24 µl were mixed with 76 µl of Hybridization mix 
(recipe in table 14) and stored at -20°C.  
2.4.17 Isolation of genomic DNA (gDNA) from zebrafish embryos 
To isolate gDNA from zebrafish, a protocol described by Meeker was used (Meeker et al., 
2007). Embryos or isolated adult fin tissues were transferred to 50 µl of 50 mM NaOH 
(Merck) and incubated at 95°C until tissues were completely dissolved. After that, the pH of 
the solutions was neutralized with 1/10 volume of 1 M Tris-HCl while samples were kept on 
ice. Before genomic DNA was used for subsequent PCR reactions, tubes were centrifuged at 
full speed in a table top centrifuge for 1 min to separate cell debris from gDNA. The isolated 
gDNA was stored at -20°C. 
2.5 Custom-made synthesis of Dmrt3 zinc finger nucleases (ZFN) 
To generate zinc finger proteins that bind and cut the zebrafish genomic dmrt3 locus, I used 
the well characterized zinc finger 268 (zif268) as framework zinc finger (Wolfe et al., 1999). 
The three DNA binding domains (ZFD) of zif268 had to be modified in such a way that they 
bound to the dmrt3 locus. This was done via PCR mutagenesis using degenerated ZFD 
primers. Resulting new binding capacities of the zinc finger proteins (ZFP) were evaluated 
using a bacterial one-hybrid system (Meng et al., 2006) and most suitable ZFD were selected 
to be fused with the endonuclease domain of FokI. 
2.5.1 Determination of degenerated primer sequences for zinc finger module synthesis 
Suitable target ZFN binding sites were determined using ZiFit 
(http://zifit.partners.org/ZiFiT/ChoiceMenu.aspx) and the ZFPserach tool 
(http://pgfe.umassmed.edu/ZFPsearch.html). Potential target sites were blasted against the 
zebrafish genome to exclude possible off-target sites. The ZFPsearch also suggested 
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sequences for degenerated primers, which were used for PCR mutagenesis of zif268. The list 
of used primers and plasmids can be found in the Appendix A2. 
2.5.2 Selecting customized zinc finger proteins  
The template zinc finger was customized using degenerated primers as explained in 2.5.3. In 
this section, I will describe how dmrt3 binding ZF proteins were selected from a library of 
randomized ZF proteins. 
To identify binding from non-binding ZF proteins, a previously described bacterial-one-
hybrid screening assay was used (Meng and Wolfe, 2006; Noyes et al., 2008). In short, the 
bacterial strain USO hisB- pyrF- rpoZ- (Addgene: 18049) was double transformed with 
customized zinc finger expression plasmids pB1H2Ω2 (Addgene: 18045) as well as a dmrt3 
target site vector pH3U3 (Addgene: 18046). The expression vector encodes for a DNA-
binding zinc finger protein with an N-terminally fused E. coli RNA-polymerase. The used 
target site vector contains a potential ZFP binding site located upstream of the promoter 
region of a gene encoding a Histidine synthetase. The bacterial strain USO hisB- pyrF- rpoZ- 
is characterized by the disability to grow on media lacking Histidine (NM-media). In double 
transformed bacteria, binding of the RNA-polymerase to the promoter region of the Histidine-
synthesizing enzyme as mediated by the binding of the ZFP to its target site, resulted in the 
expression of the enzyme and the ability of bacteria to survive the selection. If only one out of 
the three zinc finger modules failed to bind to their target sites, no Histidine synthetase was 
expressed and the bacteria died. Hence, it was possible to select binding from non-binding 
ZFPs by this bacterial one-hybrid assay. 
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Fig. 6 Zinc finger module selection strategy: US0- bacteria were double transformed with the 
customized target site vector pH3U3 and the zinc finger expression vector pB1H2. The expressed zinc 
finger (coloured boxes and black line) is N-terminally fused to a RNA-polymerase (red triangle). 
Double transformed bacteria were plated out on NM-media without Histidine. a) In the case that the 
customized zinc finger assembly does not bind to the dmrt3 binding site, the bacteria are not able to 
grow. b) In case, the customized zinc finger polymerase binds to the dmrt3 target site (colour matched), 
expression of the Histidine-synthesizing enzyme is induced and bacteria are able to survive the 
selection process. 3-AT is added to the media to distinguish the binding efficiencies of different zinc 
finger assemblies. 
Additionally, 3-amino-triazole (3-AT; Sigma) was added to the media. 3-AT is a competitive 
inhibitor of the His-synthesizing enzyme and may block bacterial grow if too little enzyme is 
produced. Since the amount of His-synthetase is correlating to the quality of binding of the 
ZFP to its target site, an increasing concentration gradient of 3-AT can be used to distinguish 
low from high affine ZFPs. 
Table 10: Required solutions and medium recipes for the bacterial one-hybrid selection  
10x M9 Salt for NM medium Total volume: 500 ml Final concentration 
Na2HPO4 30 g 422 mM 
KH2PO4 15 g 220 mM 
NaCl 2.5 g 85 mM 
NH4Cl 5 g 167 mM 
Milli-Q water Add to 500 ml  
 
Amino acid solutions for NM medium Total volume 100 ml Final concentration 
Solution I (200x): 
Phe, Lys, Arg dissolve to 100 ml water 
0.99 g, 1.1 g, 2.5 g 0.99%, 1.1%, 2.5% w/v 
Solution II (200x): 
Gly, Val, Ala, Trp dissolve to 100 ml water 
0.2 g, 0.7 g, 0.84 g, 0.41g 0.2%, 0.7%, 0.84%, 0.41% w/v 
Solution III (200X): 
Thr, Ser, Pro, Asn dissolve to 100 ml water 
0.71g, 8.4 g, 4.6 g, 0.96 g 0.71%, 8.4%, 4.6%, 0.96% w/v 
Solution IV (200X): 1.04 g, 14.6 g 1.04%, 14.6% w/v 
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First make up 9.1 ml 36.5% HCl, add 80 ml water, 
then dissolve Asp, Gln to 100 ml water 
Solution V (200X): 
Dissolve K.Glu in 80 ml water, then add Tyr + 4 g 
NaOH pellets, add water to 100 ml 
18.7 g, 0.36 g 18.7%, 0.36% w/v 
Solution VI (200X): 
Ile, Leu dissolve to 100 ml water 
0.79 g, 0.77 g 0.79%, 0.77% 
Mix all 6 solutions equally which results in an 33x amino acid master mix 
 
2x NM medium/NM selection plates Total volume 500 ml Final concentration 
Milli-Q water 418 ml  
10x M9 salt 100 ml 2x 
20% Glucose 20 ml 80 mg/ml 
20 mM adenine HCl 10 ml 400 µM 
33x amino acid mix 30 ml 2x 
1 M MgSO4 1 ml 2 mM 
10 mg/ml Thiamine 1 ml 20 µg/ml 
10 mM ZnSO4 1 ml 40 µM 
100 mM CaCl2 1 ml 200 µm 
20 mM Uracil 10 ml 400 µm 
Filter sterilize and add 1 ml of 100 mg/ml Ampicillin, 1 ml of 50 mg/ml Kanamycin and 100 µl of 100 mM IPTG; mix 250 ml of 
the medium with 3% bacto- agar to get 1x NM selection plates (add 3-AT as desired: 0- 60 mM) 
 
 
2.5.3 Customization of the zinc fingers as well as their target sites 
Degenerated primers and a PCR mutagenesis protocol were used to change the coding 
sequences of single ZFD from template zif268. Reaction reagents were mixed according to 
table 11.  
Table 11: Degenerated primer mediated PCR mutagenesis protocol for ZFD customization 
Reagent Volume/Amount Final conc. 
 
Temperature Time Cycles 
pB1H2Ω2-zif268 1 µl 100 ng 98°C 40 sec  
10 mM Primer forw. 2.5 µl 0.5 mM 98°C 10 sec 
35 cycles 10 mM Primer rev. 2.5 µl 0.5 mM 65°C 10 sec 
10 mM dNTPs 1 µl 0.2 mM 72°C 20 sec 
100% DMSO 1.5 µl 3% v/v 72°C 10 min  




0.5 µl 0.5 U/rxn 
Milli-Q water up to 50 µl  
As a result of PCR mutagenesis, pools of ZF proteins that differ at a particular ZFD were 
generated. Consequently, their binding properties towards the desired target site differed as 
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well. Depending on the module, that had to be modified, different primer combinations were 
used (Table 12). 
Table 12: Overview of primer combinations and annealing scheme to generate different zinc finger 
proteins 
 Primer combination used to amplify specific ZFP encoding fragments 
 Pre-selection primers: 
Used to randomize ZFDs 
Post-selection primer combinations: 
Used to isolate fragments that encode for 
dmrt3 sequence binding ZFD after the 
selection 
 Customized fragment Annealed with backbone fragment 
Selected fragment 
 
Module 1 p_mod1_Lib 




Module 2 p_mod2_Lib 





Module 3 p_mod3_Lib 




x reverse primer VI 
Overview of the location of used primers 
 
 
For better clarity, the protocol for one exemplary selection round will be described in more 
detail here. The primers used to customize module 1 of the 5’ binding zinc finger protein 
were designated as 5p_mod1_lib primer. These degenerated primers were used in 
combination with reverse primerVI that binds at the end of the coding sequence. The 
amplicons generated in this PCR encode for zinc finger proteins with an unselected ZFD 
(Lib) 1 in combination with the two standard zif268 (Fig. 7 a). The resulting PCR products 
were lacking a required 5’ KpnI restriction site for subsequent cloning into ZFP expression 
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vector pB1H2Ω2. Therefore, it was necessary to anneal the ZFD encoding amplicons with 
OligoI that contained an internal KpnI restriction site (Fig. 7 b).  
 
Figure 7 PCR mutagenesis and annealing for the first ZFD of the 5’ ZFP: A) Degenerated primer 
mediated ZFD mutagenesis: The coding sequences for the first ZFD of template zinc finger 268 (black 
boxes) is getting customized using the degenerated primer for the 1st module of the 5’ ZFP (red arrow) 
and reverse primer VI (black arrow). After the PCR, the first module is highly randomized but yet 
unselected (red box). B) Annealing of PCR mutagenesis amplicons from A) with OligoI: Since PCR 
products from the first round were missing the required KpnI restriction site (red label), the ZFD 
assembly had to be annealed with OligoI (black arrow with red label). 
 
For the annealing of different modules, a combined annealing and amplification protocol was 
used. Reagents were added into the reaction tube at a particular time point. During the first 
part of the reaction, sequences encoding for different modules (for example OligoI and 
module 1) were added to reaction buffer, MgCl2 and water. The reaction was heated up to 
melt the module-encoding double strand DNA and cooled down slowly to facilitate annealing 
of different modules. During the second phase, dNTPs and polymerase were added to 
elongate single stranded sequences of the annealed DNA hybrids. The PCR amplification was 
initiated during the last phase of the protocol after forward primer OligoI and reverse 















95°C 3 min / 
Amplicons of different modules: 
Encoding module fragments 
(ratio: 1:1:1) 
10x Taq reaction buffer 
Milli-Q water, 
MgCl2 
ZFD amplicons X µl 
1:1:1 
Module ratio 
95°C to 35°C 60 min -1°C/min Annealing of modules 
10x Taq 
reaction buffer 
10 µl 1x 
72°C 20 min / 




10 mM OligoI 2.5 µl 0.5 mM 
95°C 3 min  
PCR to amplify whole ZFP 
encoding DNA sequences: 
OligoI and primerVI 
10 mM PrimerVI 2.5 µl 0.5 mM 
95°C 30 sec 
35 cycles 
10 mM dNTPs 1 µl 0.2 mM 
65°C 30 sec 25 mM MgCl2 2 µl 1 mM 
72°C 25 sec Taq Polymerase 1 µl 1U 
72°C 10 min  Milli-Q water Up to 50 µl  
4°C -     
After the PCR, the ZFP encoding fragments were digested with KpnI and XbaI and analysed 
on a 2% TAE gel. Digested fragments were 108bp shorter than the undigested 412bp long 
fragments and were isolated from the gel. Purified fragments were cloned into KpnI/XbaI 
digested pB1H2Ω2 vectors and resulting plasmids were encoding for a new, randomized zinc 
finger. Plasmids were subsequently transformed into USO hisB- pyrF- rpoZ- bacteria 
harbouring the corresponding target site plasmids, and selections were done as described 
previously (see chapter 2.5.2). 
2.5.3.1 Sequential selection method 
After each round of selection, the surviving bacteria were collected and their zinc finger 
encoding plasmids were isolated and pooled. The selected library pools were used as a 
template for the next round of ZFD customization. For this, target site binding domains were 
isolated and annealed with unselected, randomized modules of the next zinc finger domain. 
These procedures were repeated until all three modules were customized. Parallel to the 
customization of the standard zinc finger, it was necessary to modify the corresponding target 
site in three steps accordingly. This altered the original zif268 target site step by step into the 
desired dmrt3 binding site (Fig. 8 a). Alterations of target site plasmids were done step-wise 
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by PCR based mutagenesis with primers (see Appendix A2) that bound to the target site and 
changed it to the desired dmrt3 target site sequence. After amplification of customized target 
site fragments, fragments were purified and digested with restriction enzymes. In parallel, the 
target site vector pH3U3 was cut with the corresponding enzymes and subsequently ligated 
with the customized ZFP target site fragments. The sequential selection took the modular 
context of already selected binding modules into account. The context-sensitivity of this 
method ensures that final selected ZFD assemblies interact well with each other, which 
increases the chances of the binding to the dmrt3 loci. On the other hand, the disadvantage of 
this sequential selection was that it was very time-consuming. One selection round had to be 
finished first before the next selection round could be started. 
2.5.3.2 Modular assembly method 
Due to the time-intensive sequential selection, a modular assembly approach was undertaken 
in parallel for the 3p binding ZFP. Selection processes for all three ZFP modules were done in 
parallel in a zif268 context. In addition, only one out of three nucleotide triplets had to be 
changed to generate corresponding target site plasmids. The modular assembly approach was 
much faster but less context sensitive than the sequential selection method. The overview 
schemes below (Fig.8) illustrate the basic principles of both selection methods. 
 
Fig. 8 A) Sequential selection and 
B) modular assembly: A) Zinc 
finger 268 was used as a template 
that was PCR customized using 
degenerated primers (arrows with 
coloured boxes). Generated 
sequences encoded for one 
unselected but randomized finger 
(patterned box) and two zinc 
finger 268 modules (black boxes). 
This zinc finger was selected 
against a 9 bp long target site 
containing the first three 
nucleotides of the dmrt3-site 
(coloured AGC). Plasmids 
encoding for zinc finger proteins 
that contained dmrt3-triplet 
binding modules (coloured boxes) 
were isolated and used as 












After three rounds of ZFD modification and selection, single bacterial colonies that survived 
high 3-AT concentrations were picked and plasmids encoding ZF proteins were isolated. The 
DNA encoding the ZFD was sequenced and unique ZF protein plasmids were identified. To 
compare and evaluate binding affinities of these particular ZF proteins towards the complete 
dmrt3 target sequence, a comparative binding assay was performed. Equal amounts of unique 
ZF protein encoding plasmid were transformed into electro-competent cells harbouring a 
pH3U3-dmrt3 target site, spread out side by side and incubated on 3-AT plates. This allowed 
comparison and identification of the best dmrt3 target site-binding ZF proteins. 
2.5.4 Generation of plasmids encoding ZFN that bind to the dmrt3 locus  
After the final isolation step, DNA sequences encoding high-affine ZF proteins were 
amplified using a primer combination of OligoI (KpnI) and primer X (BamHI). Next, ZF 
protein encoding amplicons and FokI expression vectors (Addgene: 18754/18755) were 
digested with KpnI and BamHI, purified and ligated with each other using a T4 quick ligation 
kit (Roche). Ligated plasmids were transformed into chemically competent cells and the 
presence of ZFN encoding plasmids was verified via colony test PCR and sequencing. 
 
 
B) Modular assembly: 1) 
Selections of customized 
ZFD’s were done in parallel 
for all three modules. 2) After 
all 3 modules were tested, 
modules of binding zinc finger 
proteins were isolated and 
annealed to each other. A final 
selection round was required 
to identify whole dmrt3-target 
site binding proteins. This 
selection method was less 
dmrt3-context sensitive, since 
selection took place in a 
zif268 environment.  
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2.5.5 Production of ZFN mRNA 
To produce ZFN encoding mRNA, ZFN plasmids were linearized with NotI (Fermentas) and 
mRNA was synthesised using the mMESSAGE mMACHINE Kit SP6. In-vitro transcribed 
mRNA was purified as described in chapter 2.4.15 and injected into one-cell stage zebrafish 
embryos. 
In addition, to the ZFN produced by modular and sequential assembly as described above, 
customized ZFN targeting the dmrt3-locus were obtained from ToolGene. These plasmids 
were linearized using XbaI, and the mMESSAGE mMACHINE Kit T7 was used for in-vitro 
transcription of ZFN encoding mRNAs. XbaI cuts the plasmids in front of the poly-A signal. 
Hence, it was necessary to add an additional poly-A tail to the transcripts. A poly-A tailing 
reaction was performed as described in 2.4.12. Transcripts were analysed on a 1% agarose gel 
to confirm the efficiency of the tailing reaction and successfully treated transcripts were 
purified and injected into one-cell stage embryos. 
2.5.6 Analysis of ZFN activity 
To test if the ZFN mRNA caused any frameshift mutation within the dmrt3 loci in injected 
zebrafish embryos, gDNA from pooled as well as single embryos was isolated. Using a 
primer combination that flanks the potential target site (Appendix A2: ZFN screening 
primers), dmrt3 amplicons were generated, gel purified and applied to a diagnostic restriction 
digest. PCR amplified dmrt3 fragments contained both ZFN binding sites as well as the 
spacer region. The spacer region for the self-assembled ZFNs included an MspA1I restriction 
site while the spacer region of the ToolGene made ZFNs contained a CviAII restriction site. If 
the ZFN cut within the dmrt3 loci, non-homologues repair mechanisms introduce insertions 
and deletions in the spacer region between both ZFN binding sites. The presence of a 
restriction fragment length polymorphism (RFLP) introduced by the ZFN rendered the dmrt3 
amplicon indigestible for MspAI or CviAII. Therefore, the occurrence of undigested dmrt3 




Fig. 9 Schematic overview of RFLP assay: Wild type or ZFN injected embryo gDNA served as a 
template to amplify dmrt3 encoding fragments. The PCR amplicons contained a unique restriction site 
(green label) that was flanked by the ZFN binding sequences. In case the ZFN did not cut the dmrt3 
locus, the PCR product was digested and bands with a smaller size than the PCR amplicon became 
visible on the gel. In case the ZFN introduced a frameshift (red mark), the unique restriction site was 
destroyed, which rendered the dmrt3 amplicon indigestible for the restriction enzyme (red triangle). As 
a result, the dmrt3 amplicon remained undigested after the incubation with the restriction enzyme. 
 
Single embryos that showed a RFLP in comparison to control embryos were further analysed 
by sequencing of the dmrt3 locus. For that, undigested dmrt3 amplicons were isolated, cloned 
into TOPO-blunt vectors and sequenced with vector specific primers, such as M13 reverse.  
In addition to MspAI, I also analysed the dmrt3 amplicons using a T7 endonuclease assay. T7 
endonuclease recognizes and cuts double stranded DNA that contained secondary structures 
caused by a mismatch alignment of different DNA species. If ZFNs introduced frameshift 
mutations into the dmrt3 loci, gDNA isolated from these injected embryos yield different 
gDNA species. These different gDNA species were used as templates to PCR amplify the 
dmrt3 sequence. In a next step, dmrt3 amplicons were denaturated at 95°C for 10 min. The 
melted DNA was then cooled down slowly (-1°C/min) to allow re-annealing of dmrt3 
encoding fragments. The presence of different dmrt3 sequences will result in homo- as well as 
heteroduplex variants of the dmrt3 amplicon. Re-annealed fragments were applied to T7 
endonuclease digests in 1x T7 endonuclease buffer and analysed on TAE gels. If the analysed 
embryo contained dmrt3 mutations, secondary structures in heteroduplex amplicons were 
recognized and digested by the endonuclease, and smaller fragments in addition to the 
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undigested dmrt3 homoduplex became visible on the TAE gel. An overview about this 
technique is illustrated in figure 10. 
 
Fig. 10 Schematic overview of T7 endonuclease assay: gDNA from control and dmrt3 ZFN mRNA 
injected embryos were isolated and used as a template to amplify dmrt3 PCR fragments. If the dmrt3 
fragment contained frameshift mutations (red label), the length of these fragments were different from 
wild type fragments. Next, the PCR reactions were heated up to 95°C and cooled down slowly to 
anneal frameshift fragments with unaltered dmrt3 amplicons. If two different fragments re-annealed 
with each other, a hetero-duplex formed that contained loop structures due to different fragment 
lengths. Finally, re-annealed PCR products were treated with T7 endonuclease (red triangle), which 
recognizes and cleaves double stranded DNA-loop structures and smaller fragments would have been 
become visible on analytical agarose gels. Smaller fragments than the undigested dmrt3 amplicon 
indicated dmrt3 frameshift mutations. 
If digested fragments were detectable after T7 endonuclease digest, amplicons from affected 
embryos were sequenced and analysed for frameshift mutations. 
To identify potential founders at later stages, gDNA were isolated from fin clips (see 2.4.17) 
and applied to RFLP analysis using CviAII. To confirm frameshift mutations, undigested 
dmrt3 amplicons were isolated from the gel, cloned and sequenced. Positively tested fish were 
kept separately until fish were sexually matured. Dmrt3 mosaic mutants were in-crossed with 
each other and progenies were analysed for a complete 100% RFLP indicating homozygosity 






2.6 Staining protocols and imaging 
2.6.1 RNA whole mount in-situ hybridization (WISH) 
For analysis of gene expression patterns, DIG or Fluorescein-labelled WISH probes were 
synthesized as described above. Depending on the concentration of the probe, probe stock 
solutions were diluted with hybridization mix to 1:50 - 1:200 working solutions. 
Zebrafish embryos were raised to the desired stage and fixed for at least 2 h in 4% PFA. The 
PFA was exchanged and 100% methanol was added. Embryos were stored at -20°C for at 
least overnight and on the next day. Embryos were rehydrated using a descending methanol 
series of 75%, 50% and 25% in phosphate buffered saline with tween (PBST) and each 
incubation step lasted 5 min. After hydration, the embryos were washed twice in PBST before 
embryonic structures were permeabilized with proteinase K (1.25 µl proteinase K/5 ml PBST; 
Fermentas). The concentration and incubation time of the permeabilization step was stage-
dependent. Proteinase K activity was stopped by adding 1x glycine (AppliChem) and 
embryos were rinsed twice with PBST. Next, embryos were fixed in 4% PFA for at least 20 
min. The PFA was removed and the samples were washed thoroughly with PBST (5x 5 min). 
To block unspecific binding sites, PBST was exchanged with hybridization mix and incubated 
for at least 1 h at 65°C. After this pre-hybridization step, the hybridization mix was 
exchanged with probe solution and samples were incubated at 65°C overnight. On the next 
day, probes were removed and samples were washed twice with 2x SSCT/50% formamide, 
followed by one 2x SSCT and two 0.2x SSCT washing steps. All SSCT washing steps were 
performed at 65°C and lasted 30 min. After the last washing step, unspecific antibody binding 
sites were blocked by adding 5% sheep serum (Sigma)/PBST and incubating the samples for 
1 h at room temperature. After this, the blocking solution was discarded and replaced by 
alkaline phosphatase conjugated anti-DIG/ fluorescein antibodies (Roche). The zebrafish were 
incubated for at least 2 h at room temperature before antibodies were removed and samples 
were washed thoroughly with PBST (6x 20 min). Before transcripts were visualized with 
NBT staining solution, embryos were incubated twice in pre-staining buffer for 5 min. The 
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staining was stopped by adding PBST when samples showed a sufficient colouration and 
stored in 4% PFA. Recipes and reagents used are listed below. 
Table 14: Whole mount in-situ hybridization reagents 
10x PBS solution Total volume: 1 L Final concentration 
NaCl 58.44 g 1 M 
KCl 1.45 g 19.5 mM 
Na2HPO4 8.38 g 59 mM 
KH2PO4 1.5 g 11 mM 
Milli-Q add to 1 L  
 
1x PBST Total volume: 1 L Final concentration 
autoclaved 10x PBS 100 ml 1x 
20% Tween 20 5 ml 0.1% v/v 
Milli-Q 895 ml, filtered through 0.22µm polyethersulfone bottle filter (Nalgene) 
 
 Total volume: 10ml Final concentration 
50x Glycine 1 g/10 ml PBST 50x 
1x Glycine 200 µl 50x Glycine/10 ml PBST 1x 
 
Hybridization mix   
Formamide 25 ml 50% v/v 
20x SSC 12.5 ml 5x 
50 mg/ml Heparin 150 µl 150 µg/ml 
Torula RNA 250 mg 5 mg/ml 
20% Tween 20 250 µl 0.1% v/v 
Milli-Q water add to 50 ml  
 
2x SSCT buffer/50% Formamide: Total volume: 50 ml Final concentration 
Formamide 25 ml 50% v/v 
20xSSC 5 ml 2x 
20% Tween20 250 µl 0.1% v/v 
Milli-Q water add to 50 ml  
 
2x SSCT buffer: Total volume: 50 ml Final concentration 
20x SSC 5 ml 2x 
20% Tween 20 250 µl 0.1% v/v 
Milli-Q water add to 50 ml  
 
0.2x SSCT buffer: Total volume: 50 ml Final concentration 
20x SSC 0.5 ml 0.2x 
20% Tween 20 250 µl 0.1% v/v 
Milli-Q water add to 50 ml  
 
Pre-staining buffer: Total volume: 50 ml Final concentration 
5 M NaCl 1 ml 0.1 M 
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0.5 M MgCl2 5 ml 0.05 M 
1 M Tris-HCl, pH9.5 5 ml 0.1 M 
20% Tween 20 250 µl 0.1% v/v 
Milli-Q water Add to 50 ml  
 
NBT staining solution: Total volume: 10 ml Final concentration 
5 M NaCl 200 µl 0.1 M 
1 M Tris-HCl, pH9.5 1 ml 0.1 M 
20% Tween 20 50 µl 0.1% v/v 
Milli-Q water add to 10 ml  
 
 
2.6.2 Two-colour whole mount in-situ hybridization 
The two-colour WISH is a modified version of the normal in-situ protocol. Instead of using 
only DIG-/or fluorescein-labelled probes, both probes are used together at the same time. The 
first steps until the antibody blocking step were the same like mentioned in the standard 
WISH protocol. The samples were then incubated with anti-fluorescein antibody at room 
temperature for at least 2 h. After the incubation step, samples were washed 6 times for 20 
min. The primary staining followed to detect fluorescein-labelled transcripts. The samples 
were incubated two times for 5 min in equilibration buffer and stained in “Fast Red” solution 
until the expression patterns of transcripts were clearly detectable. Staining reactions were 
stopped by washing embryos three times for 5 min with PBST. For the second colour 
reaction, it was necessary to remove the bound anti-fluorescein antibodies. This was done by 
washing the embryos two times for 10 min in antibody removal solution. After antibodies 
were removed from the samples, they were washed four times for 5 min in PBST. The 
secondary stain was performed utilizing alkaline phosphatase conjugated anti-DIG antibody 
as described above. 
Table 15: Additional reagents required for two colour whole mount in-situ hybridization 
Equilibration buffer: Total volume: 500 ml Final concentration 
Tris 6.057 g 0.1 M 
20% Tween 20 2.5 ml 0.1% v/v 
Adjust pH with 37% HCl to 8.2 
Milli-Q water add to 500 ml, filter through 0.22µm polyethersulfone bottle filter 
 
Antibody removal solution: Total volume: 50 ml Final concentration 
Glycine 3.75 g 0.1 M 
20% Tween 20 2.5 ml 0.1% v/v 
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Adjust pH with 37% HCl to 2.2 
Milli-Q water Add to 500 ml, filter through 0.22µm polyethersulfone bottle filter 
 




Immunostaining of specimen was done using fluorescense-labeled secondary antibodies. 
Embryos of the desired stage were fixed for 2 h in 4% PFA and stored at -20°C in methanol. 
Embryos were rehydrated using a descending methanol series of 75%, 50% and 25% 
methanol in PBST. Next, samples were washed and incubated in Milli-Q water for at least 1 h 
to increase tissue permeability. Unspecific antibody binding sites were blocked by incubating 
embryos in PBDT for at least 1 h. After that, the blocking solution was replaced by 500 µl of 
the diluted primary antibody in PBDT .The samples were incubated at 4°C overnight. On the 
next day, antibodies were removed and samples were washed at room temperature four times 
for 1 h with PBST with 0.1% TritonX-100 (PBSTT). Afterwards, PBDT diluted fluorescence-
labeled secondary antibodies were added and specimens were incubated for at least overnight. 
On the next day, antibodies were removed and specimens were washed four times for 1 h in 
PBSTT. After removal of non-bound antibodies, samples were ready for analysis using a 
fluorescence microscope (Nikon). A list of used primary and secondary antibodies can be 
found in the appendix A2. 
Table 16: Immunostaining reagents 
PBDT solution: Total volume: 25 ml Final concentration 
100% DMSO 250 µl 1% v/v 
BSA 0.25 g 1% w/v 
TritonX-100 125 µl 0.5% v/v 
Sheep serum 625 µl 2.5% v/v 
10x PBS 2.5 ml 1x 
20% Tween 20 125 µl 0.1% v/v 
Milli-Q water add to 25 ml  
 
PBSTT: Total volume: 1 l Final concentration 
10x PBS 100 ml 1x 
100% Tritonx-100 1 ml 0.1% v/v 
20% Tween 20 5 ml 0.1% v/v 




2.6.4 BrdU incorporation assay 
To detect proliferating cells in S-phase, embryos were dechorionized and incubated in BrdU 
solution (10 mM BrdU/15% DMSO) on ice for 20 min. Following that, the BrdU solution was 
removed and embryos were rinsed several times with PBST before they were fixed in 4% 
PFA. Embryos were kept in PFA for 2 h before the embryos were washed three times for 5 
min each with PBST. After the last washing step, 100% methanol was added and embryos 
were stored at -20°C. For staining, embryos were rehydrated using a descending methanol 
series followed by incubation in 2N HCl at 37°C for 1 h. After that, the normal 
immunostaining protocol was carried out as described before (2.6.3). 
2.6.5 Sample preparation and image acquisition  
PFA fixed and in-situ or immunostained embryos were washed three times for 5 min with 
PBST before they were transferred to 50% glycerol (AppliChem). Samples were kept in 50% 
glycerol for 10 min prior to transferring them into 100% glycerol. Image acquisition took 
place with embryos placed in 100% glycerol.  
Pictures were acquired either at low magnification using a stereomicroscope (Nikon) or at 
high magnification using a Nikon Eclipse 90i compound microscope. The NIS element basic 
software (Nikon) was used for image acquisition. Recorded images were analysed, labelled 
and edited using Photoshop. 
For confocal microscopy, stained samples were fixed in low melting agarose (1st Base) in 
glass bottom dishes and pictures were acquired on a confocal system LSM510 Meta (Zeiss). 






Previous studies have shown that dmrt genes control various aspects of neuronal 
development, for example neurogenesis in the Xenopus olfactory placode (dmrt5; Huang et 
al., 2005) or spinal cord interneuron formation in zebrafish (dmrt3; Rajaei, PhD Thesis 2012). 
Aim of the present study was to reveal potential roles of dmrt genes during neurogenesis in 
the forebrain. For this, I focussed on the two dmrt genes, dmrt3 and dmrt5, which are known 
to be expressed in embryonic forebrain regions. Gene knock-out and knock-down approaches 
were used to uncover their functions based on phenotype analysis. The first part of this 
section will describe results gained by the use of a dmrt3 and dmrt5 morpholino-based knock-
down approach. The knock-down proved to be very efficient for dmrt5 while the dmrt3 
knock-down had some limitations. Therefore, a second dmrt3 loss-of-function approach was 
conducted. The last part of this section describes the generation of dmrt3 zinc finger nucleases 
(ZFNs) and dmrt3 knock-out zebrafish. 
3.1 Spatio-temporal expression of dmrt3 and dmrt5 during forebrain neurogenesis 
Earlier studies have shown that dmrt3 is expressed in a subset of dorsal telencephalon and 
olfactory placode cells in zebrafish embryos (Li et al., 2008). A study from Guo et al., 2004 
used real-time PCR to illustrate that dmrt5 is expressed in embryonic brain tissue but failed to 
illustrate the detailed spatio-temporal dmrt5 expression patterns. Furthermore, it is known 
from Xenopus that one member of the Dmrt gene family (Xdmrt4) regulates neurogenesis in 
the developing olfactory placode (Huang et al., 2005). Taken together, the previously 
published data in combination with preliminary expression analysis of dmrt3 and dmrt5 
suggested a potential role of both dmrt genes during zebrafish forebrain development. I 
therefore addressed the question if dmrt3 and/or dmrt5 are involved during forebrain 
neurogenesis. 
Wild-type zebrafish embryos were collected and fixed at different embryonic stages to 
analyse the expression of dmrt5 by RNA whole-mount hybridization. Dmrt5 mRNA was 
untraceable in zebrafish embryos before and during shield and epiboly stages, but at bud-stage 
dmrt5 expression became detectable as a u-shaped expression domain along the anterior 
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neural ridge (arrow, Fig. 11 c). Shortly thereafter, the expression of dmrt5 expanded 
throughout the presumptive telencephalic field (Fig. 11). At the 14 somite stage, dmrt5 
expression was up-regulated in the forming telencephalic and diencephalic forebrain regions 
and was additionally expressed in the ventral midbrain. Dmrt5 transcripts were detectable 
throughout the dorsal telencephalon, the telencephalic ventricular zones, olfactory epithelium, 
dorsal diencephalon, and as a stripe of cells ventrally to the olfactory epithelium (Fig 11 e) at 
25 hpf. Weak forebrain staining was also detectable in a group of cells in the anterior and 
ventral forehead. Their position suggested that these are migrating pituitary cells (arrowhead, 
Fig. 11 e’). Expression in the aforementioned domains was maintained at 52 hpf albeit at a 
weaker level (Fig. 11 f-f”). Additionally, dmrt5 expression became restricted to the anterior 
pituitary domains (dashed area, Fig. 11 f”). The transcript levels of dmrt5 were reduced in 
telencephalon and diencephalic forebrain regions at 74 hpf, while midbrain (asterisk, Fig. 11 
g) and pituitary expression remained relatively strong (Fig. 11 g’).  
 
 
Fig. 11 Spatio-temporal expression pattern of dmrt5 until 74 hpf: Images taken at early stages. 
Images A to E are overview pictures of whole embryos. Embryos are shown from two views: A, B: 
    ov 
        dt   
vz                  vmb 
oe 
pit                                *               
pit 




animal and lateral; C-D: dorsal and lateral. Pictures E’ to G’’ are images of embryonic head regions at 
different stages from dorsal, lateral or as cross section at higher magnifications. Embryonic stages are 
indicated in the lower left corner of each image. Used abbreviations: dorsal telencephalon (dt), ventral 
midbrain (vmb), olfactory epithelium (oe), pituitary (pit), ventricular zones (vz). Scale bars in A-E, F 
and G: 100 µm, E’: 50 µm, F’/F” and G’/G”: 20 µm. 
To determine if dmrt3 and dmrt5 act in identical or separate brain compartments, expression 
patterns of dmrt3 and dmrt5 were compared by two colour-whole mount in-situ hybridization 
in 24 hpf embryos. It was found that both genes were expressed in overlapping domains of the 
dorsal telencephalon (arrow) and olfactory epithelium (arrowhead, Fig. 12 a”/b”). In figure 12 
a, the red fluorescence signal from dmrt5 expression domains were partially quenched by the 
NBT-staining of dmrt3 positive cell populations in the dorsal telencephalon, resulting in a 
weaker dmrt5 signal (indicated by the white arrow, Fig. 12 a’). Figure 12 b shows the 
overlapping expression domains of dmrt3 and dmrt5 in the olfactory epithelium (arrow head, 
Fig. 12 b/b’) although the staining of dmrt3 was very weak in this region. Thus, it is possible 
that dmrt3 and dmrt5 act redundantly and that a knock-out or knock-down of one gene could 






Fig. 12 Double in-situ dmrt3- dmrt5: Two colour in-situ hybridization of 24 hpf embryos for dmrt3 in 
blue and dmrt5 in red. Both genes are expressed in the dorsal-most parts of the lateral telencephalon 
close to the ventricular surface (arrow) and the olfactory epithelium (arrow head). A) lateral views, B) 
dorsal views of the same embryo as shown in A). Images were captured as A/B) bright field; A’/B’) 
fluorescence and A”/B”) overlay pictures of bright field and fluorescence images to illustrate 
overlapping expression domains of dmrt3 and dmrt5. Anterior left. Scale bar: 50 µm. 
Noteworthy, the expression of dmrt5 expands throughout the forebrain including the rest of 
the telencephalon and diencephalon and is additionally expressed in parts of the ventral 
midbrain. In contrast, dmrt3 expression is restricted to the dorsal telencephalon and the 
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olfactory epithelium. This suggests that Dmrt5 has a broader area of biological activity than 
Dmrt3 and that it could influence a larger cell population during brain development. This 
hypothesis is also consistent with the observation that dmrt5 expression starts earlier (bud 
stage; 10 hpf, Fig. 11 c) than dmrt3 (around 14 hpf; Rajaei F., PhD Thesis 2012).  
3.2 Design and analysis of dmrt3 and dmrt5 morpholinos 
To analyse the role of Dmrt3 in the dorsal telencephalon and olfactory placode, dmrt3 splice 
blocking morpholinos were used for gene knock-down and were previously characterized in 
our lab (Rajaei, PhD Thesis 2012). Used concentrations were 1.6 mg/ml to 3.125 mg/ml. 
To investigate the function of Dmrt5 during zebrafish forebrain development, dmrt5 splice 
site morpholinos were designed. These dmrt5 splice-blocking morpholinos bind to the exon-
intron boundaries of exon 1- intron 1 (dmrt5 splice up) and intron 1- exon 2 (dmrt5 splice 
down) (Fig. 13). In order to prevent nonspecific binding of dmrt5 morpholinos to potential 
unspecific morpholino binding sites, morpholino sequences were blasted against zebrafish 
nucleotide database to reveal possible unspecific binding sites. No other 100% identical 
sequences were found other than dmrt5. 
 
For analysing the efficiency of the used splice blocking morpholinos, total RNAs from 
morpholino and control morpholino injected as well as wild type embryos were isolated and 
reverse transcribed into cDNA. The cDNA was used as PCR template and proper splicing of 
pre-mRNA was evaluated with dmrt5 intron-flanking primers. This setting allowed the 
Fig. 13 Schematic overview of dmrt5 
splice-block morpholinos and PCR 
primer binding sites: Both dmrt5 
splice –blocking morpholinos bind to 
the internal splice acceptor and donor 
sites within the dmrt5 pre-mRNA. 
This binding results in a block of pre-
mRNA splicing and the unspliced 
mRNA gets degraded. Hence, the 
injection of dmrt5 morpholinos 
results in a loss-of function of Dmrt5 
in zebrafish embryos. Different dmrt5 
mRNA species can be detected using 
intron-flanking PCR primers (arrows) 
to evaluate splice-block efficiencies. 
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detection of cDNA templates, generated from spliced or unspliced RNA (Fig. 14). Injection of 
single splice morpholinos at 12.5 mg/ml showed that the use of single splice site morpholinos 
was not sufficient to block dmrt5 pre-mRNA splicing efficiently (block efficiency: 63% and 
11%, Fig. 14, top, lanes: 3 and 4) as two bands with expected sizes for spliced and unspliced 
dmrt5 mRNA were obtained. I therefore tested a combination of splice site morpholinos for 
injection. Splice efficiencies were determined for morpholino concentrations at 1.6 mg/ml and 
3.125 mg/ml. Injections of 1.6 mg/ml dmrt5 splice site morpholinos were not sufficient to 
block splicing of dmrt5 pre-mRNA efficiently (78%, Fig. 14, top, lane: 2). At 3.125 mg/ml, 
dmrt5 splice site morpholinos blocked pre-mRNA splicing with 97% efficiency. Only PCR 
fragments were amplified that represented unspliced dmrt5 pre-mRNA fragments (Fig. 14, 
top, lane 1). These results show that the co-injection of two morpholinos in combination leads 
to synergy effects that block dmrt5 pre-mRNA splicing efficiently at relatively low doses. A 
quantitative ImageJ analysis of obtained amplicon intensity is shown in Fig. 14 B.  
 
 
















dmrt5 splice morpholino efficiency in % 
Unspliced dmrt5 pre-mRNA 











Fig. 14 Efficiency of dmrt5 splice blocking morpholinos: A) Top row: Semi-quantitative PCR to 
determine the ratio of unspliced to spliced dmrt5 transcripts from embryos injected with different 
morpholinos. The used morpholino combinations and their concentrations are given below the gel 
picture. Lane 1 and 2: combined morpholino injections at 3.125 mg/ml (1) and 1.6 mg/ml (2). Lane 3 
and 4: single morpholino injections with dmrt5 splice up (3) and splice down (4) morpholino. Working 
solutions were both 12.5 mg/ml. The asterisk marks a weak band that represents unspliced dmrt5 
transcripts. Lane 5: uninjected control. Lower bands correspond to spliced dmrt5 transcripts (922 bp) 
while upper bands correspond to unspliced dmrt5 transcripts (1347 bp). Bottom row: Corresponding 
semi-quantitative PCR results for gapdh transcripts used as loading control. B) Quantitative data 
analysis of dmrt5 morpholino splice assay using ImageJ. Splice efficiencies were calculated according 
to intensities of semi-quantitative PCR amplicons after they were normalized against the gapdh signal. 
The numbers above the columns indicate the percentage of unspliced product in relation to total dmrt5 
transcripts. 
Both splice site morpholinos were injected in combination. A dose-response study was 
performed to determine the final morpholino concentration to be used throughout the entire 
course of the study to exclude possible nonspecific morphological defects. Indicators for 
nonspecific morpholino mediated effects were an overall altered morphology, delayed 
development and/or elevated apoptosis, especially in mid- and hindbrain regions. Combined 
injection of morpholino concentrations up to 3.125 mg/ml (each) did not alter the overall 
morphology or induce unspecific apoptosis, while morpholino concentration of 6.25 mg/ml or 
higher induced increased and nonspecific apoptosis in hindbrain regions (data not shown). 
Based on the high efficiency to block dmrt5 pre-mRNA splicing and the compatibility with 
regards to overall morphology, I used injection of combined splice up and down morpholinos 
at 3.125 mg/ml throughout the course of this study. 
Additionally, I was interested over what time periods dmrt5 splice site morpholinos were 
active. Thus, wild type zebrafish embryos were injected with splice site morpholinos at 3.125 
mg/ml and total RNAs were isolated at 24, 48, 74 and 102 hpf. The splice analysis was 
carried out as described above (Fig. 15). As shown before, the morpholinos were very 
efficient in blocking dmrt5 pre-mRNA splicing during the first 24 hpf when only 8% of 
detected dmrt5 transcripts were spliced (Fig. 15). This value increased during the next 50 
hours to 51% before the amount of correctly spliced dmrt5 products again dropped to 15% at 
102 hpf. A possible explanation is that the morpholinos get degraded during earlier time 
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points resulting in an increase in the amount of spliced transcripts. However, after 74 hpf, 
dmrt5 transcripts got endogenously down-regulated and the amount of morpholinos left 
(although less than at the beginning) were sufficient to block splicing of dmrt5 transcripts 
effectively. These data suggest, that the injected amount of splice site morpholinos was 
sufficient to block dmrt5 pre-mRNA splicing during the time window when the formation of 
the forebrain takes place.  
  
 
expression. Splicing of dmrt5was calculated in relation to wild type dmrt5 amplicon intensities. Dmrt5 
pre-mRNA splicing was efficiently blocked at early stages (24 hpf). At 48 and 74 hpf, dmrt5 pre-
mRNA splicing was still impaired yet more spliced dmrt5 mRNAs were detectable. At 102 hpf: 
endogenous dmrt5 levels were very low and calculated variations reflective of experimental limitations. 
It is worth mentioning that one of the less-similar BLAST hits was located in the pre-mRNA 
of forebrain embryonic zinc finger 2 (fezf2) and shared 16/25 nucleotides with the upstream 
dmrt5 splice morpholino target site. Moreover, the potential binding site in fezf2 pre-mRNA 
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Fig. 15 Analysis of dmrt5 splice-block 
morpholino stability: Morpholino 
stability was analysed by scoring the 
efficiency of dmrt5 knock-down. A) 
dmrt5 mRNA splice assay: Top row: 
gapdh used as loading control for 
expression at indicated stages. 
Bottom: Splicing of dmrt5 pre-mRNA 
was studied at 24 (lanes1-3), 48 
(lanes4-6), 74 (lanes 7-9) and 102 hpf 
(lanes 10-12). mRNA isolated from: 
M: dmrt5 morpholino injected, C: 
control morpholino injected, W: wild 
type embryos. Only dmrt5 morpholino 
injected embryos showed a higher 
band, indicative for unspliced dmrt5 
pre-mRNA (arrow) products, while 
the controls showed only a lower band 
(*) indicative for the fully spliced 
dmrt5 mRNA. Unspliced products: 
1347bp, spliced products: 922b. B) 
Quantitative analysis of dmrt5 
splicing: Intensities of visualized 
dmrt5 amplicons were measured using 




development and its expression overlaps with dmrt5 expression, the correct splicing of fezf2 
was investigated. For that, I used the same splice assay technique as before but replaced 
dmrt5 with fezf2 primers. Both fezf2 primers flanked the intron (81bp) of interest allowing us 
to determine if fezf2 pre-mRNA was correctly spliced. As illustrated in figure 16, fezf2 pre-
mRNA was properly spliced since no unspliced fezf2 pre-mRNA products were detected. To 
confirm the presence of dmrt5 morpholinos, non-spliced dmrt5 pre-mRNA was used as 
positive control.  
 
3.3 Gene knock-down identifies roles of dmrt genes during forebrain neurogenesis 
It was recently shown that the morpholino mediated knock-down of Xenopus Xdmrt4 resulted 
in significant down-regulation of neurogenin expression in the olfactory placodes (Huang et 
al., 2005). As a result of the down-regulation of neurogenin, Xenopus olfactory placode 
neurogenesis was impaired (Huang et al., 2005). As both dmrt3 and dmrt5 are expressed in 
the zebrafish forebrain, I tested if a knock-down of dmrt3 and/or dmrt5 affects neurogenin 
expression in a similar manner in zebrafish. Hence, the embryonic forebrain expression of 
neurogenin was examined in a dmrt3, dmrt5 and combined dmrt knock-down context. Due to 
concentration limitations in double- morpholino injections, concentrations no higher than 1.6 
mg/ml per morpholino were used. Higher doses of dmrt3 and dmrt5 morpholino co-injection 
led to severe developmental delays and in embryonic malformations (data not shown).  
Fig. 16 Morpholino targets dmrt5 but not fezf2 
splicing: Splice assays were performed as described 
before. Lane 1: DNA ladder. Lanes 2-4: loading 
control gapdh. Lanes 5-7: splice assay for fezf2. 
Lanes: 8-10: positive control: dmrt5. Only dmrt5 
pre-mRNA showed intron retention upon dmrt5 
morpholino injection, while fezf2 pre-mRNA was 
correctly spliced and showed no unspliced 
transcripts. fezf2 unspliced products: 705 bp, spliced 
products: 624 bp. dmrt5 unspliced products: 1347 
bp, spliced products: 922 bp. M = dmrt5 morpholino 





Neurogenin expression domains in the forebrain were unaltered in dmrt3 morphants upon 
injection of 1.6 mg/ml dmrt3 splice morpholinos (22/24, Fig. 17 b). This shows that a knock-
down of dmrt3 does not recapitulate results from Xenopus studies. Since dmrt3 expression 
overlaps completely with the expression domains of dmrt5, it is possible that the dmrt3 
knock-down was functionally compensated by Dmrt5. I therefore analysed the neurogenin 
expression pattern in dmrt5 morphants injected with 1.6 mg/ml dmrt5 splice morpholinos. 22 
out of 26 analysed embryos showed a strong reduction in neurogenin expression in the 
following brain domains: dorsal telencephalon, preoptic area and ventral midbrain (1, 2 and 
4b, Fig. 17 c). To test possible synergetic effects on the down-regulation of neurogenin, dmrt3 
and dmrt5 double-morphants (1.6 mg/ml splice site morpholinos each) were analysed. The 
observed down-regulation of neurogenin completely recapitulated the dmrt5 morphant 
phenotype (22/27) and showed no synergistic effects after knocking-down both dmrt genes 
(Fig. 17 d). In conclusion, a single knock-down of dmrt5 was sufficient to reduce neurogenin 
transcription in the forebrain and dmrt5 morpholino injected embryos displayed similar 
neurogenin expression patterns as double morphants. The knock-down at higher doses (3.125 
mg/ml splice site morpholino) recapitulated these results (data not shown). 
 
Fig. 17 Neurogenin expression is reduced in dmrt5 but not dmrt3 morphants: Comparison of 
neurogenin expression in forebrain domains after single and double knock-down of dmrt 3 and 5 at 24 
hpf in lateral view of head regions. While dmrt3 knock-down embryos showed no change in 
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neurogenin expression domains throughout the forebrain (B), the knock-down of dmrt5 (C) resulted in 
reduced neurogenin expression in the dorsal telencephalon (1), the preoptic area (2) and the ventral 
midbrain (4b). Adjacent neurogenin expression domains remained unaffected (3, 4a and 5). Dmrt3 and 
dmrt 5 double morphants (D) recapitulated the reduced neurogenin expression as described in dmrt5 
morphants. Used morpholino concentrations were 1.6 mg/ml. Scale bars: 50 µm, letters in red indicate 
domains with reduced neurogenin expression. 
The down-regulation of neurogenin was restricted to domains that were overlapping with 
dmrt5 expression while non-overlapping neurogenin expression domains remained unaffected 
(Fig. 18). Thus, it seems that dmrt5 and not dmrt3, is required for neurogenin expression in 
dorsal telencephalon, olfactory epithelium, preoptic area and ventral midbrain. In addition, 
when dmrt5 was knocked-down using dmrt5 morpholinos alone, the severity of neurogenin 
down-regulation correlated with the amount of unspliced dmrt5 RNA. Embryos injected with 
3.125 mg/ml splice-blocking morpholino showed a slightly stronger neurogenin down-
regulation than embryos injected with 1.6 mg/ml (data not shown). Based on the fact that 
concentrations of 3.125 mg/ml dmrt5 morpholino were sufficient to block dmrt5 pre-mRNA 
splicing efficiently, this concentration was used for all following experiments. 
 
Fig. 18 Overlapping expression domains of dmrt5 and neurogenin at 24 hpf: Dmrt5 expression 
domains are shown in red and neurogenin in blue. Arrows define overlapping expression domains of 
both genes A, A’ and A”: lateral bright field, fluorescence and overlay of both. B, B’ and B”: dorsal 
bright field, fluorescence and overlay of both. Dmrt5 and neurogenin expression overlap in dorsal 
telencephalic, olfactory epithelium, preoptic area and ventral midbrain cell populations. Scale bar: 50 
µm.  
In order to delineate the epistatic relationship between dmrt3 and dmrt5, the expression of 
dmrt5 in dmrt3 morphants and vice versa was analysed. The knock-down of dmrt3 upon 
injection of 3.125 mg/ml splice morpholinos did neither increase nor reduce the expression of 
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dmrt5 (31/31) when compared to wild type (69/69) or dmrt3 control morpholino injected 
embryos (43/43, Fig. 19 a-c). The injection of control morpholino was used to exclude the 
possibility that the observed phenotypes were due to unspecific effects of morpholino 
injection. On the contrary, knock-down of dmrt5 upon injection of 3.125 mg/ml splice 
morpholinos resulted in a loss of telencephalic dmrt3 transcription (59/59) when compared to 
wild type (57/57) and dmrt5 control morpholino injected embryos (43/43, Fig. 19 d-f). Since 
dmrt3 is expressed in a subset of dmrt5 positive cells and is dependent on dmrt5 expression, 
these results place dmrt5 at a higher hierarchical level during forebrain development than 
dmrt3. Whether Dmrt5 regulates dmrt3 directly at the transcriptional level or whether the 
down-regulation is a secondary effect due to neurogenesis defects remains unclear at the 
moment.  
 
Fig. 19 Revealing epistatic hierarchies between dmrt3 and dmrt5: Dmrt5 expression was analysed in 
dmrt3 morphants and vice versa. A-C: Examination of dmrt5 transcription after dmrt3 knock-down. No 
alterations were observed between controls (A/B) and dmrt3 morpholino injected embryos (C). D- F: 
Knock-down of dmrt5 in contrast resulted in a complete loss of dmrt3 expression while controls were 
unaffected. Used morpholinos are mentioned in the lower left-hand corner of each image. Lateral 
views, anterior to the left. Scale bar: 20 µm. 
Taken together, dmrt3 is expressed in a small subset of dmrt5 positive cells in the dorsal 
telencephalon and a dmrt3 knock-down had no visible effect on neurogenin transcription. 
Moreover, its expression is dependent on dmrt5 expression yet it is not known if dmrt3 
expression is regulated directly by Dmrt5 or if Dmrt5 regulates other processes that lead to 
dmrt3 regulation. Moreover, my data show that dmrt5 apparently has roles in multiple regions 
of the forebrain through the regulation of neurogenin expression. Therefore, follow-up studies 
were designed to further understand dmrt5 and its role during embryonic brain development. 
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3.4 Role of dmrt5 for dorsal telencephalon, olfactory region and pituitary development 
The data obtained above revealed that a reduction of Dmrt5 altered neurogenin expression in 
the a) dorsal telencephalon, b) olfactory region, c) pituitary, d) preoptic area and e) ventral 
midbrain. Potential neurogenesis defects in these regions were scrutinized. Furthermore, the 
expression of genes known to be involved during neurogenesis was analysed to resolve the 
position of dmrt5 in neuro-regulatory gene cascades. The following subsections elaborate on 
the differentially modulated gene expression patterns in wild type and dmrt5 morphant 
embryos. The concentration of injected dmrt5 splice site morpholinos was kept at 3.125 
mg/ml unless stated otherwise. To focus on the main changes seen in morphants, images of 
control morpholino injected embryos are shown in the Appendix. 
3.4.1 Dmrt5 knock-down results in dorsal telencephalic differentiation defects 
Firstly, expression of proneural genes other than neurogenin was analysed to determine if the 
transcriptional regulatory defects were only limited to neurogenin or if dmrt5 morphants show 
a general effect on proneural gene expression. Expression of neuroD, zash1a and zash1B was 
analysed in the dorsal telencephalon (Fig. 20). NeuroD is expressed throughout the whole 
dorsal telencephalon (Fig. 20 c) while zash1b is only expressed in cell populations of the 
anterior telencephalon and lateral ventricle walls (Fig. 20 e). In dmrt5 morphant embryos, 
neurogenin expression was strongly down-regulated in the dorsal telencephalon, yet the 
expression was not completely gone (20/20, Fig. 20 b). In contrast, neuroD (31/31; 29/29 in 
dmrt5 morphants injected with a morpholino concentration of 1.6 mg/ml) and zash1b (37/41), 
expression was almost completely absent in the dorsal telencephalon of dmrt5 morphants 
(Fig. 20 d/f). Additionally, although only weakly expressed in dorsal telencephalic regions of 
wild type embryos, I also observed a down-regulation of zash1a in dmrt5 morphants (34/35) 
when compared to wild type embryos (data not shown). TUNEL staining was performed to 
determine if the lack of neurogenin expressing cells was due to increased apoptosis, however 
this was not the case as the embryos did not show elevated apoptosis in dorsal telencephalic 
regions at this stage (see page 78, Fig. 28). The observed phenotype was also not rescuable by 
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p53 morpholino co-injection, which confirms that the detected defects are specific for the 
dmrt5 knock-down (data not shown).  
 
 
cephalon (arrow) and lateral ventricle walls (arrow head). All tested proneural genes were down-
regulated in dmrt5 morphants (B/D/F). Dorsal views, anterior to the left. Scale bar: 20 µm. 
As the expression levels of several proneural genes were found to be down-regulated, 
neuronal differentiation and specification processes were evaluated through the expression 
pattern of the post-mitotic neuronal marker, HuC/D and telencephalic markers, fezf2 and 
pou50. In wild type embryos, fezf2 and pou50 genes are expressed in a broad spectrum of 
neuronal cells as well as a subset of dorsal telencephalic neurons (black arrows, Fig. 21 c/e). 
These cell populations are believed to be post-mitotic since their expression domains overlap 
with HuC/D. In dmrt5 morphants, HuC/D signals were reduced in all tested embryos (n= 5) 
when compared to wild type embryos (white brackets, Fig. 21). Additionally, fezf2+ (20/20) 
and pou50+ cell populations were absent in the dorsal telencephalon of dmrt5 morphants (Fig. 
21). The down-regulation of fezf2 was not rescuable by co-injection with a p53 morpholino 
(37/37) indicating specificity of this defect, while pou50 expression was not tested in dmrt5/ 
p53 double morphants. These data show that dmrt5 morphants portrayed an impaired 
neuronal differentiation defect in telencephalic neurons most likely caused by the lack of 
proneural gene expression. 
Fig. 20 Knock-down of dmrt5 
leads to down-regulation of 
proneural genes zash1b and 
neuroD: Expression of 
neurogenin (A/B); zash1b 
(C/D) and neuroD (E/F) in the 
dorsal telencephalon of wild 
type and dmrt5 morphants at 
25 hpf. In wild type embryos 
(A/C/E), dominating proneural 
genes expressed in this area 
were neurogenin and neuroD 
(boxed areas), while zash1b 
was expressed only in the 





differentiated neurons (arrows, D/F). Dorsal views, anterior to the left side. Scale bar: 20 µm. Dashed 
line: boundary to olfactory epithelium. 
Next, I tested the expression of her genes, to determine if Dmrt5 regulation of proneural gene 
expression occurs through direct or indirect means. The family of her genes encodes 
inhibitors of proneural gene transcription and consequently prevents neuronal differentiation. 
Therefore, telencephalic and diencephalic her gene expression was analysed to test for 
possible ectopic gene expression. In wild type embryos, the two her genes her4.1 and her15.1 
are expressed around the ventricular surfaces in dorsal telencephalic regions (boxed areas, 
Fig. 22 c/e). In contrast to her4 and her15, her6 is not expressed in the dorsal telencephalon of 
wild type embryos (arrow, Fig. 22 a) and is only expressed in a small population of anterior 
telencephalon cells (asterisk, Fig. 22 a) and diencephalic expression domains. In dmrt5 
morphants on the other hand, endogenous expression of her4.1 (39/40) and her15.1 (85/94) 
were diminished. Interestingly however, the diencephalic her6 expression domain extended 
into the dorsal telencephalon (44/45, p53 co-injection: 39/39). It is known that her6 acts as 
transcriptional repressor of proneural genes (Scholpp et al., 2009); hence its ectopic up-
regulation can explain the previously described reduction of proneural gene expression. 
Consequently, neuronal differentiation processes are impaired and numbers of post-mitotic 
(HuC/D) and differentiated (fezf2/pou50) neurons are strongly reduced. 
Fig. 21 Dmrt5 morphants 
show neuronal differentiation 
defects in the telencephalon: 
A/C/E: wild type embryos. 
B/D/F: dmrt5 morphants. 
Presence of neuronal 
differentiation in wild type 
embryos as indicated by 
HuC/D signals in the dorsal 
telencephalon (A). The same 
white bracket as shown in A is 
superimposed in B to illustrate 
the lack of post-mitotic 
neurons in dmrt5 morphants. 
Only a small population of 
cells within this post-mitotic 
cell cluster express fezf2 or 




pared to wild type embryos (C-F). A/B are lateral views while C-F are dorsal views. Anterior is to the 
left. Scale bar: 20 µm. 
Given that her genes are upstream of proneural genes, up-regulation of her6 explains the 
observed neuronal differentiation defects in the dorsal telencephalon of dmrt5 morphants. 
Moreover, the observed expression changes of her4.1 and her15.1 can also be explained by 
the ectopic up-regulation of her6. Her6 expression starts in the neuroectoderm and gets down-
regulated to restricted expression domains, for example the mid-diencephalic boundary 
(Pasini et al., 2001; Scholpp et al., 2009). It seems that the down-regulation of her6 is a pre-
requisite for neuronal specification and differentiation and that the observed ectopic 
expression of her6 is maintained from earlier stages. The findings in dmrt5 morphants are in 
accordance with findings in mouse, where it has been shown that the her6 homologue Hes1 is 
earlier expressed than the her4 homologue Hes5 (Kageyama et al., 2008). This supports the 
idea that different her genes may label different stem cell populations. The ectopic up-
regulation of her6 could indicate that early stem cell populations are maintained in their early 
state and fail to develop into more differentiated her4/her15+ stem cell/progenitor 
populations. 
 
Fig. 22 The knock-down of 
dmrt5 affects her gene 
expression in the 
telencephalon: her genes 6, 
4.1 and 15.1 displayed altered 
expression patterns upon dmrt5 
knock-down. Her6 was 
ectopically expressed and 
expanded from its original 
diencephalic expression 
domain into the dorsal 
telencephalon (arrows, A/B). 
Her genes 4.1 and 15.1, which 
are normally expressed in the 
dorsal telencephalon (boxed 
area), were strongly down- 




3.4.2 The knock-down of dmrt5 leads to the maintenance of very early neural stem cell 
populations  
To test the possibility that the dmrt5 knock-down influences neural stem cell development, I 
analysed expression of marker genes for different neural stem and progenitor populations. At 
first, the expression of notch genes was examined. Notch proteins are known to be positive 
regulators of her gene expression (Takke et al., 1999; Hatakeyama et al., 2004). Hence, 
possible alterations in endogenous notch expression could explain the observed transcriptional 
changes of her genes. Therefore, dorsal telencephalic expression of notch3 was analysed in 
controls and morphants. In wild type embryos, notch3 transcripts are detectable in cell 
populations restricted to the ventricular zone and ventricle wall and label putative radial glia 
populations (arrow, Fig. 23 a). Notch3 expression overlaps completely with that of her4 and 
her15 (Fig. 22 c/e and Fig. 23 a). Both her genes are thought to be transcriptionally regulated 
by Notch3. This hypothesis is consistent with findings in dmrt5 morphants, where notch3 
transcripts were absent from the dorsal telencephalon (37/40) as well as the expression of both 
her4.1 and her15.1 genes. The ectopic her6 expression upon knock-down of dmrt5 indicates 
that the underlying regulatory transcriptional mechanisms are independent from Notch 
signalling. This is in accordance with mouse data that showed that telencephalic expression of 
the homologue of her6 (Hes1) is insensitive to Notch signalling (Hatakeyama et al., 2004). 
In addition, Notch-signalling has also been reported to be involved in radial glia maintenance 
(Yoon et al., 2008; Chapouton et al., 2010). Since a down-regulation of Notch-signalling 
components was observed, a reduced number of radial glia cells was expected. Thus, neural 
radial glia markers, blbp and gfap were investigated in wild type and dmrt5 knocked-down 
embryos (Fig. 23). In wild type embryos, both markers are expressed in dorsal telencephalic 
cell populations and label probably distinct radial glia populations that also express notch3, 
her4 and her15 (Fig. 22/23). In contrast, in dmrt5 morphants the radial glia markers, gfap 
(39/42) and blbp (72/74), were absent from the telencephalic ventricular zones (Fig. 23 f/h). 
This suggests that these radial glia populations were not formed in dmrt5 morphants. It seems 
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that Dmrt5 is required for the formation of radial glia populations from very early neural stem 
cell populations and that the loss of Dmrt5 results in the prolonged maintenance of early 
neural stem cell populations. 
 
To address the question if the down-regulation of dmrt5 leads to increased numbers of early 
neural stem cells, expression of early neural markers sox2 and pax6a was analysed. In wild 
type embryos, both genes are expressed at low levels in few cells of the telencephalon (pax6a: 
out of focus; sox2: arrows, Fig. 24). Conversely, dmrt5 morphants showed expanded pax6a 
expression from diencephalic domains into the dorsal telencephalon (30/30, Fig. 24) and the 
ectopic up-regulation of sox2 expression (36/37, Fig. 24). The ectopic sox2 and pax6a 
expression patterns overlapped completely with ectopic her6 expression and supported the 
idea that early neural stem cell populations were maintained in dmrt5 morphants. This 
suggests that Dmrt5 activity is required for the switch of early neural stem cells to neurogenic 
active notch3+/her4+/blbp+ or gfap+ radial glia cells. Without this switch, neuronal 
Fig. 23 Dmrt5 knock-down 
results in reduced radial glia 
pools: Expression analysis of 
notch3 (A/B), her4.1 (C/D), 
gfap (E/F) and blbp (G/H) 
expression. A/C/E and G: wild 
type embryos at 25 hpf. 
Images B/D/F and H show 
dmrt5 morphants at the same 
stage. As a consequence of the 
dmrt5 knock-down, radial glia 
populations are not formed and 
marker expression was 
missing. Morphants showed 
strongly reduced notch3 (B), 
her4.1 (boxed, D), gfap (F) 
and blbp (H) transcription. 
Dorsal views of 25 hpf 
embryos, anterior is to the left. 
Scale bar: 20 µm. 
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differentiation processes are blocked and neither radial glia nor terminally differentiated 
neurons are formed.  
 
Lastly, I analysed the size of the telencephalon in embryos stained for shh and krox20. Shh is 
expressed in the floor plate, the ventral diencephalon in the anterior forebrain and close to the 
forebrain-midbrain boundary (arrow heads, Fig 25). The expression domain close to the 
forebrain-midbrain boundary is also referred to as zona limitans intrathalamica: zli. Krox20 is 
expressed in rhombomeres 3 and 5 and its expression does not overlap with dmrt5 (arrow, 
Fig. 25). A knock-down of dmrt5 was not expected to influence the position of the krox20 
staining, which was used as an internal landmark. I measured the length of the most anterior 
shh-expression domain to the forebrain-midbrain boundary and the length from there to 
rhombomere 3 in wild type (n=9) and dmrt5 morphant embryos (n=20). By analysing the size 
ratios of anterior versus posterior head regions, I was able to exclude that the general brain 
structure was changed. The ratios between anterior to posterior head region were not 
significantly different between wild type and dmrt5 morphant embryos (pdmrt5Mo- wt= 0.27, Fig. 
25 a/b’). This finding implicates that the general brain structure was unaltered. Additionally to 
the general brain structure, I evaluated if the forebrain itself was changed in dmrt5 morphants. 
To evaluate this, I was using the unchanged shh-expression domain close to the forebrain-
midbrain boundary (arrow, Fig. 25 a”/b”) as well as the recess between the telencephalon and 
diencephalon (dotted line, Fig. 25 a”/b”) as internal landmarks. The measured average 
distance between both landmarks was 22.9 µm in wild type embryos and around 57.7 µm in 
Fig. 24 Knock-down of dmrt5 
results in ectopic pax6a and 
sox2 expression: Wild type 
embryos express only low 
levels of pax6a and sox2 in 
dorsal telencephalic brain 
domains (arrows, A/C). Dmrt5 
morphants showed ectopic 
telencephalic up-regulation of 
both genes (boxed areas, 
B/D). Dorsal views, anterior 
to the left. Scale bar: 20 µm. 
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dmrt5 morphants (Fig. 26 a). The telen-/ diencephalon boundary was shifted anteriorly due to 
a decreased size of the dorsal telencephalon, while the location of the shh-expression domain 
was unchanged. The increase in distance was considered to be extremely significant (pdmrt5Mo- 
wt= 5.5E-10). This shows that dmrt5 morphant telencephala are significantly smaller than in wild 
type embryos probably because of the previously described effects on neuronal stem and 
progenitor cells. To confirm that adjacent midbrain structures were unaffected, dorsal wnt1 
expression was scrutinized. The wnt1 expression domain in the dorsal midbrain was not 
significantly changed between control embryos and dmrt5 morphants (pdmrt5Mo- wt= 0.38, Fig. 
25 c/d and Fig. 26 b). This and the unchanged ventral midbrain expression domain of shh 
(Fig. 25 a’/b’) showed that effects caused by the knock-down of dmrt5 were restricted to the 
forebrain and didn’t affect other brain regions.  
 
boundary to rhombomere 3) shh-expression domain. n wt = 9; ndmrt5Mo = 20. Close-up images A”/B”: 
observed distances between the telencephalon/diencephalon boundary and the ventral shh-expression 
domain adjacent to the zona limitans intrathalamica (ZLI). Can you increase the contrast here, so that 
boundary becomes more visible. C/D: Dorsal midbrain structures were stained for wnt1 expression and 
to evaluate if dmrt5 morphants show size differences in the midbrain. The length of the dorsal wnt1 
expression domain was measured and showed no differences between dmrt5 morphants and controls. 
n= 9. Embryos are 24 hpf. Lateral views, anterior to the left. Scale bars: A-B’: 100 µm, A”/ B”: 20 µm 
and C/D: 50 µm. 
Fig. 25 dmrt5 morphants have 
smaller telencephala consistent 
with neuronal stem cell 
depletion: A-B’’: A double in-
situ was carried out to visualize 
shh (arrowhead) and krox20 
(arrow) expression. Boxed areas 
in A and B are the same areas as 
shown in A’’/B’’. A’/B’: 
Schematic drawing of shh/ 
krox20 expression domains 
observed in wild type and dmrt5 
morphants. Numbers shown are 
the average ratios between 
anterior (pituitary to forebrain-
midbrain boundary) and 




Fig. 26 Statistical analysis of measured distances in dmrt5 morphant and control embryo brains: A) 
Comparison of the measured distances between telen-/ diencephalon boundary to shh-stained ZLI 
expression domain as shown in figure 36 A”/B”. Dmrt5 morphants showed a significant increase in the 
distance. P-values: ***< 0.001, pdmrt5Mo- wt= 5.5E-10; pdmrt5Mo-ctr mo= 7.3E-10. nwt= 9; ndmrt5mo= 20, nctr mo= 
11. B) Measured length of the dorsal midbrain as indicated by wnt1 expression. No significant changes 
were observed between morphant and control embryos. n= 9.  
In summary, Dmrt5 seems to be an important regulator of dorsal telencephalic neurogenesis 
as it appears to control the timing and process of neural stem cell differentiation from early 
stem cells to more differentiated and neurogenic radial glia pools. The lack of neurogenic 
radial glia also explains the reduced numbers of differentiating and differentiated neurons.  
3.5 Dmrt5 is required for stem cell survival and neuronal differentiation in the olfactory 
system; 
Dmrt5 expression starts at the bud-stage in the forming pre-placodal olfactory fields (see page 
57, Fig 11 c/c’) and is maintained in olfactory epithelia as observed at 24 hpf and 52 hpf (see 
page 57, Fig. 11 e’), however with reduced expression levels after 52 hpf. Since I observed 
neuronal differentiation defects in the dorsal telencephalon where dmrt5 expression overlaps 
with neurogenin expression, I also scrutinized proneural gene expression in olfactory 
epithelia. For that neurogenin, neuroD and zash1a expression was analysed by RNA in-situ 
hybridization in wild type and dmrt5 morphant embryos at 25 hpf. At this stage neurogenin is 
only expressed in a few cells of the olfactory epithelium (arrow head, Fig. 27 a), while 
neuroD is expressed throughout the epithel (Fig. 27 e). Zash1a is expressed at the lateral 
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telencephalon, neurogenin (20/20) and zash1a (34/35) expression were down-regulated in 
morphants (Fig. 27 b/d). However, olfactory neuroD transcription was only slightly down-
regulated (31/31 and 29/29 in dmrt5 morphants injected with a morpholino concentration of 
1.6 mg/ml, Fig. 27 f) and none of the dmrt5 morphants showed a complete absence of neuroD 
transcripts. In addition, it is not clear if the observed reduction of neuroD expression was a 
direct consequence of the dmrt5 knock-down or an indirect consequence of the reduced size 
of olfactory epithelia. Embryos at this stage showed slightly smaller olfactory epithelia which 
could explain the observed effects for olfactory neuroD expression. 
 
 
type domains that are affected in dmrt5 morphants are marked with arrowheads. Embryos were at 25 
hpf. Dorsal views, anterior to the left. Scale bars: 20 µm 
Neurogenin and zash1a were down-regulated in the telencephalon and the olfactory 
epithelium. Contrary, neuroD expression was strongly down-regulated in the telencephalon 
but only mildly affected in the olfactory epithelium. This suggests that the underlying 
mechanisms controlling proneural gene expression may be different between both regions. 
Therefore, expression analysis of all previously tested telencephalic genes were expanded to 
the olfactory epithelium to test for potential changes in transcriptional networks that control 
neurogenesis. There were no apparent transcriptional changes detected in sox2, notch3, her6 
and pax6a, genes that are considered to be responsible for the phenotypical changes observed 
in the dmrt5 morphant telencephalon (data not shown). This finding confirms that 
Fig. 27 Proneural gene 
expression is reduced in the 
olfactory placode of dmrt5 
morphants: Expression of 
proneural genes neurogenin 
(A/B) and zash1a (C/D) were 
down-regulated in dmrt5 
morphants (B/D). Insets are 
close-up images of affected 
cells. NeuroD expression was 
slightly reduced but still present 
in morphants and may represent 
the reduced size of the olfactory 
epitehlium (E/F). A/C and E: 
wild type embryos; B/D and F: 




neurogenesis regulatory networks or the function of dmrt5 in these networks are different 
between distinct brain regions. 
However, since dmrt5 morphants showed reduced proneural gene expression in the olfactory 
epithelium, I analysed if the lack of proneural gene expression may affect cell survival of 
undifferentiated stem- or progenitor cells in the developing nose. For that, apoptosis was 
examined by TUNEL-staining in wild type, control morpholino, control morpholino plus p53 
morpholino, dmrt5 morpholino and dmrt5 plus p53 morpholino injected embryos at 24 hpf 
(Fig. 28). The concentration of dmrt5 splice site morpholinos and control morpholinos was 
3.125 mg/ml and the concentration of the p53 morpholino was 5 mg/ml. Wild type embryos 
were weakly stained and barely showed any apoptosis across the forebrain (4/5, Fig. 28 a). 
TUNEL staining of control morpholino injected embryos showed markedly increased 
unspecific apoptosis throughout the mid- and hindbrain (boxed area, Fig. 28 b/b’) but 
importantly not in the olfactory epithelium (4/5). Apoptosis in the mid- and hindbrain was 
completely rescued by co-injection with p53 morpholino indicating that the increase in 
apoptosis was caused by unspecific morpholino effects. On the other hand, dmrt5 morphants 
showed extensive apoptosis in olfactory epithelium (4/5). The increase in olfactory apoptosis 
could not be rescued by p53 morpholino co-injection, demonstrating that olfactory epithelium 
apoptosis was due to the dmrt5 knock-down (4/5, Fig. 28 c/c’). 
 
Fig. 28 Fluorescence TUNEL assays to visualize apoptosis in 
embryonic forebrain regions: Wild type (A), control morpholino, 
control morpholino plus p53 morpholino injected (B/B’), dmrt5 
morpholino and dmrt5 plus p53 morpholino injected embryos 
(C/C’) were TUNEL stained. Overlay of bright field and 
fluorescence images are shown. Wild type embryos showed barely 
any apoptosis in the forebrain. 
B) Control morpholino injected 
embryos showed unspecific 
apoptosis in mid- and 
hindbrain regions (boxed) that 
could be rescued by p53 
morpholino co-injection (B’). 
C) Contrary, dmrt5 morphants 
showed only little apoptosis in 
the midbrain but increased 
apoptosis in the olfactory 
epithelium (circled area, 
arrow). C’) Olfactory 




In addition to 24 hpf, apoptotic events were also examined at 31 and 48 hpf. At 31 hpf, 
apoptosis in olfactory epithelia was still significantly increased in dmrt5 and dmrt5/ p53 co-
injected morphants compared to controls (Fig. 29 a). At 48 hpf, apoptosis in developing 
olfactory regions was still slightly elevated in dmrt5 morphants when compared to controls 
although this increase was not significant (Fig. 29 b).  
 
Fig. 29 Average number of apoptotic events in the olfactory epithelium: Average number of apoptotic 
events measured in the developing olfactory epithelium at 31 hpf and 48 hpf. A) Apoptosis was 
significantly increased at 31 hpf in dmrt5 morphants in comparison to the used controls. n= 5 B) At 48 
hpf, apoptotic levels in dmrt5 morphants were comparable to those observed in wild type embryos. 
Dmrt5 knock-down induced apoptosis was not rescuable by p53 morpholino co-injection. n= 4-6. An 
unpaired t-test was used to calculate p-values. P-values: * < 0.05; ** p< 0.01.  
As proneural gene expression was reduced and neuronal differentiation pathways may 
potentially be impaired in dmrt5 morphants, I next tested if apoptotic cells had the identity of 
undifferentiated neuronal stem- and/or progenitor cells. This was done by labelling control 
and dmrt5 morpholino injected embryos with BrdU that labels proliferative cells in S-phase or 
anti-pH3 antibodies, which marks dividing stem- and progenitor cells in M-phase. Based on 
the BrdU or pH3 labelling, the numbers of dividing cells in wild type and control morpholino 
as well as dmrt5 morpholino injected embryos were determined. All tested control embryos 
(wild type and control morpholino injected embryos) displayed a crescent-shaped BrdU 
domain along the edges of the olfactory epithelium (Fig. 30 a/a’). This illustrated that 
embryos were rich in proliferative olfactory stem- and/or progenitor cells at 24 hpf. In 
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proliferating cells was reduced and suggesting that the identity of apoptotic cells were that of 













Furthermore, control and dmrt5 morphant embryos were analysed for phospho-Histone3, 
which labels proliferative stem-/ progenitor cells (Fig. 31). When compared to control 
embryos, dmrt5 deficient embryos showed a significant reduction in pH3+ cells in the 
olfactory region. Numbers of cells counted positive for pH3 were reduced from 26.3wt/ 
27.6ctrMo to 19.3 in dmrt5 morphants (pdmrt5Mo-wt = 0.0149; pdmrt5Mo-ctr Mo = 0.0002, Fig. 31). 
Based on the observation that both markers for dividing stem and/or progenitor cells were 
reduced while apoptotic rates were increased in olfactory epithelia of dmrt5 morphants, I 
suggest that undifferentiated olfactory stem and/or progenitor cells initiated programmed cell 
death upon dmrt5 knock-down. 
Fig. 30 BrdU labelled uninjected wild type and 
dmrt5 morphants: Examples of wild type (A) 
and dmrt5 morpholino injected embryos (B), 
stained with BrdU and fixed at 24 hpf. Dmrt5 
morphants had reduced numbers of BrdU labelled 
olfactory stem and/or progenitor cells (arrow). 
Dorsal view, anterior to the left. A’/ B’: 
Comparison of wild type and dmrt5 morphants at 
higher magnification. Compared to wild type 
embryos, fewer BrdU labelled cells were detected 
along the edges of olfactory epithelia 
(arrowhead). Overlay of bright field and 





Interestingly, at later stages I also detected defects in telencephalic areas that were adjacent to 
the developing olfactory epithelium, which will give rise to the olfactory bulbs. At 24 hpf, 
wild type, control morpholino and dmrt5 morpholino injected embryos showed no obvious 
apoptotic differences in telencephalic regions adjacent to developing olfactory epithelia (see 
page 78, Fig. 28). However, examination of these telencephalic regions at 31 hpf revealed 
first signs of increased apoptosis (Fig. 32 a), which became more evident at 48 hpf (Fig. 32 
b). The elevated apoptosis observed in control morpholino injected embryos were unspecific 
since p53 morpholino co-injection rescued the apoptosis phenotype. Additionally, regions of 
apoptotic events in control morpholino injected embryos were found throughout the entire 
telen- and diencephalon (data not shown).On the other hand, dmrt5 morpholino injected 
embryos showed a distinct apoptosis pattern positioned within the prospective olfactory bulbs, 
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Fig. 32 Increased apoptosis in the 
developing olfactory bulbs: Number of 
telencephalic apoptosis events at A) 31 
hpf and B) 48 hpf. Apoptosis at 48 hpf 
was further separated into events 
detected in telen- /diencephalon (blue 
columns) and lateral telencephalon/ 
olfactory bulb regions (green columns). 
A) At 31 hpf, a significant increase in 
apoptotic events was observed in dmrt5 
morphants when compared to wild type 
embryos. Embryos analysed: n= 5.  
* * 
Fig. 31 Numbers of pH3+ cells in olfactory 
regions of 24 hpf embryos: Numbers of 
pH3+cells in control- (wild type or control 
morpholino injected) and dmrt5 morpholino 
injected embryos. Cell counting was 
performed as a blind study where five 
embryos from each sample set were randomly 
selected. A significant down-regulation of 
pH3+ cells in the morphants could be detected. 
P-values were calculated using unpaired t-test. 
*= p< 0.05; ***= p< 0.001. n=5 
 
     




 Continue Fig. 32: B) The overall telen- / diencephalon apoptosis values were not significantly 
different (blue columns), but apoptosis in the lateral telencephalon was significantly increased in dmrt5 
morphants when compared to controls. n= 4-6. An unpaired t-test was used to calculate p-values. P-
values: (*) = 0.052; * < 0.05; ** p< 0.01. 
A progressive increase in apoptosis over time and reduced numbers of stem- and/or 
progenitor cells resulted in morphological changes that became phenotypically visible in the 
olfactory system (olfactory epithelium and associated developing olfactory bulbs) in dmrt5 
morphants at 52 hpf (Fig. 33 b/d/f). The olfactory epithelium of dmrt5 morpholino injected 
embryos appeared smaller and less structured when compared to that of wild type or control 
morpholino injected embryos. Five weeks old morphants also showed characteristically 
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(except frontal views). Images A-F DIC images, G/H bright field. Scale bars: A-F: 20 µm, G/H: 200 
µm. 
 
It was earlier shown that the development of higher olfactory structures within the 
telencephalon is dependent on the interaction with developing olfactory placodes and vice 
versa (Whitlock, 2004). This interaction is mediated through axonal projections from 
olfactory neurons to the telencephalon. Since undifferentiated olfactory stem/progenitor cells 
were dying in dmrt5 morphants, followed by the increased apoptosis in lateral telencephalic 
fields, it could be possible that such interactions between olfactory placodes and telencephalic 
fields were disturbed. Therefore, I stained axonal projections with a fluorescent antibody 
against acetylated tubulin and visualized axons by confocal microscopy to evaluate if axon 
development is impaired in dmrt5 morphants. As shown in figure 34 the size as well as the 
structure of olfactory epithelia was affected in dmrt5 morphants when compared to wild type 
embryos. Besides this, reduced numbers of large nerves were found around the olfactory 
epithelium of dmrt5 morphants (arrows, Fig. 34). The origin of these larger nerves is 
Fig. 33 Increased apoptosis 
and reduced cell division lead 
to smaller olfactory epithelia 
and olfactory bulbs: The 
knock-down of dmrt5 resulted 
in embryos with smaller 
olfactory epithelia (circled area, 
B/D/F, second olfactory 
epithelia not clearly visible) 
when compared to wild type 
embryos (A/C/E). At later 
stages (5 weeks), differences in 
the size of the olfactory bulb 
became visible between wild 
type and Dmrt5 depleted fish 
(white arrow, G/H). Gaps, 
normally not visible in wild 
type, were detectable between 
both olfactory bulbs (bracket, 
H). Lateral (A/B), dorsal (C/D) 
and frontal (E/F) views of 52 
hpf embryos; Dorsal views of 5 
weeks old adolescent fish in 
G/H; Anterior is to the left 
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unknown. However, the location adjacent to the olfactory epithelium suggests that these 
nerves may be involved in signal transmission from or to the nose. This would support the 
idea that an impaired crosstalk between olfactory epithelium and telencephalon could be 
partially responsible for the developmental defects observed in both structures. In addition to 
smaller noses and less nerves, less olfactory cilia (asterisk, Fig. 34) were detected in dmrt5 
morphants. This either indicates that the numbers of olfactory sensory neurons were reduced 
or that the development of cilia was impaired. The reduction in olfactory neurons could be 
explained by the increased cell death of olfactory stem or progenitor cells, while the lack of 
proneural gene expression may have influenced differentiation programs important for 
olfactory cilia development. 
 
Fig. 34 Dmrt5 morphants exhibit reduced numbers of olfactory sensory neurons and olfactory 
nerves: Controls and dmrt5 morphants were immunostained with an antibody against acetylated 
tubulin. While wild type (A/A’) and dmrt5 control morphants (C/C’) showed well developed olfactory 
pits with numerous olfactory sensory neurons (OSN, marked by asterisk), dmrt5 morphants illustrated 
considerably smaller olfactory pits and less OSN. Note that cilia of OSN are rich in acetylated tubulin 
giving an oversaturated signal from the olfactory pits. Depending on slightly different imaging angles, 
strong signals from clusters of cilia might prevent an optimal resolution of the olfactory pit (as seen in 
A or C). Additionally, dmrt5 morphants were missing large nerves that were surrounding the olfactory 
epithelia (arrows). Slight differences in the signal intensities from these large nerves are seen between 
wild type and uninjected control embryos.  
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In summary, dmrt5 morphant embryos are characterized by the down-regulation of proneural 
genes, neurogenin and zash1a, indicating that neuronal differentiation or specification 
processes are impaired in progenitor cells of the developing olfactory epithelium. 
Additionally, the number of olfactory stem- and/or progenitor cells is down-regulated. Higher 
apoptotic rates and reduced proliferative capacity were found in corresponding regions. This 
suggests a loss of undifferentiated stem cells pools. As a cumulative effect of persistently 
increased apoptosis, the morphants have smaller olfactory cups which show a less developed 
olfactory epithelium. Furthermore, telencephalic domains in close proximity to the developing 
nose are also marked by increased apoptosis. Although the apoptosis in olfactory associated 
telencephalic domains mainly occur at later stages, this eventually manifests as 
phenotypically visible smaller olfactory bulbs. 
3.6 Dmrt5 regulates corticotrope differentiation in the pituitary 
The early development of the pituitary is very dynamic and occurs during the first 30 hpf 
when cells are migrating from antero-lateral to more postero-medial positions. The pituitary is 
formed from pre-placodal fields which also express dmrt5. Dmrt5 transcripts could be 
detected in these pre-placodal fields from bud-stage onwards (asterisk, Fig. 35 a). Based on 
their position and behaviour, dmrt5 expressing cells stained in ventral head regions at 24 hpf 
were most probably migrating pituitary cells (arrowhead, Fig. 35 b). Definitive expression in 
pituitary cells was confirmed from 48 hpf onwards (Fig. 35 c/c’). Due to the expression of 
dmrt5 in presumptive and terminally differentiated pituitary cells during the time window of 





Fig. 35 dmrt5 expression in pituitary cells: Expression of dmrt5 in pituitary pre-placodal fields started 
at bud-stage (asterisk, A) and could be detected throughout pituitary cell migration (arrowhead, B) and 
pituitary formation (C/C’). A: dorsal and lateral view; B/C: lateral views, anterior to the left; C’: cross 




Proneural gene expression in potential migrating pituitary cells was analysed during the first 
30 hpf and seemed to be normal in dmrt5 morphants (data not shown). Therefore, wild type, 
control morpholino and dmrt5 morpholino injected embryos were examined at 48 – 74 hpf, 
after the pituitary has been formed. Marker genes specific for pituitary endocrine cell 
populations, with overlapping expression domain to dmrt5 in the anterior pituitary, were 
investigated. Expression of the following genes was analysed in controls and dmrt5 
morphants (cell type in brackets): prolactin (prl: lactotropes), proopiomelanocortin (pomc: 
corticotropes and melanotropes) and pituitary glycoprotein alpha (gsu-a: thyrotropes and 
gonadotropes). Dmrt5 morphants showed a down-regulation of pomc expression restricted to 
corticotropes of the anterior pituitary (40/42, arrow head, Fig. 36) while melanotropes in the 
posterior pituitary maintained pomc expression (asterisk, Fig. 36). The down-regulation could 
not be rescued by p53 morpholino co-injection (18/22, data not shown). The other marker 
genes seemed to be unaffected upon dmrt5 knock-down.  
Previous reports have shown a transdifferentiation from pomc to prl expressing cell fates 
when Delta-Notch signalling is affected (Dutta et al., 2008). To test whether lack of dmrt5 
expression promotes transdifferentiation of corticotropes to lactotropes, the prl expression 
domain was analysed in wild type and morphant embryos. If transdifferentiation would have 
occurred in dmrt5 morphants, an elevated number of prl+ cells and a concentrated prl domain 
with reduced pomc expression were expected. However, no obvious change in the number of 
prl+ cells was detected (50/50, Fig. 36). Moreover, gaps in between single lactotropes 
remained prl negative which suggests that transdifferentiation from pomc+ to prl+ cells did not 
take place (Fig. 36 c/d). Indeed, the gaps between single stained cells seemed to be increased 
(Fig. 36 d inserts) with a slight but significant expansion of the prl domain to the posterior 
(pdmrt5Mo-wt = 0.000811, pdmrt5Mo-ctr Mo = 0.001084; Fig. 36 g). The identity of those cells that 
were unstained and intermingled with prl positive cells remains unknown, but the neuronal 
differentiation defects observed in the other brain regions suggest that pituitary (pomc) 
progenitor cells might have failed to differentiate and remained unstained for corticotrope 
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specific marker expression. In order to evaluate if the lack of pomc expressing cells was due 
to increased apoptosis of undifferentiated corticotrope progenitors, TUNEL stainings were 
performed at 24, 31 and 48 hpf (data not shown). The time window between 28 to 31 hpf is 
important for pituitary development, since it has repeatedly been shown that the lack of 
factors involved in pituitary formation could lead to increased apoptosis in pituitary cells in 
this period (Herzog et al., 2004; Pogoda et al., 2006). In contrast to the situation in previous 
reports, no apoptosis was observed in regions of interest during this critical time window. 
Since apoptosis of corticotropes or corticotrope progenitor cells could be excluded, I tested if 
defects during pituitary patterning could explain the lack of pomc positive corticitropes. For 
that expression of pituitary homeobox 3 (pitx3) was analysed in morphants and controls. Pitx3 
is expressed before pituitary formation and demarcates pituitary pre-placodal fields (Dutta et 
al., 2005). Its function is crucial for pituitary development and it labels all cells irrespective of 
their cell type.  
  
B/D/F: dmrt5 morphant pituitaries. Dorsal views in C and D show several representative examples to 
demonstrate the more loose structure of prl domains in dmrt5 morphants. Images are split in lateral 
close up (left) and dorsal close up (right). Outlines of pituitaries in lateral views are labelled with dotted 
lines. Scale bar: 20 µm  
 
Fig. 36 Expression analysis of 
pomc, prl and pitx3 in dmrt5 
morphants: Expression of 
pomc (A/B), prl (C/D) and 
pitx3 (E/F) was analysed to 
reveal the function of dmrt5 
during pituitary development. 
Dmrt5 morphants were 
characterized by a down-
regulation of pomc in 
corticotropes (arrow, B), while 
pomc expression in 
melanotropes (arrow head b) 
was unaffected. Prl and pitx3 
expression showed also no 
obvious differences (D/F). A/C 





No changes in pituitary pitx3 expression were visible between dmrt5 morphants (35/35) and 
control embryos, suggesting that the basic pituitary patterning was not affected (Fig. 36 e/f). 
The length and width of the pituitary were also unchanged between controls and dmrt5 
morphants. The thickness of dmrt5 pituitaries were slightly but significantly increased (Fig. 
36 h). The measured pituitary dimensions in dmrt5 morphants confirmed indirectly that pomc 
negative cells were still present at this stage and were not lost through increased apoptosis.To 
test if upstream regulators of POMC synthesis were possibly affected in dmrt5 morphants, 
hypothalamic crh (corticotrophin-releasing hormone) expression was analysed. CRH is 
known to regulate POMC synthesis and is important during stress responses (Chandrasekar et 
al., 2007; Alsop et al., 2009; Alsop et al., 2009), but no crh expression differences could be 
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G) Ratio of length of the stained prl domain/ total 
length of pituitary. In dmrt5 morphants, the prl 
domain was expanded posteriorly in comparison to 
controls. An unpaired t-test was used to calculate 
p-values: **= p< 0.01, ***= p< 0.001. N= 7- 10. 
H) Overview of the total size of measured 
pituitaries in morphant and control embryos. 
Pituitary size was unchanged in length and 
broadness, but the thickness was slightly but 
significantly increased in dmrt5 morphants. 
Calculated p-value thickness: pdmrt5Mo- wt = 
0.002961. Number of tested embryos: n= 8-10.  
 
  
***                                        ** 




Reduced levels of Dmrt5 result in the reduced expression of pomc in anterior pituitary cells 
without increasing prl expression in adjacent lactotropes. Increased apoptosis of pomc cells 
could be excluded since pituitary apoptotic rates and overall pituitary dimensions were 
normal. I therefore suggest that the observed data are consistent with neuronal differentiation 
or specification defects of corticotrope precursors, which fail to differentiate completely. 
3.7 Dmrt5 regulates neuronal differentiation in the neurosecretory preoptic area and 
ventral midbrain 
This chapter describes two other brain structures that were affected in Dmrt5 deficient 
embryos: the neurosecretory preoptic area (npa) and the ventral midbrain (vmb). Both tissues 
were identified and scored as affected based on down-regulated neurogenin expression 
(circles area, Fig. 37). Besides neurogenin, transcription of zash1a was also decreased in the 
ventral midbrain regions (Fig. 37 d). These observations are in line with the described data 
from the dorsal telencephalon and the olfactory epithelium and indicate that the loss of 
proneural genes may also affect neuronal differentiation in the npa and vmb. In the present 
study, I analysed the identity and function of affected neuronal stem cell and/or progenitor 
populations in the ventral midbrain and the preoptic area.  
 
unchanged (B).Ventral midbrain expression of zash1a was also decreased (asterisk, D). Lateral views, 
anterior is to the left. Scale bar: 50 µm.  
Previous studies have shown that the preoptic area is the birth place of neuro-endocrine cells 
(Szarek et al.; Del Giacco et al., 2008). Since proneural genes were down-regulated and 
* 
Fig. 37 Neuronal 
differentiation defects in the 
neurosecretory preoptic area 
and ventral midbrain: 
Proneural gene expressions of 
neurogenin (A/B) and zash1a 
(C/D) at 24 hpf. Additionally to 
previously identified regions, 
neurogenin expression was 
reduced in the neurosecretory 
preoptic area (npa, circled) and 
the ventral midbrain (vmb, 
circled) while adjacent 
expression domains remained  
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neural differentiation and specification defects were expected in dmrt5 morphants, I looked at 
the expression of neuro-endocrine cell fate determinants of neuro-endocrine cell populations. 
Genes were chosen, whose expression overlapped with that of dmrt5 and neurogenin in the 
preoptic area: orthopedia homolog a (otpa), orthopedia homolog b (otpb) and simple-minded 
homolog 1a (sim1a) (Del Giacco et al., 2006; Eaton et al., 2006; Eaton et al., 2007; Eaton et 
al., 2008). As demonstrated in figure 38, expression of all three hypothalamic neuro-
endocrine fate determinants was strongly reduced in dmrt5 morphants (arrow, otpa: 64/67, 
otpb: 63/63, sim1a: 59/60). The down-regulation of all three genes was not rescuable by p53 
morpholino co-injection (data not shown). This indicates that Dmrt5 controls cell fate 
decisions in the neurosecretory preoptic area via regulation of otpa/ otpb and sim1a 
transcription. Noteworthy, the reduction of gene expression was restricted to those areas that 
overlapped with dmrt5 in the preoptic area while most ventral expression domains of these 
three genes were unaffected in dmrt5 morpholino injected embryos (asterisk, Fig. 38).  
  
shown in G/H were fixed at 31 hpf. Anterior is to the left. Scale bars: A/B: 100 µm, C-H: 20 µm. 
Fig. 38 Down-regulation of 
hypothalamic fate 
determinants in dmrt5 
morphants: Dmrt5 deficient 
embryos show reduced 
expression of hypothalamic fate 
determinants: otpa (A- D), otpb 
(E/F) and sim1a (G/H) in 
preoptic areas. Images A/C/E 
and G: wild type embryos, 
Images B/D/F and H: dmrt5 
morphants. Ventral, 
diencephalic expression 
domains were unaffected in 
morphants (asterisk, B). A and 
B are lateral overview images. 
C-H: magnified dorsal views 
from the preoptic area. Arrows 
indicate affected cell 
populations and asterisk mark 
unaffected ventral diencephalic 
cell populations. Embryos A to 




A knock-down of dmrt5 resulted in the down-regulation of otpa, otpb and sim1a. It was 
shown previously that a down-regulation or a loss of these hypothalamic fate determinants 
affects the development of preoptic and hypothalamic neuro-endocrine cell populations (Lohr 
et al., 2009). As regulators of neuro-endocrine cell development were reduced in dmrt5 
morphants, I next examined if these neuro-endocrine cell populations were developed 
normally in dmrt5 morphants. For that, expression of marker genes for preoptic and 
hypothalamic neuro-endocrine cell populations was analysed. Arginine vasopressin-like 
(avpl) and oxytocin-like (oxtl) label pre-optic cell populations while somatostatin1.1 (sst1.1), 
thyrotropin releasing hormone (trh), tyrosine hydroxylase (th) and corticotrophin releasing 
hormone (crh) mark hypothalamic neuro-endocrine cells. 
 
expression domains were labelled with an arrow. Embryos were at 52 hpf, anterior to the left. Scale 
bars: A/B: 50 µm, C/D: 20 µm. 
As shown in figure 39, expression of oxtl and avpl were both strongly down-regulated in the 
preoptic area. This was expected since transcription of endocrine fate determinants was 
reduced in the corresponding progenitor populations (see page 90, Fig. 38). However, 
hypothalamic transcripts of avpl were still detectable in dmrt5 morphants (arrow, Fig. 39 c/d). 
This indicates that the effects on neuro-endocrine cell populations were restricted to the otpa, 
otpb and sim1a progenitor domains that overlap with dmrt5, while dmrt5 non-overlapping 
domains were unaffected. In accordance with that, the expression of hypothalamic ventral 
Fig. 39 Dmrt5 morphants 
show absence of 
neurosecretory cells in the 
preoptic area : Double in-situ 
staining of wild type (A/C) and 
dmrt5 morphants (B/D). 
Expression of oxtl in red, avpl 
in blue. Neither oxtl nor avpl 
transcripts were detected in 
dmrt5 morphants (B/D). A/B: 
lateral views, C/D dorsal 
views, expression domains of 
oxtl and avpl are boxed. 
Unchanged hypothalamic avpl 
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brain markers (sst1.1, th, crh and avpl) were comparable to that of wild type embryos (data 
not shown). 
The defects observed in the ventral midbrain were similar to those found in the preoptic area. 
Transcriptional levels of neurogenin, zash1a and sim1a were decreased (see page 88, Fig. 37 
and Fig 40 b). Considering a similar role of Sim1a in endocrine fate determination in preoptic 
area and ventral midbrain, the endocrine marker gonadotropin releasing hormone 2 (gnrh2) 
was analysed in the ventral midbrain. Its expression was found to be down-regulated in dmrt5 
morphants (Fig. 40 d/f) and cell counts of gnrh2 positive (gnrh2+) cells in ventral midbrain 
regions at 48 hpf and 74 hpf showed significant differences in cell numbers between dmrt5 
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Fig. 40 Dmrt5 morphants 
show neuro-endocrine 
differentiation defects in 
ventral midbrain regions: 
Ventral midbrain expression 
pattern of sim1a (A/B) and 
gnrh2 (C-F) were diminished 
in morphants (B/D/F) but not 
in controls (A/C/E). A/B: 
sim1a expression, down-
regulated midbrain domains 
are labelled with arrows. C-
F: gnrh2 expression. Dorsal 
views, anterior to the left. 
Scale bar: 20 µm. 
***                 *** ***                 *** 
93 
 
Fig. 41 Statistical analysis of gnrh2 positive (gnrh2+) cell populations: Control and morphant 
embryos at A) 48 hpf and B) 74 hpf. Only in Dmrt5 deficient embryos but not in the control 
morpholino injected embryos, the number of gnrh2+ were significantly reduced. An unpaired t-test was 
used to calculate p-values: 48 hpf: ***= p< 0.001. Number of analysed embryos: n= 5. 
Taken together, the preoptic area and ventral midbrain of dmrt5 morphants showed reduced 
proneural and cell fate determinant gene expression. As a consequence, neuronal 
differentiation and specification processes are defective resulting in a loss of specific neuro-
endocrine cell populations. Hence, Dmrt5 is required for the development of the neuro-
endocrine system and it is important to note that the observed effects on gnrh2 positive cell 
populations could ultimately led to gonadal development defects. This would be the first time 
to show that a member of the dmrt gene family may influence gonadal development in a non-
gonadal, non-autonomous manner and would provide an interesting link between brain and 
sex development. 
3.8 Generation of dmrt3 targeting zinc finger nucleases and dmrt3 mutant zebrafish 
In order to knock-out dmrt3, it was first necessary to determine optimal ZFN binding sites. As 
mentioned in the introduction, Dmrt proteins contain conserved DM-domains that are 
essential for DNA binding. A ZFN mediated genomic frameshift mutation upstream of these 
positions, would either lead a) to alterations of the amino acid sequence of the DM-domain or 
b) result in premature stop-codons and truncated Dmrt3 proteins without a DM-domain. In 
both cases, the DNA binding would be severely impaired rendering Dmrt3 proteins non-
functional.  
To identify the conserved DNA-binding DM-domain, the amino acid sequence of Dmrt3 was 
aligned with other Dmrt-proteins. Based on previous reports (Narendra et al., 2002), key 
amino acids were identified that are essential for DNA binding (Fig. 42, asterisk). While the 
amino acid sequences were identical between Dmrt3 and other Dmrt-proteins at these 
conserved positions, the coding sequences differed. Therefore, generated ZFN will target only 
the dmrt3 loci. The determined dmrt3 target site was located within a RQR motif of the DNA 
recognition helix (green arrow, Fig.42), known to be essential for DNA binding. 




Fig. 42 Alignment of zebrafish and Drosophila DM-domains and selected dmrt3 ZFN binding site: 
Alignment shows the amino acid sequence similarities between D. melanogaster doublesex (dbsx: 
ensemble: FBgn0000504) and zebrafish dmrt1 (ENSDARG00000007349), dmrt2a 
(ENSDARG00000015072), dmrt2b (ENSDARG00000070013), dmrt3a (ENSDARG00000035290) 
and dmrt5 (ENSDARG00000039412). The DM domain of these proteins contains two zinc binding and 
one DNA binding motif. The two zinc-binding domains are marked with black arrows; the DNA-
binding domain is labelled as “DNA-recognition helix”. Note the high degree of amino acid sequence 
conservation within the DM-domains. Amino acid residues essential for dbsx DNA binding are labelled 
with asterisks. Point mutations at any of these amino acid residues results in an impaired DNA binding 
(Narendra et al., 2002). The green arrow indicates the location of the expected ZFN cleavage site 
within the dmrt3 sequence.  
To determine potential ZFN binding sites, bioinformatic tools ZiFit 
(http://bindr.gdcb.iastate.edu/ZiFiT/) and ZFPsearch 
(http://pgfe.umassmed.edu/ZFPsearch.html) were used. The chosen ZFN binding site (Fig. 
43) contained an internal MspA1l restriction site in the spacer region for convenient 
identification of dmrt3 ZFN knock-out embryos by RFLP analysis.  
 
  
   B)  5’ ---tCGAGCGGCAgcgggtGATGGCAGCt---  3’ 
3’ ---aGCTCGCCGTcgcccaCTACCGTCGa---  5’ 
5’ ZFN2 TS 




Fig. 43 Schematic drawing of designed ZFN and their binding sites with respect to the dmrt3 DM 
domain: A) The binding of the two ZFN to their target sites in the encoding sequence for the Dmrt3 
DM domain is mediated via its two zinc finger proteins (blue boxes). Each of the zinc finger proteins 
contains three distinct zinc finger domains (ZFD; not indicated) that binds to specific target site 
nucleotide triplets. The cut of the target sequence is mediated via the FokI heterodimer (yellow/brown 
boxes). B) Target sequences of the ZFN’s: Bold, capital letters indicate the two binding sites of the two 
ZFN. Differentially coloured nucleotide triplets mark specific binding sites of distinct ZFDs. The 
spacer region between left and right ZFN binding site is shown in small letters. A MspA1l restriction 
site spans the boundary between the left ZFN binding site and the spacer. 3’ indicates that the target 
site (TS) is located downstream of the spacer region, while 5’ labels the target site upstream of the 
spacer sequence. 
Additionally, ZFPsearch provides the user with sequences for degenerated primers that were 
used to customize a template zinc finger in a way that it binds to the determined dmrt3 target 
site. A list of used primers can be found in the Appendix A2 and the minimum diversity of 
resulting plasmid pools can be found in table 17.  
Table 17 Overview of generated zinc finger libraries: 
5p ZF (zinc finger 2) 
Module preparation  
Library Diversity 
(Selection on target site 
vector)  
3p ZF (zinc finger 1) 
Module prep.  
Library Diversity 
(Selection on target site)  
Module 1  18432 (ZF2TS1)  Module 1  221184 (ZF1TS1)  
Module 2  110592 (ZF2TS1TS2) 
110592 (ZF2TS2_2)  
Module 2  6912 (ZF1TS1TS2)  
Module 3  13824 (ZF2Dmrt3) 
13824 (ZF2TS3_2)  
Module 3  12288 (ZF1Dmrt3)  
 
Table legend: Depending on the level of primer degeneration for zinc finger module (ZFM) synthesis, 
pools of different ZFM encoding amplicons had to be generated and cloned into ZF expression vectors. 
The numbers indicate the minimum size of different ZFM- encoding plasmid libraries and correspond 
to the level of primer degeneration that were used to generate the libraries. The abbreviations noted in 
brackets name the corresponding target sites. ZF= zinc finger; TS= target site; several sequential target 
sites are labelled TS1TS2, while particular single target sites are labelled TS”position of the triplet”_2. 
 
After identification of the potential ZFN target site, the standard zinc finger zif268 (Addgene) 
had to be changed from its preferred binding site towards the identified dmrt3 target site. This 
was done via PCR-based mutagenesis. Degenerated primers were used in a first round of PCR 
to amplify new, variable ZFMs (Fig. 44; lanes 2) at one out of three possible ZFM positions. 
PCR amplified fragments encoding for the other two ZFMs remained unchanged. Modified 
fragments and the unchanged two neighbouring ZFM were annealed with each other resulting 
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in amplicons that encode for a new zinc finger protein (Fig. 44; lane 3). The annealing of 
different modules was done with a modified PCR protocol (see 2.5.3; Table 12/13). 
Depending on the mode of selection (see 2.5.3; Fig. 8), different annealing strategies were 
used, but only one out of three zinc finger modules was changed at a time while the remaining 
two domains remained unchanged. The two unchanged neighbouring modules were used as 
anchors that position the new assembly over its target site. 
              
                 
Annealed fragments were cloned into the plasmid pB1H2Ω2, from which zinc finger proteins 
are expressed as fusion proteins with an N-terminally fused RNA-polymerase. Expression 
plasmids were transformed into his- deficient bacteria harbouring the corresponding dmrt3 
target site plasmid pH3U3. Only if the expressed zinc finger fusion protein binds to its target 
region in pH3U3, the RNA-polymerase is positioned in close proximity to the promoter of the 
Histidine-synthetase and the used bacterial strain is capable to survive the selection on the 
Histidine deficient selection media (for more details see chapter 2.5.2). In addition, the 
selection plates contained an increasing concentration gradient of 3-AT, allowing to 
distinguish between low affine and high affine dmrt3 zinc finger proteins. By selecting only 
those colonies that are able to survive on high 3-AT concentrations, it was ensured to isolate 
plasmids encoding for zinc finger modules with high affinity to the dmrt3- target site. After 
transformation of plasmids encoding for modified zinc finger proteins, selection plates were 
incubated for two to five days at 37°C and removed when first bacterial colonies became 
visible (Fig. 45).  
Fig. 44 Amplification and annealing of zinc finger module 1 
using degenerated primers: Lane 1: DNA ladder. Lane 2: PCR 
amplified and customized fragment encoding for zinc finger 
module 1 (354bp). Lane 3: After annealing of ZFM1 with 
oligonucleotide 1 (Oligo1: 76bp) only one band with the 
corresponding size of the annealed fragment (412bp) were 
detectable on the TAE gel. The illustrated annealing of ZFM1 
with oligo1 is exemplarily for all performed annealing steps of 
different module encoding fragments. 








Fig.45 Selection of binding zinc fingers on NM-media plates: NM-media selection plates lack 
Histidine but contain a 3-AT gradient ranging from 0 mM to 40 mM. A) Positive control: original 
Zif268 selected against its preferred target site. The right half of the plate was covered with a bacterial 
lawn that showed a high to low density gradient from low to high concentrations of 3-AT. The left half 
of the plate remained empty for this experiment. B) Left half shows a negative control, where the 
template zinc finger was selected against the customized dmrt3 target side. Experimental results on the 
right side of the plate showed a bacterial lawn density gradient from a high number of colonies at the 
lowest stringency to single colonies at high concentrations of 3-AT. 
Colonies growing at relative high concentrations of 3-AT indicating high affinity binding of 
the selected ZFM to the dmrt3 target site were pooled and ZFP encoding plasmids were 
isolated from these as plasmid libraries. After isolation of plasmids from 3-AT resistant 
colonies, single plasmids as well as the whole library were sequenced to identify changes in 
the sequence of the DNA binding domains. As shown in figure 46, sequencing results of 
single plasmids confirmed altered zinc finger domains within PCR mutagenized modules. The 
changes within these domains were variable in nature as expected due to the high degree of 
primer degeneration. The high variability in the zinc finger domain encoding sequence is also 
reflected by the ‘N’ residues at all altered positions in the sequencing results for the pooled 
library. 
0 mM 
A)      B) 




Fig. 46 Confirming modifications of particular zinc finger domains by sequencing: Sequence 
alignment of randomly picked ZF-expression plasmids after the first selection round. The sequence at 
the top shows the coding sequence for template zif268. All six zinc finger domains were highly diverse 
within sequences encoding the DNA-binding domain of the first ZFM. The lane “lib” illustrates the 
sequenced pool of all selected plasmids and shows that the whole library is varied as evident by ‘N’ 
residues. 
Depending on the selection strategy, the modifications of different zinc finger domains were 
done in parallel for all three modules or sequentially one module after each other. While 
parallel selection was faster, it selected only modules that bound best to dmrt3 nucleotide 
triplets flanked by two original zif268 target sites not taking the module context into account. 
Hence, the resulting whole dmrt3 ZF protein may not contain modules that interact well with 
each other. Since the binding of one zinc finger module can influence the binding of the 
neighbouring module, the used sequential selection method addressed this problem better than 
the parallel selection method and increased the chances of a successful selection process. The 
disadvantage of this method was that one selection step had to be completely finished before 
the next module was tested.  
After the last selection round, 13 different zinc finger proteins were identified for the 3’ target 
sequence, while only one zinc finger protein was identified for the 5’ target sequence. The 
selected ZFP were generated via the sequential selection method as modular assembly yielded 
no dmrt3 binding ZFP. To address the question, which of the isolated 3’ zinc finger proteins 
bound best to the desired dmrt3 target site, a comparative affinity assay was performed (Fig. 
47). Equal amounts of zinc finger expression plasmids encoding for one particular dmrt3-zinc 
finger protein were transformed into the same amount and batch of his- deficient bacteria. His- 
bacteria harbouring the complete dmrt3 target site plasmid were plated out next to each other 
on 3-AT selection plates. Bacteria synthesizing high-affine ZFP were able to survive and 
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grow at higher concentrations of 3-AT. By comparing the maximum growth front of the 
different bacterial lawns, it was possible to distinguish high affine dmrt3 ZFPs from lower-
affinity ZFPs (Fig. 47).  
 
bacteria were able to survive the most stringent conditions whereas ZF1-17 transformed bacteria 
survived only less stringent conditions. 
After identification of the three best binding 3’ ZFPs and one 5’ ZFP, a unique BamHI 
restriction site was introduced 3’ of the completed ZF assembly by means of PCR 
mutagenesis and plasmids were digested with KpnI/BamHI. ZFP coding fragments were 
isolated and cloned into Fok-RR/Fok-DD endonuclease expression vectors resulting in 
plasmids encoding for four customized dmrt3 zinc finger nucleases (Fig. 48 a), three for the 
3’ target site and one for the 5’ target site. Since the Fok-endonuclease is active as dimer, two 
ZFNs have to interact with each other to introduce frameshift mutations. Based on the yield of 
distinct ZFN plasmids, three different ZFN combinations were possible from which all were 
tested. Plasmids encoding ZFNs for the right as well as the left dmrt3 target site were 
linearized with NotI. Plasmids were purified and mRNAs encoding the desired ZFN were 
prepared according to the protocol. mRNA concentrations from 20 to 100 ng/µl were injected 





Fig. 47 Comparative ZF-
binding assay: To find out 
which of the ZFP showed 
highest binding efficiencies, 
equal amounts of ZF encoding 
plasmids were transformed 
into US0- cells and plated out 
next to each other on 3-AT 
gradient plates. The 3-AT 
concentration ranged from 0 
mM (bottom) to 60 mM (top). 
Positive control on the right: 
original zif268 selected against 
its original target site. Black 
bars represent the maximum 
growth front of the bacterial 
lawns. As shown in this 
picture, ZF1-1 transformed  
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into one-cell stage zebrafish embryos and surviving injected fish were analysed for genomic 
dmrt3 frameshift mutations. 
 
                   
position 130 to the C-terminus. B) Qualitative and quantitative analysis of synthesized, polyadenylated, 
capped mRNA encoding for dmrt3 binding ZFN’s Lane 1 and 4: RNA ladder; Lane 2: ZFN1_1; Lane 
2: ZFN1_14; Lane 5: ZFN1_7; Lane 6: ZFN2_24. Note that the picture shows two different gels from 
two separate mRNA synthesis experiments.  
The evaluation of ZFN activity and identification of potential founder fish was done by 
analysing isolated genomic DNAs from ZFN injected zebrafish using the T7 endonuclease 
assay. The assays were used to identify mutations in the dmrt3 locus. T7 endonuclease 
recognizes and cuts hair pin loops in DNA-hybrids, formed between normal and frameshift 
dmrt3 gDNA (see 2.5.6, Fig. 10). The size of the undigested dmrt3 homodimer was 382bp. If 
heterodimers between wild type and mutant dmrt3 amplicons were formed, a T7 mediated cut 
around the spacer region was expected. Hence, T7 digested heterodimers were expected to be 
around 200bp in size. I analysed 72 ZFN mRNA injected embryos with T7 endonuclease but 
only 13 of the embryonic gDNA showed a partial digestion into smaller fragments whose 
sizes corresponded to the expected fragments. A representative result is shown in Fig. 49 a. 
Correct T7 activity under the used experimental conditions was confirmed as positive control 
fragments were digested almost completely (labelled ‘+’, Fig. 49 a). Reactions yielding 
additional bands with sizes corresponding to the T7 digested dmrt3 fragments were sequenced 
A) 
Fig. 48 Amino acid sequences of 
selected ZFNs and prepared mRNA: 
A) Amino acid sequence alignment of 
generated 3’ ZFNs. The N-terminal 
end contained the three ZFDs (motifs 
different from the original zinc 
finger). The FokI-RR endonuclease 
domain extended from amino acid  
 
 









(reaction products sequenced labelled with asterisk, Fig. 49). Unfortunately, no frameshift 
mutation within the dmrt3 loci was detectable (Fig. 49 b). In addition to the “T7 pre-
screening” of embryos, I also sequenced pools of ZFN mRNA injected embryos directly 
without T7 pre-screening. In total, 200 embryos were sequenced (20 pools with 10 embryos 
each) that were previously injected with the two ZFN combinations: ZFN1-7 x ZFN2-24 and 
ZFN1-14 x ZFN2-24. Unfortunately, all tested sequences were negative for a dmrt3 mutation 
(data not shown). A possible explanation for positive T7 results could be that dmrt3 
amplicons formed internal loop-structures during the re-annealing, which then got digested by 
T7 giving “false-positive” results. Finally, expression of dbx1a was analysed as it was shown 
to be strongly down-regulated in dmrt3 morphants (Rajaei, PhD Thesis, 2012). I analysed 10 
embryos injected with the two ZFN combinations (ZFN1-1 x ZFN2_24 and ZFN1-14 x 
ZFN2_24) and compared the cell numbers of dbx1a positive (dbx1a+) cells in a defined region 
of the spinal cord to wild type embryos. The ratio of dbx1a+ cells per somite were unaffected 
in ZFN mRNA injected embryos (5.12 and 5.99 dbx1a+ cells/somite compared to 5.79 dbx1a+ 
cells/somite in wild type). Taken together, these data suggest that the self-designed 
customized ZFNs, although showing efficient binding in the in-vitro selection assay, were not 
affine enough to bind and cut the zebrafish dmrt3 loci in-vivo in embryos.  
 
Fig. 49 T7 endonuclease screen of 
ZFN injected single embryos: A) T7 
endonuclease treated dmrt3 
amplicons generated from gDNA of 
ZFN injected embryos were 
analysed on a 1.5% TAE gel. Lanes 
1, 20 and 21: DNA ladder. Lanes 2-
19 and 22-25: T7 digested dmrt3 
amplicons. Lanes 2-19 and 22/23 
were dmrt3 amplicons of ZFN 
mRNA injected embryos. Lanes 
24/25: amplicons of uninjected 
control embryos (labelled ‘c’). Last 
lane: various annealed ZFP encoding 
fragments used as positive control 
(‘+). gDNA from samples labelled 





Fig. 49 continued: B) Alignment of sequenced dmrt3 amplicons from ZFN injected embryos that 
showed additional bands after T7 endonuclease digest. The binding sequences (TS) of both ZFNs as 
well as the sequence of the spacer region that was expected to be cleaved by FokI are indicated above 
the alignment. None of the sequences showed mutations around the expected cleavage site of the ZFN. 
Based on these results, our laboratory purchased a pair of tailor-made dmrt3 ZFN from 
ToolGen (South Korea). These ZFNs were generated according to a protocol provided by 
ToolGen. Both ZFN pairs consist of a 3-module and a 4-module ZFP separated by a spacer of 
five to six base pairs. Therefore, binding affinity and specificity were expected to be higher 
than our own self-made ZFNs. Predicted binding locations were directly 3’ of the dmrt3 start 
codon and introduced frameshift mutations were expected to result in pre-mature translational 
stops and non-functional Dmrt3 proteins (Fig. 50). Plasmid information can be found in the 
Appendix A2.  
 
 
    5’-tcGCCCTACCTCTAcatggGGGGCCCGGtg-3’ 
    3’-agCGGGATGGAGATgtaccCCCCGGGCCac-5’ 
              ZFN2 TS            ZFN1 TS 











CviAII right ZFN#2 TS 
Left ZFN#2 TS  
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Fig. 50 Schematic overview about the predicted target sequences of the commercial ZFNs and their 
location with respect to the DM domain: A) The binding of the two ZFN to their target site in the 
encoding sequence for the dmrt3 DM domain is mediated via its two zinc finger proteins (green boxes). 
The cut of the target sequence is mediated via the two FokI heterodimer (yellow/brown boxes). B) 
Target sequence of ZFN’s: Bold, capital letters indicate the two binding sites, while differentially 
coloured nucleotide triplets mark the binding sites of distinct zinc finger modules. The spacer region 
between left and right ZFN binding site is shown in small letters. A CviAII restriction site spans the 
boundary between the left ZFN binding site and the spacer and can be used for diagnostic purposes. 
The predicted cleavage site is around 25-30bp downstream of the start codon. 
Only ZFN pair #2 were processed since it had a higher in-vitro activity than ZFN pair #1 
(personal communication, ToolGene). Plasmids encoding ZFN pair #2 were linearized with 
XhoI and purified according to the protocol. Capped mRNA was transcribed using T7 
polymerase according to the protocol. Synthesized mRNAs needed to be polyadenylated (Fig. 
51) since XhoI cuts before the plasmid-internal poly-A signal. 
   
Capped mRNAs at a concentration between 20 to 100 ng/µl were injected into 1-cell stage 
zebrafish embryos. Genomic DNAs from pools as well as single embryos were isolated and 
analysed for frameshift mutations introduced by dmrt3 ZFN using RFLP analysis. Using a 
restriction enzyme cutting site for CviAII located in the spacer region between the left and the 
right ZFN binding site, gDNA based amplicons from different ZFN-injected embryos were 
screened for frameshift mutations. At first, 100 pooled embryos (10x 10 ZFN mRNA injected 
embryos) were screened to evaluate the activity of the used ZFN in a large scale approach. 
For this, I isolated pooled gDNA, amplified fragments of the dmrt3 loci that flanked the new 
ZFN target site and digested the amplicon with CviAII. Native dmrt3 amplicons containing 
the CviAII restriction site were digested in the middle of the sequence resulting in fragments 
of around 350bp in size (arrow, Fig. 52). dmrt3 fragments cleaved by ZFN were devoid of the 
Fig. 51 Polyadenylation reaction of transcribed 
ZFN mRNA: mRNAs encoding two different 
ZFN pairs were transcribed from ZFN encoding 
template plasmids and polyadenylated. Lanes 
labelled with ‘-‘: unprocessed mRNA’s. Lanes 
labelled with ‘+’: polyadenylated ZFN mRNA’s. 
A size shift from unprocessed to processed 
mRNA indicates a successful poly-A reaction. L 
and R are abbreviations for the left and the right 
target site binding ZFN. 
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CviAII restriction site. Thus, the presence of undigested amplicons with a size at around 
700bp (asterisk, Fig. 52) was indicative for mutated dmrt3 loci and active ZFNs. As shown in 
figure 21, 8 out of 10 pools were partially insensitive to CviAII-digestion since fragments 
with a size of around 700bp were detected on TAE gels. Amplicons from uninjected control 
embryos were completely digested. This shows that enzyme conditions were optimal and 
suggests that the undigested fragments were mutated dmrt3 amplicons. After evaluating that 
the commercial ZFNs were active in zebrafish embryos, I repeated the injections and analysed 
single embryos using the same CviAII assay as for pooled embryos. Results recapitulated the 
obtained data from the pooled embryos assay and showed that ZFNs were very efficient in 
introducing frameshift mutations into the genomic dmrt3 locus. 15 out of 19 tested embryos 
showed amplicons insensitive to CviAII digestion while 8 out of 8 uninjected control embryos 
were completely digested (data not shown). To verify that the commercial ZFNs mutated the 
genomic dmrt3 locus, undigested fragments were gel extracted, cloned and sequenced. 
Sequencing data confirmed frameshift mutations in the dmrt3 loci and showed that one fish 
can have several mutation variants (Fig. 53). 





* * * 
* * * * 
Fig. 52 CviAII restriction fragment 
length polymorphism assay to evaluate 
ZFNs activity: Dmrt3 amplicons were 
generated from pooled gDNA and 
digested by CviAII. Lanes 1 and 37: 
DNA ladder. Lanes 2, 5 and 7: DNA 
fragments obtained from uninjected 
wild type fish. Fragments were 
completely digested (arrows). Lanes 9- 
36: DNA fragments from ZFN mRNA 
injected embryos. In 8 out of 10 
samples, some of the dmrt3 amplicons 
remained undigested leaving a higher 
molecular weight band (asterisk). This 
suggests that ZFNs mutated the CviAII 
restriction site in the spacer region. 





                     ZFN#2L            ZFN#2R 
                 ------------catg    g--------- 
Native_dmrt3:  TCGCCCTACCTCTACATG----GGGGGCCCGGTGTCCCAGCC   
    dmrt3_12:  TCGCCCTACCTCTACATG----GGGGGCCCGGTGTCCCAGCC   
     dmrt3_3:  TCGCCCTACCTCTACATGCATGGGGGGCCCGGTGTCCCAGCC  (+4) 
     dmrt3_1:  TCGCCCTACCTCTAAA-------GTCGCCCGGTGTCCCAGCC  (+1,∆4) 
     dmrt3_2:  TCGCCCTACCTCT------------CGCCCGGTGTCCCAGCC  (∆8) 
    dmrt3_11:  TCGCCCTACCTCTA-----------------GTGTCCCAGCC  (∆13) 
     dmrt3_9:  TCGCCCTACCTC--------------GCCC----TCCCAGCC  (∆14) 
 
Fig. 53 Sequence confirmation of dmrt3 frameshift mutations: To confirm the identity of CviAII 
undigested fragments, CviAII resistant dmrt3 amplicons of one promising candidate were cloned into 
TOPO blunt vector and sequenced. Several distinct frameshift mutations in the dmrt3 locus could be 
identified after sequencing multiple TOPO clones of one CviAII digestion resistant dmrt3 amplicon. 
The first lane shows the native dmrt3 sequence. Except lane 2 (clone 12), all clones showed mutations 
of different nature. Various insertions and deletions were introduced into the dmrt3 locus. The changes 
in the sequence are indicated on the right site: insertions and the length of inserted sequence as ‘+x’, 
deletions and the length of deletion as ‘∆x’. The two ZFN binding sites are indicated above the 
sequences and the spacer region is shown in lowercase letters. The CviAII restriction site is highlighted 
in yellow. 
ZFN mRNA injected embryos were raised, gDNA was isolated from fin clips and potential 
founders were identified using the above mentioned RFLP assay. From 22 tested founders, 9 
fish were carrying dmrt3 mutations (data not shown). At the moment, positively tested fish 
are individually kept until they are sexually matured. In the future, these dmrt3 mosaic 
mutants will be crossed with each other and wild type fish to identify founder fish. F1 
generation embryos will be analysed using RFLP assays, sequencing the gDNA loci and 
WISH techniques to analyse for changes in marker gene expression such as dbx1a that was 
previously found down-regulated in dmrt3 morphants 
In summary, I generated dmrt3 knock-out zebrafish using tailor-made zinc finger nucleases. 
We will use dmrt3 mutants to support previously generated dmrt3 knock-down data for the 
spinal cord (Rajaei, PhD Thesis 2012) and expand the functional analysis of dmrt3 into 
forebrain regions. Furthermore, since the morpholino mediated dmrt3 knock-down was not 
100% efficient, additional functions of Dmrt3 could become visible in dmrt3 null mutants that 





In Xenopus, dmrt4 is expressed in the anterior neural ridge and becomes restricted to the 
telencephalon and the olfactory placodes at later stages (Huang et al., 2005). Xdmrt4 is 
located upstream of the two proneural bHLH transcription factors neurogenin and xebf2 and 
regulates their expression. Both factors are important for neuronal determination and 
differentiation within the olfactory epithelium. When xdmrt4 was knocked-down, the 
expression of neurogenin and xebf2 was down-regulated and neuronal differentiation was 
impaired. Consistent with this finding, the expression of the pan-neuronal marker NCAM was 
down-regulated indicating that terminal differentiation was affected (Huang et al., 2005). The 
study by Huang et al. (2005) gave a first indication about the function of a DM-transcription 
factor as an essential regulator of neuronal differentiation in the olfactory epithelium. 
However, they failed to show whether the initial neuronal determination and differentiation 
defects in the olfactory epithelium also resulted in a reduced production, differentiation or 
survival of terminally differentiated olfactory neurons at later stages. In addition, the 
functions of xdmrt4 for telencephalic neuronal determination and differentiation remained 
completely unaddressed. 
The zebrafish genome does not contain a dmrt4 ortholog (Volff et al., 2003; Hong et al., 
2007). Instead, two other members of the dmrt family in zebrafish are expressed in the 
developing olfactory placodes and forebrain from earliest stages onwards: dmrt3, which starts 
to be expressed in the early forebrain at 14 hpf, and dmrt5, which commences at bud-stage 
(10 hpf). Their spatio-temporal expression patterns in zebrafish are comparable with that of 
dmrt4 in Xenopus, and coincide with early neuron formation. This suggests possible roles for 
both zebrafish dmrt genes during forebrain neurogenesis.  
The question if dmrt5 has a role during neuronal development in zebrafish was recently 
addressed by Yoshizawa et al. (2011). In this study, the authors analysed the function of 
dmrt5 in the dorsal telencephalon by analysing dmrt5 mutant zebrafish. It was shown in dmrt5 
mutants that her6 expression was ectopically up-regulated in the dorsal telencephalon. As 
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Her6 blocks proneural gene expression (Pasini et al., 2001; Scholpp et al., 2009), neurogenin 
expression was down-regulated leading to neuronal differentiation defects in this brain region 
(Yoshizawa et al., 2011). The study of Yoshizawa et al. indicated that Dmrt5 may have a 
comparable role in the zebrafish telencephalon to that of Xdmrt4 during the development of 
the olfactory epithelium in Xenopus. However, the study of Yoshizawa et al. lacks a) a 
detailed analysis investigating the underlying molecular mechanisms of how Dmrt5 controls 
telencephalic brain development and b) an analysis of early neural stem cell populations. 
Furthermore, they did not address the functional consequences of the differentiation defect in 
the dorsal telencephalon as well as other additional roles of Dmrt5 in the olfactory epithelium, 
pituitary, preoptic area and the ventral midbrain.  
Lastly, it is known from more recent work in mouse (Gennet et al., 2010) that the mammalian 
ortholog of dmrt5 (Dmrta2) is also expressed in the olfactory epithelium, the telencephalon 
and additionally in the ventral midbrain. Dmrta2 is required for the determination and 
differentiation of ventral midbrain cell fates from neural progenitor populations and a reduced 
expression of Dmrta2 led to compromised midbrain differentiation (Gennet et al., 2010). In 
addition, they revealed that the overexpression of Dmrta2 in neuralized stem cells led to 
increased numbers of dopaminergic neurons, which are normally formed from progenitor 
pools of the ventral midbrain. Interestingly and in contrast to mammals, zebrafish 
dopaminergic neurons do not originate from the midbrain (Rink et al., 2001; Rink et al., 
2002; Ryu et al., 2006; Schweitzer et al., 2012). However, based on the study of Gennet et al. 
(2010) it could be that zebrafish Dmrt5 also controls neuronal differentiation and 
determination of midbrain progenitor pools, yet the identity of these pools may differ between 
mammals and zebrafish. So far, nothing is known about the function of dmrt5 in the ventral 
midbrain of zebrafish. 
The aim of this study was to reveal the roles of dmrt3 and dmrt5 during fore- and midbrain 
formation in zebrafish embryos. Although several studies examined the role of DM-
transcription factors for the development of the central nervous system (Huang et al., 2005; 
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Gennet et al., 2010; Yoshizawa et al., 2011), these studies only addressed either distinct 
aspects of development (only early neuronal determination as in Huang et al., 2005; or only 
neuronal differentiation as in Yoshizawa et al., 2011) and/or they analysed only particular 
brain regions (the olfactory placode as in Huang et al., 2005; the dorsal telencephalon as in 
Yoshizawa et al., 2011; or the ventral midbrain as in Gennet et al., 2010). In addition, these 
studies were done in five different models: Xenopus, zebrafish, chick, mouse and neuralized 
stem cell cultures. This study tries to provide a more comprehensive analysis of the functions 
of dmrt3 and/or dmrt5 as well as the underlying molecular mechanisms. Moreover and in 
contrast to previous studies, analysis of dmrt3/5 functions was not restricted to one particular 
brain region of interest. All brain compartments in which dmrt3/5 are expressed during brain 
development of zebrafish were included in this study, namely the dorsal telencephalon, 
olfactory epithelium, ventral midbrain, preoptic area and the pituitary. This provides the 
possibility to analyse and compare the function of dmrt genes between different brain regions 
within one species. To analyse the detailed function of dmrt3 and dmrt5 I used knock-down 
and knock-out approaches using gene specific splice block morpholinos and zinc finger 
nucleases, respectively.  
4.1. Evaluation of dmrt3 and dmrt5 splice site morpholinos for gene-specific knock-down 
For knock-down of dmrt3 function, I used splice site morpholinos that were previously 
characterized extensively in our lab (Rajaei, PhD Thesis 2012). I followed the 
recommendations and morpholino injections were done at a dose of 3.125 mg/ml (personal 
communication Flora Rajaei). The used morpholino dose injections of 3.125 mg/ml resulted 
in a knock-down of endogenous dmrt3 by 67%, which proved to be sufficient to impair spinal 
cord interneuron formation in the absence of apoptosis.  
The dmrt5 splice site morpholinos used in my experiments were newly designed and 
uncharacterized. I therefore first evaluated their splice blocking efficiency and compatibility 
with overall embryogenesis. A combined concentration of 3.125 mg/ml per each dmrt5 
morpholino was sufficient to block splicing of 97% of the dmrt5 pre-mRNA transcripts 
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without affecting overall embryo morphology. Concentrations higher than 3.125 mg/ml per 
morpholino were avoided due to non-specific side effects (data not shown). Based on these 
results (Fig. 14), I used concentrations of 3.125 mg/ml (dmrt3/ dmrt5) splice site morpholino 
during the course of the study. An exception was the dmrt3/dmrt5 double knock-down 
approach, for which I reduced the concentration to 1.6 mg/ml per morpholino per gene 
because injection with concentrations of 3.125 mg/ml per morpholino per gene resulted in 
unwanted morphological alterations and increased apoptosis throughout the bodies of dmrt3/ 
dmrt5 double morphants. 
To determine the specificity of the dmrt knock-down and exclude non-specific morpholino 
defects, observed phenotypes were compared to phenotypes of embryos that were injected 
with control morpholinos that failed to bind and block dmrt splicing (control morpholino 
sequences: see table 1). Representative results of control morpholino injected zebrafish 
phenotypes are given in the main text (Fig. 15, 16, 19, 26, 28, 29, 31, 32, 34, 36, 41) as well 
as in the Appendix A1. In general, the injection of control morpholinos into zebrafish 
embryos did not change the phenotype of control morphants when compared to wild type 
embryos. These data indicate that the observed dmrt3/dmrt5 knock-down phenotype was 
specific due to a gene specific down-regulation of dmrt3/5 and not due to unspecific 
morpholino-induced defects.  
The only difference between the phenotype of control morphants and uninjected embryos was 
the observed up-regulation of apoptosis in dmrt5 control morpholino injected embryos (Fig. 
28, 29 and 32). It was shown previously that some morpholinos induce unspecific apoptosis 
via the activation of the pro-apoptotic protein p53 (Robu et al., 2007). The observed increase 
of apoptosis in control morphants, proved to be unspecific as it was completely rescuable by 
the co-injection of a p53 morpholino. Contrary to this, none of the observed dmrt5 knock-
down phenotypes were rescuable upon co-injection with p53 morpholinos, indicating that 




It is also noteworthy, that there are several instances where the observed defects only affected 
particular cell types, while directly adjacent cell types and brain structures were completely 
normal. As example, pomc positive corticotropes of the anterior pituitary were affected upon 
the knock-down of dmrt5, while pomc positive melanotropes were developing normally (Fig. 
36). These observations indicate the knock-down did not cause a general developmental delay 
of morphants. 
Lastly, I want to point out that a part of the dorsal telencephalon data (alterations of the 
following markers: her6, neurogenin, neuroD, HuC/HuD) are consistent with the findings 
made in the dmrt5 mutant line used by Yoshizawa et al., 2011 indicating gene specific knock-
down activities of the used dmrt5 splice-blocking morpholinos. Taken together, the examined 
phenotypes in dmrt5 morphants are most likely specific due to a gene specific knock-down of 
dmrt5. 
4.2. Dmrt3 and Dmrt5 as regulators of neurogenin expression in zebrafish 
After the evaluation of morpholino activity and specificity, I addressed the function of Dmrt 
proteins during zebrafish fore- and midbrain neurogenesis. As previous studies indicated a 
role for Dmrt proteins during neurogenesis, I analyzed the fore- and midbrain expression 
profile of neurogenin in dmrt morphants to determine if neurogenesis was affected in these 
regions. While dmrt3 morphants showed no change in neurogenin expression, dmrt5 
morphants showed a significant down-regulation of neurogenin in the dorsal telencephalon, 
preoptic area, olfactory placode and ventral midbrain. Dmrt3/dmrt5 double morphants 
exhibited exactly the same defects in neurogenin expression pattern as the dmrt5 morphants, 
demonstrating that double morphants had no synergistic effects with regards to neurogenin 
down-regulation. Thus, I conclude that only dmrt5 but not dmrt3 regulates neurogenin 
expression in the developing zebrafish forebrain. The observed down-regulation of 
neurogenin in the dorsal telencephalon upon the knock-down of dmrt5 confirms previously 
published dmrt5 mutant data (Yoshizawa et al., 2011) but is also consistent with data from 
Xenopus. It seems that zebrafish Dmrt5 is a functional homologue to Xenopus Dmrt4 with 
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regards to the Dmrt-regulated neurogenin expression during the development of the olfactory 
epithelium. Besides these two regions, I observed a down-regulation of neurogenin in the 
ventral midbrain of dmrt5 morphants, which confirms and explains the neuronal specification 
and differentiation role of Dmrt5 during ventral midbrain development as it was indicated in 
mouse and chick (Gennet et al., 2010). In addition, I also observed a down-regulation of 
neurogenin expression in the preoptic area of dmrt5 morphants. A possible neuro-regulatory 
function of a member of Dmrt proteins during preoptic area formation hasn’t been shown so 
far.  
Due to the fact that previous studies analysed individual brain regions in different species, it 
was not possible to directly compare different regions within one species. One similarity 
between all affected brain regions was that the down-regulation of neurogenin expression was 
restricted to those domains that overlap with dmrt5 expression. Importantly, non-overlapping 
domains that do not express dmrt5 were unaffected in dmrt5 morphants. These data strongly 
imply that dmrt5 may play a crucial role during neurogenesis in distinct forebrain regions 
through direct or indirect regulation of neurogenin expression in a cell-autonomous manner. 
However, I also observed tissue specific differences between different brain regions which 
will be discussed in the following sections. 
4.3. Dmrt5 regulates the switch from neuroectodermal stem cells to radial glia cells 
In zebrafish embryos, dmrt5 starts to be expressed at 10 hpf in multipotent neuroectodermal 
stem cells of the anterior neural ridge and the prospective telencephalon. These cells will give 
rise to the olfactory placode as well as cells of the dorsal telencephalon. As neurogenin 
expression was down-regulated in dmrt5 morphants, neuronal determination and 
differentiation defects can be expected in these neuroectodermal stem cell populations. In 
wild type zebrafish embryos at 24 hpf, the dorsal telencephalon can be divided into a 
proliferative and a differentiating region. The proliferative region, or ventricular zone, is 
marked by the expression of blbp and gfap which serve as marker genes for neural stem cells, 
in particular radial glia cells (Kriegstein et al., 2003; Raymond et al., 2006; Pellegrini et al., 
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2007; Marz et al., 2010). In addition to the expression of blbp and gfap, dorsal telencephalic 
radial glia cells are characterized by expression of notch3. The overlapping expression of 
radial glia markers blbp and gfap with notch3 indicates that Notch signalling may be involved 
in dorsal telencephalic radial glia maintenance as described previously (Wolfe et al., 1999; 
Kageyama et al., 2008; Yoon et al., 2008; Chapouton et al., 2010). The stem-cell maintaining 
function of Notch signalling is probably mediated via Notch effectors her4 and her15 (Takke 
et al., 1999; Shankaran et al., 2007; Yeo et al., 2007), which are also co-expressed in 
blbp/gfap/notch3-positive radial glia cells. Her genes encode for transcriptional repressors of 
proneural gene expression. They are required to maintain stem cell populations by 
suppressing neuronal differentiation and specification processes governed by proneural genes 
(Fig. 54 a). 
Radial glia cells can give rise to new radial glia cells and immature neurons or neuronal 
precursor cells with restricted proliferative capacities. These immature neurons migrate from 
the ventricular zone towards the lateral telencephalon and activate expression of proneural 
genes (neurogenin, zash1a, zash1b, neuroD) as well as the postmitotic neuronal marker 
HuC/HuD (Barami et al., 1995; Kim et al., 1996). These neuronal differentiation markers are 
restricted to areas that do not overlap with areas that show expression of radial glia markers 
(notch3, her4, her15, blbp and notch3; Fig. 54 a). 
In dmrt5 morphants, neurogenesis was severely impaired. Embryos injected with dmrt5 
morpholinos showed a down-regulation of radial glia markers blbp and gfap as well as a 
reduced expression of Notch-signalling markers (notch3, her4 and her15). These data suggest 
that the number of radial glia cells was reduced in dmrt5 morphants. One possible 
consequence of impaired Notch signalling and radial glia maintenance is pre-mature 
differentiation of radial glia into neurons. However, this possibility was excluded since 
numbers of differentiating and differentiated neurons were strongly reduced in dmrt5 
morphants. This was evident by reduced expression of proneural genes (neurogenin, zash1a, 
zash1b, neuroD), postmitotic neuronal marker HuC/HuD as well as markers for distinct dorsal 
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telencephalic cell populations (fezf2, pou50 and dmrt3). Increased apoptosis of 
undifferentiated neural stem cells could also be excluded as explanation for reduced radial 
glia cells since TUNEL staining did not reveal any elevated numbers of apoptotic cells in 
dmrt5 morphants (Fig. 28). Consequently, these data suggest that the described differentiation 
defects in dmrt5 morphants were likely due to early specification defects at the transition from 
neuroectodermal stem cells to neurogenic radial glia cells (Fig. 54 b). To support this 
hypothesis, I performed a set of RNA in-situ hybridisation experiments to analyse expression 
of pax6a and sox2 which are markers for early neuroectodermal cell types (Krauss et al., 
1991; Amirthalingam et al., 1995; Okuda et al., 2006). It was shown that sox2 belongs to one 
of the earliest neuronal markers in neuroectodermal cells (Mizuseki et al., 1998). As shown in 
Fig. 24, pax6a as well as sox2 were ectopically up-regulated in dmrt5 morphants, which 
indicates that dmrt5 morphants might be characterized by the presence of increased numbers 
of early neural stem cells. The ectopic up-regulation of sox2 not only indicates expansion of 
early neural stem cells. Its ectopic expression may also explain the failure of dmrt5 morphants 
to generate radial glia. It was shown in chick that Sox2 function is required to maintain early 
neural stem cells while its ectopic miss-expression inhibits neuronal differentiation (Graham 
et al., 2003). In dmrt5 morphants, sox2 is ectopically expressed and therefore may prevent the 
maturation from early stem to neurogenic radial glia cells. In addition to the ectopic 
expression of neural specifier molecules in the dorsal telencephalon, dmrt5 morphants were 
also ectopically expressing her6 in this area. Earlier research in mouse and zebrafish showed 
that her6 (the ortholog of Hes1 in mouse) is expressed broadly in neuroectodermal stem cells 
but its expression is gradually down-regulated to restricted areas as neural differentiation 
proceeds (Ohtsuka et al., 2001; Pasini et al., 2001; Scholpp et al., 2009). The prolonged 
maintenance of early neural stem cells could serve as an explanation, why dmrt5 morphants 
were ectopically expressing her6 in the dorsal telencephalon. Moreover, it has been reported 
in mice that the ectopic overexpression of Hes1 (the ortholog of zebrafish her6) inhibits 
neuronal differentiation (Ishibashi et al., 1994; Ohtsuka et al., 2001). Thus, the observed 
ectopic expression of her6 could explain why early neural stem cells failed to generate radial 
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glia cells in dmrt5 morphants. Based on the observations made in my study, I propose the 
following model: Dmrt5 is required to initiate the switch from neuroectodermal cells to radial 
glia cells by down-regulating the expression of early-stem cell promoting transcription factors 
such as sox2 or her6. The loss of Dmrt5 function therefore results in a prolonged expression 
of these factors which prevents the gradual change from early stem cells to cells with radial 
glia identity (Fig. 23 and 54 b). As a secondary consequence of failed radial glia formation in 
dmrt5 morphants, the number of neurons positive for e.g. HuC/HuD and neurogenin was 
reduced. It seems that Dmrt5 plays a crucial role during telencephalic neuroectodermal 
specification and acts as a switch that promotes cellular identity changes from 
neuroectodermal stem cell to radial glia. 
 
Fig. 54 Model for dmrt5 regulated dorsal telencephalon development: In wild type embryos (left 
side), early neuro-ectodermal stem cells express her6, sox2 and pax6a, which maintain neural stem cell 
fates and repress differentiation. At bud stage, dmrt5 expression emerges in a subset of cells of the 
presumptive telencephalon, leading to the down-regulation of these early stem cell markers. This 
initiates a developmental switch and early stem cells gradually differentiate into radial glia cells that 
can be found close to the ventricular surface at 24 hpf. This fate change is accompanied by 
characteristic changes of dorsal telencephalic cells. Radial glia cells express notch3 and her4, which are 
important for the maintenance of this stem cell population. Ultimately, neurogenic radial glia cells give 
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rise to daughter cells with a neuronal cell fate. Newly differentiated neurons start expression of 
proneural genes as well as the postmitotic marker HuC/HuD and migrate into regions of the dorso-
lateral telencephalon. In morphants with reduced Dmrt5 levels (right side), neuro-ectodermal stem cells 
maintain expression of sox2, her6 and pax6a. Consequentially, early stem cells fail to form radial glia 
and radial glia markers are missing (blbp, gfap, notch3, her4). Due to a lack of neurogenic radial glia 
cells, less neurons were formed and the expression of respective marker genes were also reduced. 
This model is supported by her gene expression data in zebrafish, which are in accordance 
with findings in mouse (Hatakeyama et al., 2004; Kageyama et al., 2008). It was reported that 
the development of radial glia from neuro-ectodermal stem cells is a gradual process that 
involves a change in Hes (her) gene expression. In mouse, early stem cells are characterized 
by expression of Hes1 (her6) and Hes3 followed by the expression of Hes1 (her6) and Hes5 
(her4) in radial glia cells. It seems that the combinatorial changes of transcriptionally active 
Hes genes coincide with the maturation process from predominantly symmetrically dividing 
early stem cells to neurogenic, asymmetrically dividing radial glia cells. In zebrafish, her6 
expression starts early in neuroectodermal cells but is subsequently down-regulated as a pre-
requisite for neuronal differentiation (Pasini et al., 2001; Scholpp et al., 2009). As shown with 
my data, radial glia cells are positive for her4 and her15 expression, indicating that dorsal 
telencephalic neural stem cells are undergoing a similar “her gene maturation” from her6 in 
early stem cells to her4/her15 in radial glia in zebrafish as described in mouse (Hatakeyama 
et al., 2004; Kageyama et al., 2008). Based on the data from mouse and zebrafish, the 
following role of her6 in early neuroectodermal cells could be possible. Assuming that a 
down-regulation of her6 in neuroectodermal stem cells is a permitting pre-requisite for the 
expression and function of neuro-determining proneural genes, the her6 down-regulation may 
contribute to the switch from early neuroectodermal stem cells to more differentiated radial 
glia cells with their respective marker gene expression (such as her4 and her15). In dmrt5 
morphants, her6 expression was ectopically up-regulated while the induction of radial glia 
marker expression (her4/her15) was down-regulated. It could be therefore possible that the 
persistent her6 expression is partially responsible for the absent switch of neuroectodermal 
stem to radial glia cells. In this model, Dmrt5 is required to switch-off her6 expression, 
providing a transcriptional environment that allows the expression of early neuro-
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determination factors and the gradual change from early stem cells to radial glia cells. In 
summary, it seems likely that dmrt5 plays an important role during the development of the 
dorsal zebrafish telencephalon by initiating the switch from neuroectodermal cells to radial 
glia. 
4.4. Dmrt5 regulates neurogenesis the olfactory system 
The aim of this study was to understand how Dmrt proteins regulate forebrain development. 
The early onset of dmrt5 expression in olfactory pre-placodal fields around bud-stage and 
sustained expression at later stages suggests that dmrt5 is involved in regulation of neural 
differentiation in this area similar to the situation described in Xenopus olfactory placodes 
(Huang et al., 2005). Therefore, I analysed the expression of proneural genes neurogenin, 
neuroD and zash1a in dmrt5 morphants and wild type embryos at 25 hpf. In wild type 
embryos, all three proneural genes are expressed in distinct cell populations of the olfactory 
epithelium (Fig. 27) which partially overlap with BrdU positive proliferative progenitor/stem 
cells (Fig. 30). This suggests that a particular proneural gene may have specific roles in 
distinct progenitor domains.  
In dmrt5 morphants, expression of neurogenin and zash1a was strongly reduced or lost while 
neuroD expression was only slightly reduced. The down-regulation of neurogenin and zash1a 
indicates that neuronal differentiation and specification were affected in the developing 
olfactory placode of dmrt5 morphants. However, previous studies suggested that a loss of 
Neurogenin function can be partially compensated by NeuroD (Madelaine et al., 2011). Since 
dmrt5 morphants exhibited residual expression of neuroD, the expected defects in neuronal 
differentiation might be prevented by functional compensation through NeuroD. Therefore, it 
was expected that neuronal differentiation defects could be limited to those aspects of 
olfactory placode development that are exclusively governed by Neurogenin and Zash1a but 
not by NeuroD. However, dmrt5 morphants still showed drastic defects in the developing 
olfactory epithelium as apoptosis was significantly increased at 24 and 31 hpf when compared 
to controls. Dying cells were probably olfactory progenitor/or stem cells as indicated by 
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reduced signals from proliferative markers BrdU and pH3. Stem or progenitor cells may 
require direct cell-cell interactions with surrounding cells. If these supporting cells develop 
normal while stem or progenitor cells fail to differentiate in time, they miss essential signals 
from their environment and thus undergo apoptosis. Thus, a possible explanation for the 
increased cell death in the pool of olfactory progenitors in dmrt5 morphants could be the loss 
of environmental cues due to failure of differentiation. Consequently, the development of the 
olfactory epithelium was severely impaired in dmrt5 morphants affecting the size of the 
olfactory epithelium, the structure (smaller olfactory pits), the number of olfactory sensory 
neurons as well as their olfactory cilia (see Fig. 33/34). Due to the observed reduction in the 
number of olfactory sensory neurons (OSN), a loss or a reduction of the olfactory sensory 
nerve is expected. Additionally, it was previously shown that Neurogenin1 is required in the 
developing olfactory system to control aspects of olfactory nerve fasciculation and axon path 
finding (Madelaine et al., 2011). As dmrt5 morphants showed a reduced expression of 
proneural genes in the olfactory epithelium, fasciculation problems of the olfactory nerve 
were anticipated. However, the lack of olfactory sensory nerves as well as possible 
fasciculation problems have to be confirmed by the use of a retrograde lipophilic dye like DiI 
applied to the olfactory pit or employment of suitable transgenic lines that drive reporter gene 
expression under control of an olfactory sensory neuron specific promoter, such as the 
olfactory promoter for omp. Additionally to the defects observed in the olfactory epithelium, I 
observed a reduced number of larger nerves around the developing olfactory epithelium 
(white arrow, Fig. 34). These nerves are most probably branches of the lateral line nerve and 
their absence in this region of dmrt5 morphants could be explained by path finding defects 
that also affects other nerve populations other than the olfactory nerve. 
Moreover, knock-down of dmrt5 not only influenced stem and/or progenitor cells in the nose, 
but also had a negative impact on olfactory bulb development. The number of apoptotic cells 
in lateral telencephalic regions in dmrt5 morphants was comparable to control embryos at 24 
hpf. However, at 31hpf apoptosis was significantly increased in the morphant situation. At 48 
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hpf, apoptosis in dmrt5 morphants had increased further and concentrated in lateral 
telencephalic domains. Affected telencephalic cells are presumably progenitor cell 
populations that are involved in olfactory bulb development. The described phenotype could 
also explain why olfactory bulbs in adolescent dmrt5 morphants were smaller compared to 
wild type embryos. It was shown in previous studies that the interaction between the 
developing olfactory placode and the olfactory bulbs (lateral telencephalon) is from bilateral 
importance for their development (Whitlock et al., 2000; Wang et al., 2001). Olfactory 
sensory neurons send out axonal terminals into the olfactory bulbs and support their 
development via stimulating signals (Wang et al., 2001). In dmrt5 morphants, the loss of 
olfactory progenitor cells resulted in reduced numbers of olfactory sensory neurons. 
Consequently, fewer olfactory sensory neuron axons reach the developing olfactory bulbs. As 
a result of the reduced interaction or lack of inductive signals from the olfactory neurons, 
telencephalic cells underwent apoptosis. Therefore, it seems possible that the observed 
telencephalic effect is secondary and occurs as a consequence of olfactory epithelium cell 
apoptosis and/or failure of migration or axon guidance into telencephalic olfactory regions. 
This could explain why I observed increased apoptosis in the olfactory epithelium first, before 
it was increased in the developing olfactory bulbs.  
In summary, I conclude that dmrt5 is an important regulator for the development of the 
olfactory system. It controls proneural gene expression in olfactory progenitor cells which is 
essential for their differentiation into olfactory sensory neurons.  
4.5 Comparison between telencephalic and olfactory defects in dmrt5 morphants 
Upon dmrt5 knock-down, both the dorsal telencephalon as well as the olfactory system were 
characterized by a down-regulation of neurogenin expression. However, dmrt5 morpholino 
induced expression changes of other proneural genes showed remarkable differences between 
the two structures. NeuroD, which is expressed in both regions, was strongly down-regulated 
in the dorsal telencephalon upon dmrt5 morpholino injection while its expression was only 
slightly affected in the adjacent olfactory epithelium. In addition to that, expression of 
119 
 
regulators of neural development such as pax6a, her6 and sox2 was altered in the dorsal 
telencephalon of dmrt5 morphants, while it was unchanged in the olfactory epithelium. The 
differences seen in the expression analysis in the nose and the dorsal telencephalon of dmrt5 
morphants have indicated that the genetic networks must be controlled differently in these 
two regions. Therefore, it seems that dmrt5 may play distinct roles in different tissues. It is 
tempting to speculate that these diverse specific functions of Dmrt5 are mediated via so far 
unknown tissue specific transcriptional co-regulators. This idea could explain why knock-
down of dmrt5 manifests in different phenotypes e.g. the described differences in neuroD 
expression. 
4.6. Role of Dmrt5 for Corticotrope differentiation 
Besides the dorsal telencephalon and olfactory epithelium, I also observed dmrt5 expression 
in pituitary pre-placodal fields at bud-stage and migrating pituitary cells at 24 hpf (Fig. 35). 
The spatio-temporal pattern of dmrt5 expression suggests a role for dmrt5 during pituitary 
formation. Remarkably, the expression of dmrt5 was restricted to the anterior pituitary 
indicating that Dmrt5 influences only the anterior subset of pituitary cells. A potential 
differentiation defect in anterior pituitary cells was assessed via analysing marker gene 
expression specific for anterior pituitary cell populations. In dmrt5 morphants, the expression 
of the corticotrope and melanotrope marker pomc (Hansen et al., 2003) was reduced in 
corticotropes while melanotrope expression domains remained unaffected. To assess the 
possibility of apoptosis among pomc progenitor cells, TUNEL stainings were performed at 31 
and 48 hpf but showed no obvious differences between dmrt5 morphants and controls. The 
size as well as the pituitary patterning was also normal in dmrt5 morphants as indicated by the 
unaffected expression of the pituitary patterning marker pitx3 (Dutta et al., 2005). 
Subsequently, I tested the possibility of a potential transdifferentiation from corticotropes to 
lactotropes, through the expression analysis of the lactotrope marker gene prl (Herzog et al., 
2003). Transdifferentiation from corticotropes to lactotropes was excluded since the prl 
positive domain was not expanded. However, the prl expression domain was slightly loosened 
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and shifted posteriorly. At last, expression of the hypothalamic upstream regulator of POMC 
synthesis, crh (Chandrasekar et al., 2007), was analysed but no difference in the expression 
pattern was evident between the controls and dmrt5 morphants. 
Taken together, at least two possible scenarios could explain the observed phenotype (Fig. 
55). I) The knock-down of dmrt5 function could have negatively influenced the 
differentiation program and pomc progenitor cells transdifferentiate into cell populations of 
the medial pituitary (gonadotropes, somatotropes, and thyrotropes). Or II) Corticotrope 
progenitor cells might remain undifferentiated due the dmrt5 knock-down. Less differentiated 
cells are usually characterized by a bigger cell size. This would explain why the morphant prl 
expression domains were not as concentrated as they were in control embryos. Furthermore, 
the larger cell size of undifferentiated corticotrope progenitors and an altered cell-cell 
interaction would explain why the prl expression domain was shifted posteriorly. Considering 
the role of Dmrt5 as differentiation regulator and its effects on neural stem and/or progenitor 
cells, the second scenario seems the more favourable option. 
                
 
Fig. 55 Proposed model for dmrt5 function during pituitary development: Dmrt5 expression is 
restricted to anterior pituitary cell populations where it controls corticotrope differentiation. Two 
hypotheses are possible to explain the underlying molecular mechanism of the observed phenotype. I) 
Dmrt5 inhibits medial pituitary fates and acts permissively for corticotrope cell fates or II) Dmrt5 is 
required for proper differentiation of corticotrope progenitor cells, which remains undifferentiated in 
dmrt5 morphants.  
There were some limitations in the study of the pituitary. Due to their vastly mobile nature of 
the cells during the first 30 hpf, it was difficult to specifically locate gene expression patterns 
of the tested proneural genes to the migrating pituitary cells. Therefore, the pituitary was the 




only tested structure where a conclusive effect on proneural gene expression could not be 
shown by RNA in-situ hybridisation experiments. The suggested model is based on the loss of 
a terminally differentiated cell populations and the seemingly conserved role of Dmrt5 as a 
regulator of proneural gene expression in the other four brain regions.  
4.7 Dmrt5 controls neuro-endocrine cell differentiation in the preoptic area and ventral 
midbrain 
The preoptic area and ventral midbrain are known to be the birth places of neuro-endocrine 
cell populations (Lohr et al., 2011). Effects detected in these areas are both described in this 
section since underlying mechanisms and affected genes appeared to be similar. In 
accordance to the observed effects in telencephalon and olfactory epithelia, a knock-down of 
Dmrt5 function also decreased proneural gene expression (neurogenin and zash1a) in the 
preoptic area and ventral midbrain. As a consequence of the diminished proneural gene 
expression in these domains, an effect on the neuro-endocrine forebrain system was expected. 
Hence, expression patterns of genes involved in cell fate regulation and cell type specific 
marker genes were analysed. The three investigated genes otpa, otpb and sim1a are crucial for 
development of the neuro-secretory preoptic area and hypothalamus (Del Giacco et al., 2006; 
Eaton and Glasgow, 2006; Blechman et al., 2007; Eaton and Glasgow, 2007; Eaton et al., 
2008). As shown in this study, down-regulation of all three genes was evident in regions of 
the preoptic area while ventral diencephalic expression domains were only slightly reduced or 
unaffected. In addition, sim1a expression was extenuated in specific ventral midbrain regions. 
Due to their described roles as neuro-endocrine fate determinants, follow up examinations of 
neuro-endocrine marker genes (avpl and oxytocin) were performed to determine the identity 
of the affected cell populations. In agreement with previous reports by Eaton et al., expression 
of avpl and oxytocin was strongly reduced in the preoptic area of dmrt5 morphants (Eaton et 
al., 2008). Both genes encode for small peptides with hormonal activity, which are released 
into the bloodstream from the neuro-endocrine region of the pituitary (Lohr and 
Hammerschmidt, 2011). It is known that these peptides, among others, are involved during 
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ion maintenance and osmoregulation (Busby et al., 2010; Gutnick et al., 2011). The lack of 
expression of both genes could explain the lethality of dmrt5 morphants between 8 and 11 dpf 
as a result of impaired osmoregulation, which is of significant importance for survival of 
aquatic animals. The morphants developed normally during the first few days except that the 
majority of morphants did not inflate their swim bladder. Around 8 dpf, most of the Dmrt5 
depleted zebrafish larvae died and some of them showed indications of impaired 
osmoregulation, such as massive eye edema or heart edema. In parallel to endocrine cell 
populations of the preoptic area, I also evaluated the impact of otpa, otpb and sim1a 
deficiency in hypothalamic neurons. Surprisingly and in contrast to other studies (Del Giacco 
et al., 2006; Eaton and Glasgow, 2006; Blechman et al., 2007; Eaton and Glasgow, 2007; 
Eaton et al., 2008), the hypothalamic expression domains of hormone-encoding genes were 
unaffected in dmrt5 morphants. Hypothalamic expression patterns of sst1.1, th, crh, trh and 
even avpl were unaffected. Although expression levels of hypothalamic fate determinants 
were reduced the described effects were restricted to the preoptic area and not found in the 
ventral diencephalon or hypothalamus. The impact on differentiated neuronal populations was 
limited to altered expression domains of otpa, otpb and sim1a, which suggest that the 
remaining unchanged expression domains of hypothalamic fate determinants were sufficient 
to promote normal neuronal development. The obtained discrepancies between our study and 
other studies stem from different experimental approaches. Our study was based on knock-
down of dmrt5, which indirectly influenced the neuro-secretory preoptic area by decreasing 
the expression levels of preoptic fate determinants. In contrast, the previous studies were 
aimed directly at otpa, otpb and sim1a. As a consequence, ventral diencephalic expression 
domains of these genes remained unaffected in our approach, while other studies showed the 
opposite.  
Besides the impact on cell populations of the preoptic area, sim1a expression diminution was 
also observed in the ventral midbrain. Sim1a in the ventral midbrain could act as fate 
determinant in a similar fashion as in the preoptic area or hypothalamus. I saw an effect on the 
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expression pattern of the neuro-endocrine marker gnrh2 expression in dmrt5 morphants. 
Gnrh2 positive cell populations in the ventral midbrain were significantly reduced in dmrt5 
morphants when compared to controls. At the moment it is unknown whether the down-
regulation of gnrh2 expression is a direct consequence of the failed neuronal specification due 
to reduced sim1a expression. Underlying molecular mechanisms leading to the reduced gnrh2 
expression are still under investigation. In addition, we are also trying to reveal functional 
consequences of the GnRH2 reduction. GnRHs regulate sex determination and/or 
differentiation processes via regulating the levels of sex hormones, follicle stimulating 
hormone (FSH) and luteinizing hormone (Kwok et al., 2005; So et al., 2005). Therefore, it is 
of great interest to assess if dmrt5 morphants have an altered sexual development. Studies 
have shown that dmrt genes are expressed in gonads and control certain aspects of sex 
determination and/or differentiation in a gonad cell-autonomous manner (Raymond et al., 
2000; Kim et al., 2007). In contrast, dmrt5 is expressed in the fore- and midbrain and controls 
the development of gnrh2+ cells. Based on the described involvement of dmrt genes during 
sex development and a defect on gnrh2 positive cell populations, it is tempting to speculate 
that the loss of gnrh2 expression may affect sex development. However, the sex hormone 
regulating gonadotropins in zebrafish is GnRH3 and not GnRH2 (Abraham et al., 2010). 
Expression of gnrh3 was tested but found to be unaltered in dmrt5 morphants (data not 
shown). As a result, it is rather unlikely that the expression levels of FSH and LH are 
changed. Nevertheless, it cannot be excluded that partial facets of sexual development and/or 
behaviour will be affected in dmrt5 morphants. Oka et al. showed that gnrh2- positive 
neurons regulate neuronal activity as neuro-modulators in multiple brain regions (Oka, 2010). 
In addition, it was shown in goldfish and musk shrews that GnRH2 administration changed 
sexual behaviour (Kauffman et al., 2004; Kauffman et al., 2004; Matsuda et al., 2008). 
Hence, it could be possible that dmrt5 morphants exhibit altered sexual behaviours due to 
reduced levels of gnrh2 expression. With regards to the family of dmrt genes, this would be 
the first time to show that a member of the dmrt family regulates sex development and/or 
behaviour through a gonad independent mechanism. As gnrh2+ cells act most probably neuro-
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modulatory on other neuronal cell populations, a lack of gnrh2 expression would lead to 
alternate activities in those GnRH2- modulated neuron populations. That means, instead of 
acting cell-autonomously on specific gonadal cell populations, Dmrt5 could act indirectly on 
sexual behaviour via controlling gnrh2+ cell development and the activity of Gnrh2 regulated 
neuron populations.   
4.8 Future experiments 
There are a few more aspects regarding the function of dmrt5 that are worth examining in 
future studies. It would be very helpful to identify direct and indirect Dmrt5 target genes via a 
comparative ChIP and microarray analysis. Dmrt5-ChIP experiments will reveal information 
about target promoter regions bound by Dmrt5, while loss-of-function (dmrt5 morphants) and 
gain-of-function (dmrt5 BAC transgenic lines) microarray data will help to identify and 
distinguish directly bound and regulated from indirectly regulated genes. Those genes that are 
directly regulated by Dmrt5 should appear in overlapping data-sets of ChIP and microarray 
experiments, while indirectly regulated genes should be only present in the microarray data. 
One of the addressed questions would be whether Dmrt5 directly binds to the promoters of 
sox2 and her6. Both genes are neuroectodermal markers as well as factors involved in stem 
cell maintenance but yet it is unclear if both, only one or none of the genes are direct targets 
of Dmrt5 (ChIP-microarray data set). If both genes may appear in the ChIP-microarray data 
set, it seems that Dmrt5 regulates multiple genes that are acting synergistically to each other 
to maintain early neural stem cell character. If only one of those genes is directly regulated, 
but the other one indirectly (only microarray data set), it may help to understand the cascade 
and order of genes that are involved during neural stem cell maintenance as well as at which 
level of this regulatory hierarchy may Dmrt5 act.  
The cortex is a structure in the mammalian brain that is homologous to the zebrafish 
telencephalon and is important for behavioural patterns. As zebrafish dmrt5 morphants 
developed smaller telencephala due to a lack of radial glia and neurons, it could be possible 
that Dmrt5 morphants show altered behaviour patterns. However, it is very difficult to track a 
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potential change of behaviour to a particular telencephalic cell population due to the lack of 
reference data. Therefore, I didn’t follow this question during my study. Nevertheless, as the 
cortex is the mammalian homologue to the zebrafish telencephalon and there are several 
instances of functional homology between zebrafish dmrt5 and dmrt gens of more recent 
vertebrate groups, I would also expect smaller cortices in Dmrt5 knock-out (KO) mice. Due to 
the fact that the cortex is important for behavioural patterns and the accessibility of brain 
maps in mice that links particular behaviours to distinct cell populations within the mouse 
cortex, it should be very interesting to analyse Dmrt5 KO mice for behavioural changes. In 
this model, one might be able to asses whether the entire cortex or only particular cortical 
layers are affected by a Dmrt5 knock-out. In addition, it would also be of interest to see if 
affected cortex structures were linked to distinct sensory, motor or associative fields. If so, 
dmrt5 KO mice could be tested specifically for a particular behaviour that is thought to be 
exclusively linked to the affected brain region. These studies could link the function of Dmrt5 
during cortex development and the development and differentiation of neuronal progenitors to 
behavioural aspects. If links could be established between a behavioural disorder in model 
organism and the lack of Dmrt5, this information could provide useful hints for understanding 
so far idiopathic human behavioural disorders. 
Another behavioural assay could be conducted in zebrafish for the analysis of Dmrt5 function 
during olfactory system development. In wild type embryos, small molecules are detected via 
olfactory sensory neurons, which send out sensory information into the olfactory bulbs where 
these information gets further processed (Li et al., 2005). The observed phenotypical changes 
in the olfactory system of dmrt5 morphants imply that morphants may have problems during 
olfaction. Firstly, since olfactory sensory neurons detect small molecules and initiate 
olfaction, the reduced numbers of neurons might reduce the overall capability of 
chemoreception in dmrt5 morphants. Secondly, the observed changes in higher olfactory 
brain centers suggest that dmrt5 morphants may also have problems in processing olfactory 
neuronal input. I therefore conducted preliminary behavioural tests to analyse embryonic 
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olfaction according to a publication from Lindsay and Vogt (Lindsay et al., 2004). In this 
publication, zebrafish medium was incubated with fish food and filter sterilized to prepare 
fish food-conditioned medium. The conditioned medium evoked an increased reactivity in 
young zebrafish larvae after it was added to the larvae, while normal unconditioned medium 
didn’t increase zebrafish activity. To date, experimental outcome is pending since the 
experimental setting requires further fine-tuning before valid data can be acquired. Once the 
experimental setting is optimized, dmrt5 depleted embryos will be checked for behavioural 
changes during olfaction such as an increased activity of zebrafish larvae after administration 
of fish food conditioned medium (Lindsay and Vogt, 2004).  
Next, based on the experimental data obtained from the analysis of the pituitary in dmrt5 
morphants, it seems that corticotropes progenitors either I) transdifferentiated into medial 
pituitary cell types or II) remained completely undifferentiated. The first possibility could be 
tested by double WISH, through the analysis of prl and medial pituitary markers. Prl positive 
cells in anterior pituitary parts should not intermingle with medial pituitary cell populations. 
However, if lactotropes would be found intermingled with gonadotropes, thyrotropes or 
somatotropes, transdifferentiation processes might have taken place. This would explain the 
loss of pomc positive cells and the loosened prl positive cell cluster. Since the prl positive 
adjacent cells are from unusual origin, cell-cell interaction may be influenced and the whole 
prl positive domain is loosened and shifted posteriorly. In this scenario, Dmrt5 acts as the 
permitting factor of corticotrope differentiation by blocking medial pituitary cell fates. To 
address possibility II) The active and terminally differentiated neuro-endocrine cells can be 
distinguished from undifferentiated cells based on their sub-cellular compartments. If 
corticotrope cells remained undifferentiated, I would expect to see less active and smaller 
organelles involved in hormone synthesis (e.g. Golgi-apparatus). The use of electron-




Lastly, findings made in the ventral midbrain of dmrt5 morphants suggest an indirect role of 
Dmrt5 during sex development via a possible alteration of gonadotropin expression levels. 
The expression changes could result in alterations of sexual behaviour or gonad development. 
Hypothetically, these dmrt5 morpholino mediated alterations of sexual behaviour or gonad 
development need to be tested by behavioural studies and gonad analysis in dmrt5 morphant 
adults. The use of dmrt5 morphants that are devoid of Dmrt5 function during the first few 
days of development provides a great tool to separate early Dmrt5 functions on gonadal 
development and sex differentiation via gnrh2 from those functions that are mediated through 
its gonadal expression at much later stages (Guo et al., 2004). 
4.9 Conclusion 
As a final conclusion, the presented data strongly suggest a possible role for Dmrt3 during 
terminal differentiation of dorsal telencephalic and olfactory placode neurons and an essential 
role for Dmrt5 in transcriptional regulation of genetic networks involved in neuronal 
differentiation. Dmrt5 controls neuronal differentiation and specification throughout the 
developing embryonic brain in a context sensitive manner. The best example to illustrate this 
functional diversity are the described impacts on the olfactory epithelium and telencephalon. 
While telencephalic expression of neuroD was reduced in dmrt5 morphants, olfactory 
epithelium expression of neuroD remained unaffected. In contrast, olfactory stem and/or 
progenitor cells became apoptotic in morphants while telencephalic stem cells were 
maintained at an early stage. A possible explanation for these tissue specific effects in 
morphants could be that Dmrt5 interacts with various tissue specific co-regulators. However, 
all of the characterized brain regions showed impaired neuronal differentiation that manifest 
as severe morphological and/or physiological defects of the forebrain.  
Future experiments using dmrt5 knock-down and dmrt3 knock-out approaches will help to 
elucidate yet unanswered questions and complete the hypothesized models for Dmrt3 and 
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A.1 dmrt5 control morpholino injected embryos showed identical phenotypes as wild type 
embryos 
The following images show whole mount in-situ hybridization results of control morpholino injected 
embryos. The stage and magnification are identical with wild type and dmrt5 morphant images shown 
in the main text. To simplify the comparison between control and dmrt5 morphant in-situ results, 
images are grouped similar like in the main results part and are labelled with corresponding figure 
numbers. The label on the left side of each panel, describes the region of interest as well as the image 
theme (for example: proneural genes, her genes etc.). In general, the dmrt5 control morpholino 
images are showing identical in-situ staining like wild type embryos.  
Control morpholino experiments are shown for the following figures: 
Fig. 20 Knock-down of dmrt5 leads to down-regulation of proneural genes zash1b and neuroD: 
Fig. 21 Dmrt5 morphants show neuronal differentiation defects in the telencephalon: 
Fig. 22 The knock-down of dmrt5 influences her gene expression in the telencephalon: 
Fig. 23 Dmrt5 knock-down results in reduced radial glia pools: 
Fig. 24 Loss of dmrt5 results in ectopic pax6a and sox2 expression: 
Fig. 25 Neuronal stem cell depleted dmrt5 morphants have smaller telencephalon: 
Fig. 27 Proneural gene expression is reduced in dmrt5 morphants: 
Fig. 30 BrdU labelled uninjected wild type and dmrt5 morphants: 
Fig. 33 Increased apoptosis and reduced cell division led to smaller olfactory epithelia and olfactory bulbs: 
Fig. 36 Expression analysis of pomc, prl and pitx3 in dmrt5 morphants: 
Fig. 37 Neuronal differentiation defects in the neurosecretory preoptic area and ventral midbrain: 
Fig. 38 Down-regulation of hypothalamic fate determinants in dmrt5 morphants: 
Fig. 39 Alterations of neurosecretory preoptic area hormone production in dmrt5 morphants: 





A.1 Chapter 3.5: Role of dmrt5 for dorsal telencephalon, olfactory region and pituitary development 
3.5.1 Dmrt5 knock-down results in dorsal telencephalic differentiation defects 
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A.1 Chapter: 3.6 Dmrt5 is required for stem cell survival and neuronal differentiation in the olfactory system; 
Control morpholino experiment to 
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A.1 Chapter 3.7: Pituitary differentiation                            A1 Chapter 3.8: Neurosecretory preoptic area and ventral midbrain differentiation 
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A1 Chapter 3.8: Neurosecretory preoptic area and ventral midbrain differentiation 
       Control morpholino experiment to 
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A.2 List of used primers, plasmids and morpholinos 
Zinc finger generation 
Degenerated primer for ZFM customization 




randomization of the DNA binding zinc finger domains within different zinc finger 
modules, has to be combined with different set of reverse primers depending on the 




















used for completion of the 5’ end (incl. KpnI cutting site) 
zif268 primer VI CTCTAGACGTCCTTCTGTC used for completion of 3' end (spans XbaI site) 
Primers used during sequential selection strategy; isolation of specific modules 
varModul1rev (3p_mod1_rev) CTGAAGTTCCTCATGCAGATTCGACACTGGAAGG used in combination with oligo1, isolation of module 1, ZF1 
varModul1and2Rev 
(3p_mod2_rev) CGCGAACTTCCTGCCGCAGATGTCACAGGCAAAAG used in combination with oligo1, isolation of module 1 and 2, ZF1 
5p_mod1_rev GCTGAAGTTCCTCATGCAGATTCGACACTGGAAGGG used in combination with oligo1, isolation of module 1, ZF2 
5p_mod2_rev CGCGAACTTCCTGCCGCAGATGTCACAGGCAAAAGG used in combination with oligo1, isolation of module 1 and 2, ZF2 
Primers used during modular assembly strategy, isolation of specific modules 
Module 2 forw CCCTTCCAGTGTCGAATCTGCATGAGGAACTTCAGC 
binds 5’ of ZFM2, used during single module isolation during modular assembly 
method 
Module 3 forw. GCCTTTTGCCTGTGACATCTGCGGCAGGAAGTTCGCG 




Primers for subcloning the ZFP encoding sequence into Fok nuclease expression vector 
Primer X CTAGTTGGGATCC TCTTATGTGGATCTT GGTGTG introduces a unique BamHI restriction site 3' of the last ZFM encoding sequence 
Customization of zif268 target site vector 
sequential selection strategy 











5p_TS2rev: GTGTAAAGAA TTCGTCCCGAGCGCGCAGCG GCCGCCCGGG TGTAC 
5p_TS3forw: GTACACCCGGGCGGCCGCTTGCCGCTCGGGACGAATTCTTTACAC 
5p_TS3rev: GTGTAAAGAA TTCGTCCCGAGCGGCAAGCG GCCGCCCGGG TGTAC 
Modular assembly strategy 
5p_TS2forw2: GTACACCCGGGCGGCCGCTGCGCGCGCGGGACGAATTCTTTACAC 
 
5p_TS2rev2: GTGTAAAGAA TTCGTCCCGCGCGCGCAGCG GCCGCCCGGG TGTAC 
5p_TS3forw2: GTACACCCGGGCGGCCGCTTGCTGGGCGGGACGAATTCTTTACAC 
5p_TS3rev2: GTGTAAAGAA TTCGTCCCGCCCAGCAAGCG GCCGCCCGGG TGTAC 
pH3u3_MCS_prim_rev CCTCTAGGTTCCTTTGTTACTTCTTCCGCCGCC used with TS forward primers to generate target site fragments 
pH3U3_MCS_prim_forw CCGGCGGCAACCGAGCGTTCTGAACAAATCC used with TS reverse primers to generate  target site  fragments 
Primers to screen self-made ZFN injected zebrafish 
dmrt3HindIIIup-4 CATGGAAGCTTCCACCATGAATGGCTACGGATCGC amplification of a 382bp long fragment that flanks the self-made ZFN target site, 
used to amplify fragments for RFLP, T7 endonuclease assay and sequencing Zfdmrt3Exon1downn0 CTTGCGGTGTTTTGGGGGTCCC 
Primers to screen company made ZFN injected zebrafish 
DMRT3inside1rev GCATATCGGCAAGATCCCTA amplification of a 690bp long fragment that flanks the company-made ZFN target 
site, used to amplify fragments for RFLP and sequencing Zfdmrt3Exon1downn0 CTTGCGGTGTTTTGGGGGTCCC 




Name Comments Antibiotic resistance Addgene No 
Ph3U3-zif268Ω Target site backbone vector Kanamycin 18046 
pB1H2Ω-zif268 Zinc finger expression vector backbone Ampicillin 18045 
pCS2-HA-GAAZFP-FokI-RR Fok-endonuclease backbone I Ampicillin 18754 
pCS2-Flag-TTGZFP-FokI-DD Fok- endonuclease backbone II Ampicillin 18755 
Dmrt3-ZFN2_pair2 left ToolGene ZFN Ampicillin / 
Dmrt3-ZFN_pair2 right ToolGene ZFN Ampicillin / 
Bacteria 
USO hisB- pyrF- rpoZ- omega knockout Bacteria hybrid selection strain, lacks Histidine synthesizing enzyme Tetracyclin 18049 
Functional analysis of dmrt3 and dmrt5 
Probe production 
gene name Name of primer 5' to 3' sequence cloned into ZFIN ID/ Ensembl ID 
dmrt5 
zfDMRT5 forw TTCGCGCTACGGAGAAGTAT 
TOPO-BluntII 
ZDB-GENE-041116-2/ 
ENSDARG00000039412 zfDMRT5 rev TCTATTGCTGAGCGTCATGG 










ENSDARG00000009823 zfPou50rev TCAGCGAACTCTTCCCAAAC 










ENSDARG00000070913 zfSox2rev TTCATATGCGCGTAGCTGTC 
radial glia marker 
blbp zfBLBPforw GATGCATTTTGTGCCACTTG TOPO-BluntII ZDB-GENE-000627-1/ 
x 
 





ENSDARG00000025301 zfGFAPrev TGAGTCCATCCACCTGTCTG 















ENSDARG00000038386 zfZash1arev TTTACGAACGCTCAAAACCA 




































ENSDARG00000033726 zfTSHb_rev CCAATATGCTTGGGCGTAGT 
pre-optic area and hypothalamus 
avpl zfAVPLforw TCTGCTGTCTGTGTGTGTGC TOPO-BluntII ZDB-GENE-030407-2/ 
xi 
 



































ENSDARG00000006868 zfTRH1r GGGCTCCGCTCGTGTCCAGG 
Splice test primers 
dmrt5 
zfDMRT5spliceForw1 TAAGCGCTACTGCAGATGGA 
Both primers are binding into intron flanking exons, allowing the amplification of 








M13 Forward (−20) GTAAAACGACGGCCAG 
M13 Reverse CAGGAAACAGCTATGAC 
Sp6 ATTTAGGTGACACTATAG 
T7 TAATACGACTCACTATAGGG 





Gene Resource ZFIN ID/ Ensembl ID 
dbx1a Flora Rajaei ZDB-GENE-000128-8/  ENSDARG00000086393 
dmrt3 Flora Rajaei ZDB-GENE-021220-3/  ENSDARG00000035290 
her6 Ram Vinod Roy ZDB-GENE-980526-144/ ENSDARG00000006514 
krox20 Yao Sheng ZDB-GENE-980526-283/  ENSDARG00000042826 
NeuroD Yao Sheng ZDB-GENE-990415-172/  ENSDARG00000019566 
th Ram Vinod Roy ZDB-GENE-990621-5/  ENSDARG00000030621 
shh Yao Sheng ZDB-GENE-980526-166/  ENSDARG00000068567 
Zash1b Yao Sheng ZDB-GENE-980526-174/  ENSDARG00000094379 
Plasmids for riboprobe production 
Gene Vector backbone Resource ZFIN ID/ Ensembl ID 
delta-A pDrive Winkler lab (Jan Brocher) ZDB-GENE-980526-29/  ENSDARG00000010791 
notch3 pDrive Winkler lab (Jan Brocher) ZDB-GENE-000329-5/  ENSDARG00000052139 
pax6a pBluescriptIISK Veladimir Korzh ZDB-GENE-990415-200/  ENSDARG00000045045 
POMC pCRII-TOPO vector Winkler lab (Thuy Than To) ZDB-GENE-030513-2/  ENSDARG00000043135 
wnt1 pGEM1 Winkler lab ZDB-GENE-980526-526/  ENSDARG00000055554 
Used antibodies and antibody fragments for staining protocols 
Name of antibody species Working dilution Company 
Anti- acetylated Tubulin mouse 1:1000 Sigma 
Anti- BrdU-G3G4 mouse 1:1000 Developmental Studies Hybridoma Bank 
Anti-digioxigenin AB fragments sheep 1:2000 Roche 
Anti-Fluorescein AB fragments sheep 1:2000 Roche 
Anti-HuC/HuD mouse 1:1000 Molecular probes 
Anti-mouse Alexa flour 488 goat 1:1000 Invitrogen 
Anti- phospho Histone 3 (pH3) rabbit 1:1000 Millipore 
Anti-rabbit Alexa flour 488 goat 1:1000 Invitrogen 
xiii 
 
A.3. List of used Materials and Reagents 
 A.3.1 Equipment: 
Company Name Comments 
Balance 
Mettler Toledo EL303  
Centrifuges 
Beckman Coulter Avanti J-26 xp  
Labnet Spectrafuge 16M Phenol-Chloroform clean up 
Sorvall 
Legend Micro21  
Legend Micro21R Thermofuge 
Sprout Microcentrifuge  
Chillers and Freezers 
ARDO NVE1810  
Liebherr Medline chiller  
Sanyo Biomedical freezer at -20/ -80°c 
WISD Wise Cryo freezer  
Gel electrophoresis 
Bio Rad 
Gel trays and combs  
Power pac basic  
Wide Mini Sub Cell GT  
Syngene G:Box gel documentation system  
WISD WUV-M10 UV table  
Heat blocks and Incubators 
Contherm Digital Series incubator at 37°c, bacteria 
Eppendorf Thermomixer compact  
Infors Multitron shaking incubator at 37°c, overnight cultures 
MRC Dry bath incubator  
Sanyo CO2 incubator at 28/ 30°c, zebrafish 
Light sources for microscopy/ microinjection 
Dolan-Jenner Fiber Lite Mi-150  
Microinjection 
Eppendorf Femtojet microinjector  
Harvard Apparatus GC100F-10 glass capillaries  
Narishige Needle puller PC-10  
Microscopy 
Leica S8APO  
Nikon 
Digital Sight camera system  
Eclipse 90i High magnification and DIC pictures 
Intensilight C-HGFI UV source  
SMZ1000 For microinjections and general overview pictures 
Zeiss LSM510 Meta High resolution confocal microscopy 
xiv 
 
PCR machines/ Sequencing machines 
Applied Biosciences Veriti 96 Well Thermal cycler  
Applied Biosystem Abi3130x1 sequencer  
Biometra T-personal PCR machine  
Stirring hot plates and pH meter 
Favorit Stirring hot plate  
Schott pH meter  
WISH vessel shaker and Vortex machines 
Chiltern MT19 vortex  
Grant Bio POS-300 vessel shaker  
Scientific Industries Vortex Genie 2  
Stovall Life Sciences Vessel shaker  
Water bath for in-situ technique 
GFL Type 1003 water bath  
 
A.3.2 Used Enzymes and Kits: 
Company Name Comments 
Enzymes (other than restriction enzymes) 
Fermentas 
PNK phosphorylation reactions 
Proteinase K solution in-situ protocol 
RiboLock RNAse inhibitor RNA protocols 
SAP dephosphorylation reactions 
SP6 RNA polymerase probe production 
Taq Polymerase clone test PCR’s 
T7 RNA polymerase probe production 
Finnzymes Phusion high fidelity PCR reactions 
NEB 
T4 ligase Ligation reactions 
T7 Endonuclease ZFN mutant screens 
Roche T4 ligase Ligation reactions 
Restriction enzymes 
Fermentas ApaI, BamHI, EcoRI, EcoRV, HindIII, 
KpnI, NotI, RsrII, SmaI, SalI, XbaI, XhoI 
 
NEB BsmI, CviAII, KpnI, MspA1I, XbaI  
Enzyme Kits 
Ambion 
mMessage mMachine Kit SP6/ T7  
Poly (A) tailing kit  
Applied Biosystems Big Dye Terminator v3.1 cycle sequencing kit  
Fermentas RevertAid first strand cDNA kit  
Invitrogen 
Zero-Blunt TOPO PCR cloning kit 
(pCR Blunt II TOPO vector) 
 
Millipore AopoTag peroxidase in-situ apoptosis 
detection kit 
 
Roche Rapid DNA ligation kit  
xv 
 
Other used Kits 
Promega 
Wizard plus SV Miniprep DNA purification 
system 
 
Wizard SV Gel and PCR clean-up system  
Qiagen RNEasy Mini Kit  
 
 A.3.3 Chemicals and consumables 
Company Name Comments 
1st Base 20x SST, Agarose, Tris  
AppliChem Albumin fraction V, Glycerin  
Amresco Phenol-Chloroform, pH 4.7 RNA isolation 
Becton- Dickinson Difco LB agar, LB broth  
Bio Rad Agarose, beta-Mercaptoethanol  
Calbiochem Ammonium chloride (NH4Cl)  
Fermentas IPTG  
Gadot Ethanol  
Gibco Kanamycin  
J.T. Baker Methanol  
Kanako Kaguka Isopropanol  
Merck 
Calcium chloride (CaCl2), Chloroform, di Sodium hydrogen phosphate (Na2HPO4), Glycine, 
Magnesium chloride hexahydrate (MgCl2 * 6H2O), Phenol, Potassium chloride (KCl), 
Potassium dihydrogen phosphate (KH2PO4), Potassium hydroxide (KOH), Sodium chloride 
(NaCl), Sodium hydroxide (NaOH), Sodium sulphide (Na2SO3), Zinc sulphate heptahydrate 
(ZnSO4) 
Roche Anti-DIG/ Fluorescein AP Fab fragment, BCIP/ NBT solution, Blocking reagent, Fast Red tablets 
Sigma 
3-amino 1,2,4 triazole, Agar, Adenine hydrochloride, Amino acids (L-Amino acid Kit), 
citric acid, D- glucose, Dimethylsulphoxide (DMSO), Ethyl-3-aminobenzoate methyl 
sulfonate salt (Tricaine), Formamide, Isoamylalcohol, Phenol-Chloroform-Isoamylalcohol 
(25:24:1, pH 8), Torula yeast RNA, Sheep serum, Sodium acetat, Tetracycline 
hydrochloride, Thiamine hydrochloride,  Triton-X 100, Uracil 
SCRS Tween 20  
US Biological Ampicillin sodium salt  
Consumables 
Axygen Scientific 
0.2 and 1.5 ml microtubes (“Eppendorf 
tubes”), 10 µl pipette tips  
Becton Dickinson Syringes (3 ml to 10 ml)  
Continental lab products Sterile/ non-sterile pipettes  
Eppendorf Microloeader  
Greiner Bio one 0.2 and 1 ml pipette tips, 2 ml, 15 ml and 50 ml tubes  
Nalgene Bottle top filter (250/ 500 ml)  
Nipro Syringe needles (various sizes)  
Sartorius stedim Syringe filter  
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